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Abstract 
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Abstract 
Hormaomycin (HRM) is a nonribosomal peptide antibiotic isolated from Streptomyces 
griseoflavus W-384. It contains several unprecedented nonproteinogenic building blocks 
bearing chlorine, nitro or cyclopropyl moieties (Andres et al., 1989). HRM acts as a bacterial 
hormone by inducing cellular morphogenesis and increasing production titers of antibiotics in 
other Streptomyces spp.. Additionally, HRM is an antibiotic with high potency against 
coryneform actinomycetes (Andres et al., 1990) and also exhibits in vitro activity against a 
range of malarial parasites, such as Plasmodium falciparum (Otoguro et al., 2003). 
 
Studies of HRM biosynthesis have been hampered by genetically inefficient manipulation of 
its producing strain S. griseoflavus W-384. In addition, the inconsistent and low production of 
HRM in wild type strain has prevented us from investigation of its antibacterial and hormonal 
mechanism of action.  
 
In order to address these problems, S. griseosflavus W-384 was firstly optimized for genetic 
engineering. The protoplast transformation system was established, allowing us to introduce 
two types of foreign plasmids (integrative and free-replicating) into this strain. Additionally, a 
conjugation system to mediate plasmid transfer between Escherichia coli and S. griseosflavus 
W-384 was optimized. The results provided the practical procedures to perform further 
molecular analysis of HRM biosynthetic genes. 
 
To enhance the fermentation titres of HRM, the role of its cluster-encoded regulatory genes 
was investigated. A copy of hrmA or hrmB was placed under control of the constitutive ermE* 
promoter on the pWHM4*-based vector and was individually expressed in S. griseosflavus 
W-384, resulting in an increase of HRM production and its analogues as much as 135-fold. 
For the HrmB overproducer, six novel bioactive HRM analogues were isolated and 
characterized. This study demonstrates that HrmA and HrmB are positive regulators in HRM 
biosynthesis. A third regulatory gene, hrmH, was identified as a protein capable of shifting the 
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metabolic profile of HRM and its derivatives. Its manipulation resulted in the generation of an 
additional HRM analogue. 
 
To elucidate the HRM biosynthetic pathway, functional analysis of genes involved in the 
biosynthesis of unusual amino acids was carried out by gene knock-outs as well as genetic 
and chemical complementations. The results suggested that hrmI and hrmJ are essential for 
the biosynthesis of 3-(trans-2’-nitrocyclopropyl)alanine [(3-Ncp)Ala]. Manipulation of hrmD 
revealed its indispensable role in the biosynthesis of 4-propenylproline [(4-Pe)Pro]. 
Additionally, an eighth HRM analogue (HRM A8) was generated by feeding 4-ethinylproline 
[(4-Et)Pro] into hrmD mutant. HRM A8 will be further employed to determine molecular 
target of antibacterial and hormonal activities by “Click chemistry”. The gene knock-out and 
genetic complementation of hrmQ further proved that HrmQ is a halogenase catalyzing the 
chlorination of 5-chloro-1-hydroxypyrrole-2-carboxylic acid [Chpca]. 
 
HRM, as a signaling metabolite, can induce the aerial mycelia formation and sporulation in 
other Streptomyces spp.. To investigate its hormonal mode of action, HRM was tested against 
seven bld mutants derived from well-known Streptomyces coelicolor A3(2) and three bald 
mutants generated from Streptomyces griseus.  
 
By overexpression of pathway-specific activators and mutasynthesis, eight HRM analogues 
were discovered and generated. Antibiotic assays with the eighth new congeners provided 
insights into structure-activity relationship and identified structural positions that could permit 
the generation of active analogs suitable for pull-down studies and target identification. 
Molecular analysis of the biosynthetic genes gave deeper insights into the HRM biosynthesis.  
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Chapter 1 Introduction 
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Chapter 1  Introduction 
1.1 Streptomycetes as antibiotic producers 
Streptomycetes are Gram-positive soil-dwelling filamentous and sporulating bacteria that 
belong to the phylum of Actinobacteria. Over 500 Streptomyces species were discovered, they 
act as a “cleaner” in nature which can break down dead plant or animal matter and make organic 
nutrients available to the ecosystem. Compared to other bacteria, streptomycetes exhibit more 
sophisticated and characterized colonial morphologies. Streptomyces colonies growing on the 
agar plates are usually dry and often excrete colorful pigments, allowing us to visually observe 
the production of secondary metabolites (Figure 1.1).  
 
 
Figure 1.1: The typical morphologies of Streptomyces colonies grown on the agar plates (Photo by 
Tobias Kieser, Celia Bruton and Jennifer Tenor). A, The typical morphologies of Streptomyces colonies 
producing colorful pigments. B, A close view of the colonies of the model strain, Streptomyces 
coelicolor A3(2) producing antibiotic actinorhodin, a blue pigment. 
 
Streptomycetes also possess a very complex developmental life cycle (Figure 1.2) that 
resembles that of filamentous fungi. They reproduce and disperse through the formation of 
spores. The morphological differentiation of Streptomyces spp. is coordinated with 
environmental changes throughout entire developmental program, allowing them to adapt to 
diverse conditions (Hopwood 2007; Flärdh and Buttner 2009). When a Streptomyces spore is 
triggered and germinates in its suitable physiological condition and nutrients, it will grow to 
form filamentous substrate mycelium by extension and branching during taking up the nutrient 
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from the surrounding substrate. In response to the depletion of nutrients and to unidentified 
signals, the substrate mycelium densely interlaces together to generate aerial mycelium. In 
general, the production of antibiotics is initiated at the transition between these two phases 
(Flärdh and Buttner 2009). Aerial hyphae break the surface tension from the substrate and grow 
into the air. Next, the aerial hyphae undergo massive septation and differentiate into a long 
chain of uninucleated compartments. Finally, these compartments develop into mature spores 
containing a single copy of the genome per each and continue with next generation when 
encountering favorable conditions (Hopwood 2007). 
 
 
Figure 1.2: The life cycle of streptomycetes. Modified from (Angert 2005). A free spore germinates 
under favorable conditions, and then grows to form substrate mycelium by extension and branching. 
After ~2 days, substrate mycelium grows away into the air to form aerial mycelium. Finally, the distal 
parts of aerial mycelium undergo septation to develop a chain of spores. The spores get mature and 
released to continue with the next generation. 
 
Streptomyces genomes carry a much higher G + C content (more than 70%) than those of most 
other Gram-positive bacteria, such as Staphylococcus spp., Streptococcus spp., and Bacillus 
spp. (less than 50%) (Hopwood 2006). It is known that streptomycetes possess linear 
chromosomal DNA and plasmids, as compared to the common circular chromosomes and 
plasmids in other prokaryotes. Terminal inverted repeats (TIRs) are situated at both ends of the 
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linear DNA, ranging from 24 to 500 kb with terminal proteins covalently attached to their free 
5’ ends (Sakaguchi 1990; Hopwood 2006). TIRs often exhibit high frequency of genetic 
instability including deletions, amplifications and even circulations during the developmental 
progress of streptomycetes, which has no influence on vitality but may play an important role in 
evolution (Volff and Altenbuchner 1998). The chromosomal DNA is 8-11 Mb in size which is 
twice as large as that of Escherichia coli or Bacillus subtilis (Kieser et al., 1992). The first 
complete genome sequence of Streptomyces coelicolor A3(2) was published in 2002 (Bentley 
et al., 2002). Subsequently, genomic analysis of other species became available in the 
following years, such as Streptomyces avermitilis, an industrial producer of antiparasitic 
compounds avermectins (Ikeda et al., 2003), Streptomyces scabies, the plant scab parasite 
(Loria et al., 2006), and Streptomyces griseus, a producer of the first antituberculosis agent 
streptomycin (Ohnishi et al., 2008). Streptomyces genomes harbor many genes for secondary 
metabolites which group into clusters including biosynthetic, regulatory and resistant genes. 
For instance, the S. coelicolor A3(2) chromosome contains more than 20 gene clusters 
encoding known or predicted secondary metabolites and accounting for 5% of entire genome 
(Bentley et al., 2002). S. avermitilis carries over 30 gene clusters for secondary metabolites, 
which is 6% of the whole genome (Ikeda et al., 2003).  
 
The most attractive property of streptomycetes is the ability to produce numerous secondary 
metabolites with a range of biological activities. Many of these compounds can be used as 
antibacterial, antiparasitic, antifungal, antitumor and immunosuppressive agents in human 
medicine, agriculture, and food industries. Over two-thirds of clinically useful antibiotics are 
produced by Streptomyces spp. (Figure 1.3) (Kieser 2000). 
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Figure 1.3: Clinically useful antibiotics produced by Streptomyces spp.. 
 
For decades, natural products have been the most important source of new drugs. But since 
early 1990s, inappropriate antibacterial treatment and overuse or misuse of antibiotics have 
contributed to the emergence of antibacterial resistance. Thus, antibacterial resistance is a 
major challenge in the discovery of new drugs. Routine screening methods are very difficult 
to discover novel effective antibiotics. To meet this demand, semisynthesis has been utilized 
to modify the present drugs for increasing the stability and potency, but failed to generate 
novel bioactive compounds with structural diversity (Newman 2008). Therefore, recently, lots 
of biologists and chemists have turned attention to marine and unusual environments for 
discovery of new drugs (Fenical and Jensen 2006; Wilson and Brimble 2009). However, this 
does not mean that streptomycetes, as excellent ubiquitous drug producers are exhausted to 
provide new compounds. It was estimated that only 3% of antibiotics from streptomycetes 
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have been characterized so far (Watve et al., 2001).The past decade of research on genetic 
basis of secondary metabolism has provided us some promising strategies to obtain novel 
natural products: (I) Engineering of biosynthetic pathways from different organisms has been 
proven to be an efficient approach to generate natural product-like compounds (Wilkinson and 
Micklefield 2007; Luzhetskyy et al., 2007). (II) Genome sequencing projects have opened up 
exciting new avenues for discovery of new compounds. It is demonstrated that a 
microorganism has the potential to produce far more secondary metabolites than the number 
of verified natural products by bioinformatic analysis of its full genome sequence. However, 
the production of these orphan secondary metabolites is too low to be detected or not active 
under standard fermentation conditions (Challis 2008a). Therefore, activation of such cryptic 
gene clusters or their expression in suitable heterologous hosts may lead to isolation of novel 
interesting natural products.  
 
Polyketides (PKs) and nonribosomal polyketides (NRPs) are two large classes of natural 
products that possess a wide range of functional and structural diversity with a variety of 
bioactivities. To understand the biosynthesis and regulation of these molecules will allow us 
to genetically manipulate the biosynthetic pathway and eventually generate novel natural 
products. In the following sections, a brief introduction to the biosynthesis of these two types 
of compounds will be reviewed, and followed with the three different approaches to obtaining 
new natural compounds by utilizing PKs and NRPs assembly mechanism. In addition, the 
regulation of antibiotic biosynthesis in Streptomyces spp. will be briefly introduced. The final 
part of introduction will be the summary of previous research on the biosynthesis of 
hormaomycin (HRM), a signaling nonribosomal peptide, which provides the foundation for 
this doctoral work. 
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1.2 Biosynthesis of PKs and NRPs 
Many PKs and NRPs compounds have been applied in clinic. The famous examples of PKs 
include the antibacterial erythromycin (Staunton and Wilkinson 1997; Staunton 1998), 
antifungal nystatin (Brautaset et al., 2000), antitumor agent epothilone (Walsh et al., 2003) and 
antiparasitic avermectin (Ikeda and Omura 1995) (Figure 1.4). 
 
 
Figure 1.4: Examples of biologically active PKs. 
 
Some well-known NRPs include antibacterial vancomycin (Samel et al., 2008) and the 
PKs/NRPs anticancer agent bleomycin (Shen et al., 2002) and immunosuppressant cyclosporin 
A (Weber et al., 1994) (Figure 1.5). 
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Figure 1.5: Examples of biologically active NRPs and PKs/NRPs. 
 
1.2.1 Polyketide biosynthesis 
PKs are assembled by multifunctional enzyme complexes called polyketide synthases (PKSs) 
through repetitive decarboxylative Claisen condensations of specific building blocks. PKSs 
typically composed of repeated modules with distinct functions. Each module minimally 
consists of three domains: a ketosynthase (KS), an acyl carrier protein (ACP) and an 
acyltransferase (AT). The starter and extender units are present in the host as coenzyme A (CoA) 
Chapter 1 Introduction 
8 
 
thioesters. PKSs mostly utilize acetyl-CoA or propionyl-CoA as starter units and malonyl-CoA 
and methylmalonyl-CoA as the common extender units. However, malonyl-CoA and 
methylmalonyl-CoA can also be utilized as starter units (Leadlay et al., 2001; Waldron et al., 
2001) and CoA derivatives of other carboxylic acids can also serve as extender units, such as 
ethylmalonyl-CoA and methoxymalonyl-CoA (Reeves et al., 2001; Haydock et al., 1995). The 
simplest starter unit acetyl-CoA is attached to a cysteine thiol of KS domain catalyzing 
condensation. The chain extender unit malonyl-CoA is bound to a thiol residue of ACP. During 
the condensation between acetyl and malonyl units, one unit of CO2 is released to yield an 
extended chain in the form of a β-keto ester bound to the ACP (Figure 1.6). 
 
 
Figure 1.6: Basic steps during polyketide biosynthesis.  
 
The 4’-phosphopantetheine (4’-PP) residue attached to ACP, which functions as a long flexible 
arm that carries the growing chain and delivers it to the KS domain in the following module for 
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the next cycle of chain elongation (Staunton and Weissman 2001). PKS modules often contain 
some additional domains for various functional modifications on the polyketide chain. For 
example, the hydroxyl group is catalyzed by ketoreductase (KR) domain, the removal of H2O 
is caused by dehydratase (DH) domain and the formation of a fully saturated bond is from 
enoyl reductase (ER) domain (Peirú et al., 2010). In general, the initiation and termination 
modules are slightly different from PKS extension modules. An initiation module often lacks 
a KS domain and the starter unit is selected by AT domain and transferred to the ACP domain, 
generating the activated thioester bond (Fischbach and Walsh 2006). The termination module 
takes place at the last stage of polyketide synthesis to release the final polyketide catalyzed by 
the thioesterase (TE) domain (Fischbach and Walsh 2006).  
 
Based on the modular features of the PKSs, PKSs are generally categorized into three types: 
type I, type II and type III PKSs. The PKSs are also can be divided into two classes, iterative 
and noniterative PKSs. Type I PKSs are multimodular megasynthases composed of linearly 
arranged domains. In noniterative type I PKSs, each extension module only catalyzes one 
elongation cycle, which is collinear with the sequence of biosynthetic reactions of PKs. 
Consequently, the chemical structures of the PKs can be predicted according to the order of 
PKSs genes and vice versa (Hertweck 2009). A well-known example is the erythromycin A 
PKS, 6-deoxyerythronolide B (6-dEB) synthase (DEBS) from Saccharopolyspora erythraea 
(Donadio and Katz 1992). One propionate starter unit and six units of methylmalonyl-CoA 
extender are assembled by this PKS to give 6-dEB, as a moiety of erythromycin A. The entire 
PKS (DEBS) consists of three polypeptides, DEBS1, DEBS2 and DEBS3. Each DEBS 
contains two modules that participate in the chain elongation and modification to build up a 
linear polyketide chain that is finally released into 6-dEB catalyzed by TE (Cortes et al., 1990) 
(Figure 1.7).  
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Figure 1.7: The biosynthetic pathway of erythromycin A that is a well-known polyketide assembled 
by type I PKS. Adapted from (Cortes et al., 1990). The entire PKS contain six modules. Each module 
consists of three domains, KS, AT and ACP. Some modules possess optional domains for 
modifications such as, KR, DH, and ER.  
 
However, some recently discovered type I PKSs do not follow the one-to-one correspondence 
relationship between the PKS architectures and the chemical structures of PKs. In these 
enzymes, each module lacks an integral AT domain. As opposed to the cis-AT PKSs, the 
essential AT activities are carried out in trans by free-standing ATs encoded by genes that are 
physically separated from the PKS genes (Piel 2002; Cheng et al., 2003). Therefore, this type 
of PKSs is referred to as trans-AT PKSs. In comparison with cis-AT PKS-derived PKs, the 
metabolite structures assembled by trans-AT PKSs are usually difficult to be predicted 
following the co-linearity rule owing to the presence of several unusual sets of domains. 
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Phylogenetic studies also suggest that multimodularity in cis- and trans-AT PKSs evolved 
independently (Jenke-Kodama et al., 2006). Trans-AT PKS-derived PKs have been isolated 
from many bacteria, insects and marine sponges (Figure 1.8) (Piel 2010), most of which 
possess bioactivities and some may be used as antibiotics or potential anticancer agents. Deep 
investigation of the biosynthetic enzymology of these remarkable natural products will lead to 
the discoveries of novel natural products by combinatorial biosynthesis. 
 
 
Figure 1.8: Examples of bioactive trans-AT PKS-derived PKs. 
 
In contrast to the multimodular enzymes mentioned above, iterative type I PKSs possess one 
large multidomain module carrying all the active sites required for polyketide biosynthesis, The 
single multifunctional protein is used iteratively to catalyze multiple cycles of chain extension 
and subsequent β-keto processing. These PKSs are typically involved in the biosynthesis of 
fungal polyketides, such as 6-methylsalicylic acid (Staunton and Weissman 2001) (Figure 1.9) 
and lovastatin (Kennedy et al., 1999). 
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Figure 1.9: The organization of domains in iterative type I PKSs and biosynthetic pathway of 
6-methylsalycilic acid. A, An iterative type I PKS, is one large multidomain protein assembled by 
following domains, KS, MAT, DH, KR and ACP, which is iteratively used during the polyketide 
biosynthesis. B, Biosynthesis of 6-methylsalycilic acid  
 
Type II PKSs consist of multiple proteins, each of which is mono-functional. An example is the 
aromatic polyketide actinorhodin that is produced by S. coelicolor A3(2), the biosynthesis of 
which is assembled by type II PKSs (Figure 1.10).  
 
 
Figure 1.10: The organization of proteins in type II PKSs and biosynthetic pathway of actinorhodin. A, 
Type II PKSs consist of multiple mono-functional subunits, KS, CLF, ACP, AT, KR, ARO and CYC. B, 
Biosynthetic pathway of actinorhodin. 
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These proteins are used iteratively for the assembly of the polyketide chain. Within type II 
PKSs, the polyketide chain is built up by iterative cycles of elongation while remaining 
covalently tethered to an ACP scaffold and is finally modified through the action of tailoring 
enzymes to yield a structurally complex polycyclic aromatic compound. 
 
Type III PKSs are homodimeric iterative PKSs and contain two independent active sites each of 
which catalyzes single or multiple condensation reactions to generate polyketides with different 
lengths. In contrast to type I and II PKSs, type III PKSs lack ACPs and KSs, but acyl-CoA 
substrates are incorporated directly (Shen 2003). The well-known examples of this family are 
plant-specific naringenin-chalcone synthases (CHSs) and stilbene synthases (STSs), providing 
the starting substances for the biosynthesis of a large number of biologically important 
substances such as phenylpropanoid metabolites (Austin and Noel 2003). CHSs and STSs are 
ubiquitous in plants, but type III PKSs are also present in bacteria such as S. griseus (Funa et al., 
1999) and fungi such as Neurospora crassa (Funa et al., 2007; Rubin-Pitel et al., 2008);. 
 
1.2.2 Nonribosomal peptide biosynthesis 
NRPs are a big family of natural products that are synthesized by nonribosomal peptide 
synthetases (NRPSs), which are found in many bacteria, fungi, sponge and other higher 
organisms. These metabolites exhibit functional biological activities including antibiotics (e.g. 
penicillin, actinomycin, vancomycin, and daptomycin), siderophores (e.g. enterobactin and 
mycobactin), toxins (e.g. microcystins, nodularins, and cyanotoxins), immunosuppressive 
agents (e.g. rapamycin and cyclosporin), and so on (Figure 1.5). The assembly of 
nonribosomal peptide by NRPSs provides an alternative approach for the production of 
polypeptides via a biosynthetic pathway different from the well-known translation mechanism. 
NRPSs are organized in modules, each of which is usually responsible for the incorporation of 
an amino acid into the growing peptide chain (Figure 1.11) (Condurso and Bruner 2012). The 
structural diversity of nonribosomal peptides depends on the number and order of modules 
within NRPSs. Each module minimally consists of an adenylation (A), a thiolation (T) or a 
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peptidyl carrier protein (PCP), and a condensation (C) domain (Fischbach and Walsh 2006; 
Felnagle et al., 2008; Condurso and Bruner 2012). 
 
 
Figure 1.11: The reaction mechanism involved in nonribosomal peptides biosynthesis. Black ball, PCP 
or T domain. 
 
The amino acid residue is selectively activated by A domain as amino acyl adenylate at the 
expense of ATP and Mg
2+
. The thiol moiety 4’PP attached to PCP attacks to the activated 
amino acid to form an aminoacylthioester intermediate via thiolation (Finking and Marahiel 
2004). The C domain is responsible for catalyzing the peptide bond formation between two 
activated amino acids on adjacent modules to yield the growing peptide chain through 
condensation. Additional tailoring domains optionally present in each individual module such 
as formylation (F), cyclization (CYC), oxidation (Ox), reduction (Red), N-methylation (NMT) 
and epimerization (E) for modifications of amino acids. After a series of repeating steps of 
adenylation and condensation, the growing peptide chain reaches the final module containing 
a TE domain. This TE domain catalyzes the release of final product. Very often, the final 
peptide undergoes multiple modifications, such as glycosylation, acylation, halogenation or 
hydroxylation, to yield structurally diverse natural products that exhibit various biological 
activities. Such modification genes are unusually associated with NRPS genes and organized in 
the same gene clusters (Fischbach and Walsh 2006; Felnagle et al., 2008; Condurso and Bruner 
2012). 
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The assembly mechanisms involved in the biosynthesis of NRPs and PKs as well as the 
modular architectures of NRPS and PKS system have provided the basis to generate the 
natural product-like compounds via genetically engineering the known biosynthetic pathways, 
such as combinatorial biosynthesis and precursor-directed biosynthesis. With these 
foundations, novel structurally and functionally diverse natural products can be discovered 
through genome mining.  
 
1.3 Combinatorial biosynthesis 
Since the first hybrid “unnatural” natural product, mederrhodin A, was generated via the 
genetic manipulation of PKS biosynthetic pathway between S. coelicolor A3(2) and 
Streptomyces sp. AM-7161 (Hopwood et al., 1985), combinatorial biosynthesis has become a 
promising and efficient tool for (Floss 2006; Menzella and Reeves 2007) developing novel 
structurally diverse natural products via genetically engineering the biosynthetic pathway of 
natural products. To develop new compounds with potential pharmaceutical use, this strategy 
depends on enzymes with broad substrate tolerance for improving the properties of drugs, such 
as absorption, toxicity and excretion.  
 
Manipulation of modular PKSs and NRPSs has been the major focus of combinatorial 
biosynthesis, contributing to the production of more structurally diverse natural compounds 
libraries (Menzella and Reeves 2007). The modification of compounds by combinatorial 
biosynthesis generally relies on whether this compound is made through linear or branched 
biosynthetic pathway. For example, in the linear biosynthetic pathway, the modifications of 
single or multiple domains in one module of multifunctional PKS involved in erythromycin 
biosynthesis led to 61 different 6-DEB analogs (McDaniel 1999). The novel compounds can 
also be generated by introduction of modification domains involving in glycosylations, 
methylations, oxidations, halogenations, and epimerizations. For instance, the Streptomyces 
peucetius dnmV mutant defective in the biosynthesis of daunosamine, a sugar moiety in 
daunorubicin, was replaced by the eryBIV gene from the erythromycin producer 
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Saccharopolyspora, resulted in a strain producing the antitumor drug of 4’-epidoxorubicin 
(Madduri et al., 1998). Combinatorial expression of hrmQ encoding a halogenase in HRM 
biosynthesis with genes of the clorobiocin gene cluster led to the production of hybrid 
aminocoumarins with an additional chlorine (Heide et al., 2008). However, in a branched 
biosynthetic pathway, the compound is usually assembled from several components 
biosynthesized separately. Each biosynthetic building block can be switched into similar 
components derived from other organisms, leading to the generation of hybrid compounds. For 
instance, novclobiocin 102 or novclobiocin 114 was created by exchange of biosynthetic genes 
involved in novobiocin and chlorobiocin biosynthesis from two different Streptomyces spp. 
(Eustaquio et al., 2004). 
  
In addition to engineering biosynthesis of polyketides, there is current interest in engineering 
NRPSs to generate peptide with potential bioactivities. According to the assembly mechanism 
of NRPSs, the structural diversity of peptides mostly depends on the precursors that can be 
incorporated into nonribosomal peptides, including different amino acids, aromatic acids or 
hydroxyl acids. It is known that the A domain is responsible for recognition, activation, and 
incorporation of different precursors into peptides. Therefore, the substrate selectivity of A 
domain can be changed via mutation of several amino residues in substrate-binding pocket 
(Stachelhaus et al., 1999; Challis et al., 2000; Eppelmann et al., 2002).  
 
1.4 Precursor-directed biosynthesis 
Precursor-directed biosynthesis (PDB) represents a means to generate the analogues of known 
clinically important natural products by feeding unnatural precursors into producing organisms 
(Figure 1.12). These precursors can be recognized and incorporated into the enzymatic 
cascades to give new compounds PDB is often applied in providing a series of structurally 
diverse analogues of PKs and NRPs. Many clinically important natural product analogues have 
been generated successfully via this approach.  
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Figure 1.12: The general principle of precursor-directed biosynthesis and mutasynthesis. 1, a 
substance (in green); 2, a native precursor (in red); 3, a nonnative precursor (in blue); 1+2, a natural 
product; 1+3, a precursor-directed product. A, Natural biosynthesis. 2 is incorporated into 1 to form 
1+2. B, Precursor-directed biosynthesis. 3, as a competitor of 2, is fed into the fermentation culture, 
leading to the production of 1+2 and 1+3. C, Mutasynthesis. The fermentation broth of a mutant strain, 
which is unable to provide 2, is fed with 3, only resulting in the production of a single product 1+3. 
 
There are many successful examples of PDB. The β-lactam antibiotic penicillin V 
(phenoxymethylpenicillin) is generated by adding the phenoxyacetic acid to the fermentation 
broth of Penicillium chrysogenum (Demain and Elander 1999). 15-propargyl erythromycin A, a 
novel antibiotic, as equipotent as the widely used macrolide erythromycin A was generated by 
feeding a set of diketides into an engineered E. coli strain evolved for improved polyketide 
production (Harvey et al., 2012). A library of ammosamides G-P was created through adding a 
variety of aryl and alkyl amines into the fermentation media of Streptomyces variabilis (Pan et 
al., 2013).  
 
However, PBD often leads to a mixture of natural and unnatural products with similar physical 
properties, thus the difficulties in separation of this mixture will be a basic problem for PDB 
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(Kennedy 2008). Thereby, mutasynthesis, as an alternative approach of PDB, is derived from 
PDB. The only difference between these two methods is that the desired novel compound can 
be generated efficiently through mutasynthesis by feeding a particular precursor into a mutant 
strain that is deficient in the natural product biosynthetic pathway.  
 
The principle of mutasynthesis was first proven by the generation of four new analogues of 
neomycin via feeding a mutant of Streptomyces fradiae 3535 unable to synthesize the antibiotic 
neomycin with aminocyclitols streptamine and 2-epistreptamine (Shier et al., 1969). The term 
“Mutasynthesis” was firstly coined by Rinehart et al. (Kenneth 1977) and originally proposed 
to be an alternative approach to classical PDB, leading to increased titres of the target natural 
product analogues with structural diversity (Birch 1963). Many of applications of 
mutasynthesis have been successful since the first demonstration in 1969. Some examples are 
summarized in Table 1.1. 
 
Table 1.1: Some important compounds generated via mutasynthesis. 
Mutants Nonnative precursors Product Activity Reference 
Streptomyces 
avermitilis 
Cyclohexanecarboxylic 
acid 
Doramectin 
 
Antiparasitic 
 
(McArthur 1998) 
Streptomyces 
fradiae 
Streptamines; 
Epistreptamine 
Hybrimycins; 
Neomycins 
Antibiotic 
 
(Shier et al., 1969); 
(Rinehart 1977) 
Streptomyces  
tendae Tü901 
 
 
Pyrimidines;  
Benzoic acid 
derivatives 
Nikkomycin 
X and Z; 
Nikkomycin 
Bx/Bz 
Insecticidal 
and 
acaricidal; 
Antibiotic 
(Delzer et al., 1984); 
(Bormann et al., 1999) 
Pseudomonas 
aeruginosa 
Salicylic acid analogues Pyochelins Iron 
transporter 
(Ankenbauer et al., 
1991) 
Streptomyces 
roseochromogenes 
 
3-dimethylallyl-4-hydro
xybenzoic acid 
analogues 
Clorobiocin 
analogues 
Antibiotic (Galm et al., 2004) 
Streptomyces 
hygroscopicus 
 
4,5-dihydroxycyclohex-
1-enecarboxylic acid 
analogues 
Rapamycin  
analogues 
Anticancer 
agent 
(Ritacco et al., 2005) 
Streptomyces 
parvulus Tü4055 
different dicarboxylic 
acid 
Borrelidin 
analogues 
Antibiotic; 
antimalarial 
(Moss et al., 2006) 
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In addition to the examples listed above, there still remain further important applications of 
mutasynthesis. For instance, reblastatin analogues were generated via adding 
3-amino-5-hydroxybenzoic acid (AHBA) analogues into the mutant of geldanamycin producer 
Streptomyces hygroscopicus K390-61-1, which provide the potential candidates of antitumor 
agents (Rascher et al., 2005). The new ansamitocin derivatives belonging to maytansinoids, as 
“warheads” in tumor-targeted immunoconjugates (Yu 2005), were prepared by feeding 
aminobenzoic acid analogues into fermentation cultures of Actinosynnema pretiosum HGF073 
that is unable to synthesize the required starter unit AHBA, which offer the basis for 
structure-activity relationship (SAR) studies (Knobloch et al., 2011). 
 
PDB has been demonstrated as a powerful tool to yield a series of analogues of known 
important drugs, some of which possesses novel activities. However, it still has limitation that 
the resulting compounds often lack structural diversities. Therefore, recently developed 
genome mining is becoming a promising strategy to discover structurally and functionally 
diverse novel natural products. 
 
1.5 Genome mining for natural product discovery 
Genome mining is a technique to seek and identify genes responsible for the biosynthesis of 
natural products based on the full genome sequence data of a variety of organisms (Figure 1.13) 
(Challis 2008b).  
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Figure 1.13: Genome mining for natural product discovery. 
 
Comparative analysis of whole genome sequences can reveal biosynthetic gene clusters for 
potential new secondary metabolites that are not structurally related to previously uncovered 
compounds and often are overlooked under standard cultivation conditions. The likely reason 
is that the gene clusters encoding these new secondary metabolites are usually silent or barely 
expressed (Winter et al., 2011). The whole genome sequencing of a wide range of organisms, 
including actinomycetes, myxobacteria, cyanobacteria, fungi, and plants revealed the metabolic 
capacities of these organisms to produce a wide range of structurally complex natural products 
with diverse bioactivities. Many novel natural products have been successfully discovered by 
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genome mining, including polyketides, nonribosomal peptides, as well as terpenes (Figure 
1.14). 
 
 
Figure 1.14: Some natural products discovered by genome mining. 
 
The co-linearity rule of modular PKSs and NRPSs has facilitated the logical prediction of the 
structural features of new natural products assembled by these two systems that are unveiled 
by genome sequencing (Fischbach and Walsh 2006). Typically, more than one PKSs or 
NRPSs modules are responsible for the biosynthesis of polyketides or nonribosomal peptides. 
AT domains in PKS modules or A domains in NRPS modules generally share conserved 
sequence motif, which suggests their substrate specificity (Haydock et al., 1995; Stachelhaus 
et al., 1999; Challis et al., 2000). The presence of tailoring domains in individual modules 
often allows us to predict that the metabolic building blocks get modified initially before its 
incorporation into the final products (Fischbach and Walsh 2006). The structural features of 
cryptic metabolites can often be derived via application of the above bioinformatic analysis 
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and their assembly line modular systems (Challis and Ravel 2000; McAlpine et al., 2005; 
Banskota et al., 2006; Nguyen et al., 2008; Chen et al., 2007; Freeman et al., 2012).The 
putative physico-chemical properties of cryptic metabolites also can be predicted based on the 
above derived structural features. Thus, the cryptic products with predicted physico-chemical 
properties can be easily screened and analyzed in their fermentation broths. This approach has 
been successfully employed for discovery of several natural products from cryptic pathways 
(Lautru et al., 2005; McAlpine et al., 2005; Banskota et al., 2006) 
 
The genomisotopic approach is another approach to uncover the cryptic metabolites by 
feeding isotope-labelled predicted precursors of the natural products into the fermentation 
broths of organisms. The target compound can be subsequently identified by radio-liquid 
chromatography-mass spectrometry (radio-LC-MS) or nuclear magnetic resonance (NMR). 
For example, the culture of Pseudomonas fluorescens Pf-5 was fed with L-[
15
N]Leu, enabling 
the targeted purification of the novel cyclic lipopeptide orfamide A guided by 
1
H-
15
N 
heteronuclear multiple-bond correlation spectroscopy (HMBC) NMR (Gross et al., 2007). This 
approach is of value to be applied in the discovery of peptides, particularly peptides containing 
non-proteinogenic building blocks, but less useful in polyketide targeting.  
 
Another very important approach to unveil unknown metabolites is comparative metabolic 
profiling of wild type and mutants. For this purpose, the essential genes involved in PKSs and 
NRPSs governing the biosynthesis of secondary metabolites have to be inactivated. Subsequent 
comparative metabolic profiling between wild type and its mutants by high performance liquid 
chromatography (HPLC) shows the corresponding natural compounds in the wild type strain. 
For instance, myxochromides S1-3 (Figure 1.14) isolated from Stigmatella cellulosum are 
identified by this approach (Wenzel et al., 2005), and bacillaene B from Bacillus 
amyloliquefaciens FZB 42 (Figure 1.14) assembled by trans-AT PKS/NRPS (Chen et al., 2006; 
Moldenhauer et al., 2010).  
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Heterologous expression of entire cryptic gene clusters has become a promising alternative way 
to detect the corresponding natural products. The sav76 gene encoding the terpene synthase of S. 
avermitilis was heterologously expressed in E. coli (Chou et al., 2010). Incubation of resulting 
protein with farnesyl diphosphate led to the isolation and characterization of avermitilol 
(Figure 1.14) which was not detected in the wild type strain, S. avermitilis (Chou et al., 2010). 
Extra copies of sav76 were introduced into the genome-minimized S. avermitilis mutant 
(Komatsu et al., 2008) under control of the native promoter, which led to the production of 
avermitilol, along with small amounts of avermitilone, germacrene A, B and viridiflorol. The 
corresponding terpene synthases have been determined in the S. avermitilis genome (Chou et 
al., 2010). It also has been demonstrated that cryptic microviridin gene clusters from 
cynobacteria can be heterologously expressed in E. coli (Ziemert et al., 2010). 
 
In addition to the approaches described above, some other strategies also have been applied in 
activation of silent gene clusters to obtain the novel natural products. For instance, comparative 
metabolic profiling (Bok et al., 2006; Bergmann et al., 2007), in vitro reconstitution (Lin et al., 
2006) and cocultivation of different organisms to trigger the expression of silent gene cluster 
(Bertrand et al., 2013; König et al., 2013). 
 
Natural product biosynthesis is often governed by complex regulation systems in their 
organisms. It has been demonstrated that manipulation of regulatory genes located in silent 
gene clusters can lead to the discovery of novel natural products (Gottelt et al., 2010; 
Bergmann et al., 2007). The genus Streptomyces is a very important source for natural 
products, the genome of which contains dozens of secondary metabolites gene clusters 
besides those for characterized compounds (Bentley et al., 2002). The regulation system in 
Streptomyces spp. is particularly complex and controls not only gene expression during 
development but also at the onset of antibiotic production (Bibb 2005). Thereby, investigation 
of regulatory genes in Streptomyces spp. can provide important insights into drug discovery.  
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1.6 Regulation of antibiotic biosynthesis in Streptomyces spp. 
Previous studies suggested that the expression of physically distinct gene clusters in the 
chromosome are usually subjected to multiple levels of regulation (Bibb 2005; Huang et al., 
2005). The regulators encoded by genes located within gene clusters are referred to as 
pathway-specific regulators. Such regulators often play a key role in triggering the expression 
of their own biosynthetic gene clusters, which belong to “low level” regulators. Some of these 
regulators are the only key factors in triggering the onset of antibiotic biosynthesis. 
Overexpression of such regulatory genes may lead to the significant increase of antibiotic 
production (Gramajo et al., 1993). The onset of the antibiotic biosynthesis is often coordinately 
controlled by both pathway-specific regulators and pleiotropic regulators. In contrast to 
pathway-specific regulatory genes, pleiotropic regulatory genes are usually situated outside of 
the biosynthetic gene clusters and involved in the regulation of multiple antibiotics biosynthesis 
and morphological differentiation in a “ higher level” way (Huang et al., 2005). 
 
Pathway-specific regulators can be broadly classified into two families, SARP (Streptomyces 
antibiotic regulatory protein) family, and LAL (Large ATP-binding regulators of the LuxR) 
family (Bibb 2005). SARPs, are also known as OmpR family containing an OmpR-like 
DNA-binding domain, which have been found involved in the regulation of production of a 
wide variety of secondary metabolites. For example, ActII-ORF4 and RedD governing the 
production of actinorhodin (ACT) and undecylprodigiosin (RED), respectively in S. coelicolor 
A(3)2 (Arias et al., 1999; Takano et al., 1992); Takano et al., 1992), and SfmR2 and SfmR3 
controlling saframycin production in Streptomyces lavendulae (Li et al., 2008). Among above 
examples, it has been shown that actII-ORF4 and redD are positive regulatory genes that 
contain TTA codon as a special feature. However, some exception still exists. For instance, 
AfsR, as one of well-understood SARP family proteins, belonging to pleiotropic regulators, is 
encoded by afsR gene which is located outside of any gene cluster in S. coelicolor A3(2) and it 
has direct or indirect effect on at least two secondary metabolites biosynthesis. Relative to the 
SARP family, the LAL family is little understood of their overall role in the regulation of 
Chapter 1 Introduction 
25 
 
antibiotics production. These proteins possess an ATP/ADP-binding domain at the N terminal 
end and a DNA-binding domain at the C terminal end (Henikoff et al., 1990). For example, 
PikD involved in pikromycin production and three LAL homologues encoded in nystatin gene 
cluster (Wilson et al., 2001). Studies about the mutation or deletion of these proteins suggest 
the presence of a more complex regulatory cascade governing the production of these natural 
products (Bibb 2005).  
 
The pleiotropic regulators characterized so far mostly respond to environmental changes such 
as nutrition conditions, pH or temperature, and function as global regulators to control both 
morphological differentiation and secondary metabolites in Streptomyces spp.. Stress caused by 
nutritional limitations can contribute to the generation of intracellular signaling messengers. 
For instance, when S. colicolor A3(2) is grown on media under conditions of amino acid 
starvation, the pleiotropic regulatory gene, relA is triggered and translated into a stringent factor 
ppGpp (Chakraburtty and Bibb 1997). This signaling molecule subsequently governs the 
antibiotic biosynthesis in S. coelicolor. Growing the relA mutant under the condition of 
nitrogen limitation leads to the defective biosynthesis of ppGpp, which fails to produce ACT 
and RED (Hesketh et al., 2001; 2007). These results indicate that ppGpp directly activates the 
pathway-specific regulators of ActII-ORF4 and RedD for the production of ACT and RED 
(Hesketh et al., 2007). Except for the failure in the biosynthesis of ACT and RED, the relA 
mutant shows a remarkable effect on morphological differentiation. The mutant exhibits a 
large white colony that is conspicuously different from the small grey colony from wild type 
strain (Chakraburtty and Bibb 1997). However, the phenotype of relA mutant can be restored 
by growing under conditions of phosphate limitation (Hesketh et al., 2001). DasR, a pleiotropic 
transcriptional repressor, inhibits the production of antibiotics. The inactivation of dasR 
represses the chitin degradation and triggers the accumulation of N-acetylglucosamine 
(GlcNAc), a signaling molecule, and switches on the morphological development and 
antibiotic production (Rigali et al., 2008). Cyclic AMP receptor protein (Crp), as a master 
transcription regulator governs various cellular processes in many bacteria (Korner et al., 
2003). In S. coelicolor A3(2), Crp binds to eight of 22 gene clusters and plays a key role of 
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controlling morphological development and antibiotics production (Derouaux et al., 2004a; 
2004b). Overexpression of Crp leads to the upregulation of ACT, calcium-dependent antibiotic 
(CDA) and RED in S. coelicolor A3(2) (Gao et al., 2012). Introduction of Crp into different 
Streptomyces species activates the cryptic gene clusters to generate new secondary metabolites 
(Gao et al., 2012). These findings suggest that Crp, as a global regulator, provides a powerful 
tool for tapping the novel natural products with potential bioactivities. 
 
The pleiotropic regulatory genes mentioned above mainly affect the antibiotics production. 
There are bifunctional regulators with indirect pleiotropic effect on secondary metabolites and 
direct influence on morphological differentiation, exemplified by the well-known bld genes in 
S. coelicolor A3(2). Mutants of bld genes fail to form aerial mycelia and subsequent sporulation, 
called “bald” mutants (Merrick 1976). These bald mutants are defective in secondary 
metabolism and colony appearance. For example, bldA encodes the only tRNA in Streptomyces 
recognizing leucine codon UUA. Its mutant loses the capacity to form aerial hyphae and 
produce antibiotics. The deficient antibiotics production in bldA mutant is partially due to the 
presence of TTA codons in pathway-specific regulatory genes controlling the biosynthesis of 
secondary metabolites (Chater and Chandra 2008).  
 
In addition to pathway-specific and pleiotropic regulators, the antibiotic biosynthesis is also 
controlled by extracellular signaling hormones, such as, γ-butyrolactones produced by many 
streptomycetes. Initially, γ-butyrolactone was discovered in S. coelicolor A3(2); however, since 
the regulation system in S. coelicolor A3(2) is very complex and involves many regulatory 
cascades, the mechanism is still not clear. The characterized γ-butyrolactone is 
2-isocapryloyl-3R-hydroxymethyl-γ-butyrolactone (A-factor) isolated from S. griseus 
(Horinouchi and Beppu 1992). In general, A-factor is required for development and secondary 
metabolism. AsfA is essential for the biosynthesis of A-factor. When the concentration of 
A-factor reaches a critical point, A-factor binds to the A-factor-specific receptor (Arp) attached 
to the promoter of adpA. Then, Arp is released from the promoter, leading to the transcription of 
adpA. AdpA belongs to AraC/XylS transcriptional regulator family, and activates the 
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transcription of strR, the pathway-specific regulatory gene for streptomycin biosynthesis, and 
induces the expression of other regulators involved in the morphological differentiation 
(Ohnishi et al., 1999; 2005) (Figure 1.15). Among these are AmfR that induces the subsequent 
expression of the SapB ortholog to initiate aerial-hypha formation, SsgA required for the 
regulation of sporulation septation, and σAdsA, an extracytoplasmic function (ECF) sigma factor 
of AdsA that is only involved in aerial mycelium formation (Horinouchi 2007).  
 
 
Figure 1.15: The A-factor signaling cascade in S. griseus (Adapted from Flärdh and Buttner, 2009). 
AfsA is required for the biosynthesis of A-factor. When A-factor accumulates, it will bind to its own 
receptor ArpA, which subsequently activate the expression of Adp regulon. AdpA, as a global regulator 
governs the expression of downstream genes involved in aerial mycelium formation, sporulation and 
secondary metabolism. 
 
1.7 Aerial mycelium formation in Streptomyces spp. 
The striking features of morphological differentiation in streptomycetes are the formation of 
aerial hyphae and subsequent sporulation presenting a fluffy grey lawn on the colony surface. S. 
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coelicolor A3(2) serves as a model for studies of both morphological development and 
secondary metabolism. The bld genes are involved in the onset of aerial mycelium formation 
(Horinouchi 1996). Many bld mutants have been generated that are defective in forming aerial 
hyphae (Lawlor et al., 1987; Nodwell et al., 1996; Elliot 1998; Pope et al., 1998; Bibb 2000; 
Bignell 2000; Molle and Buttner 2000). All the bld genes in S. coelicolor are part of a complex 
extracellular signaling cascade to regulate the aerial mycelium formation. The effect of bldA on 
morphological differentiation occurs through the UUA codon in the mRNA of bldH (Lawlor et 
al., 1987). BldH is analogous to AdpA in S. griseus controlling the development and secondary 
metabolism (McCormick and Flardh 2012). Most of bld mutants can be restored to form aerial 
hyphae and produce antibiotics completely or partially when they are grown on the medium 
with poor carbon sources, except for the bldB mutant (Willey et al., 1993). The bldB gene 
encodes a DNA-binding protein, involved in catabolic repression in Streptomyces. Mutation of 
bldB results in complete loss of antibiotics production and defective morphological 
differentiation (Pope et al., 1998). BldC is a putative transcriptional activator which belongs to 
the MerR family. The bldC mutants are defective in differentiation and antibiotic production on 
minimal medium and show severe delay on the aerial mycelium formation on rich medium 
(Hunt et al., 2005). BldD, as a small DNA-binding protein can bind to the promoters of whiG, 
bldN and sigH (Elliot 1998; 2001).The bldG gene encodes a developmental anti-anti-sigma 
factor, as a regulator of stress response involved in antibiotic production and sporulation 
(Bignell 2000). BldK is an oligopeptide importer that is responsible for the import of an 
extracellular signal molecule that can induce the production of secondary extracellular signal 
molecule acting on the products of bldA and bldH to initiate the development and secondary 
metabolism (Nodwell et al., 1996). σBldN encoded by bldN is a ECF family sigma factor that is 
analogous to that of σBldN in S. griseus , which is required for aerial mycelium formation in S. 
coelicolor (Bibb 2000). BldM, as the only known target of σBldN, is an atypical response 
regulator for following biological action in morphological development and secondary 
metabolism (Molle and Buttner 2000). 
 
Small surface-active peptide (SapB) is required for coating the surface of S. coelicolor hyphae 
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in a hydrophobic sheath, allowing the hyphae to escape from the aqueous colony and to form 
aerial mycelium in the air (Willey et al., 1991). Extracellular complementation studies have 
demonstrated that the aerial hyphae formation of all the characterized bld mutants can be 
restored by the growth of bld mutants near wild-type S. coelicolor strain or addition of purified 
SapB protein (Willey et al., 1993). These findings suggest the important role of SapB in 
morphogenesis. SapB has been structurally characterized as a lantibiotic-like peptide, derived 
from ramS gene in ram gene cluster (Kodani et al., 2004). It shows no antibiotic activity but 
acts as an extracellular signal for the initiation of development (Kodani et al., 2004). In addition 
to SapB, there are at least two classes of other proteins, the chaplins and the rodlins, involved in 
the synthesis of the hydrophobic sheath (Flärdh and Buttner 2009; Chater 2001). The deletions 
of all chaplin genes in Streptomyces result in the failure of aerial mycelium formation on either 
poor or rich medium. The expression of SapB depends on the presence of chaplins (Capstick et 
al., 2007).  
 
It has been demonstrated that the bld genes are required for the production of SapB and chaplins 
on rich medium (Capstick et al., 2007; Nodwell and Losick 1998; Willey et al., 1991; Willey et 
al., 1993). A hierarchical extracellular signaling cascade has been proposed based on the studies 
of extracellular complementations among all characterized bld mutants (Willey et al., 1991; 
Willey et al., 1993; Nodwell et al., 1996; Nodwell and Losick 1998). Based on this scheme 
(Figure 1.16), the bldJ mutant is defective at the earliest step in sending signal 1 proposed to be 
an extracellular oligopeptide which is uptaken by the BldK oligopeptide permease. The bldK 
and bldL mutants can secret signal 1, but fail to produce signal 2. Mutations of bldA and bldH in 
S. colicolor are capable of producing both signal 1 and signal 2, but unable to make signal 3, the 
subsequent steps in the signaling of bldG, bldC, bldD and bldK mutants perform in the same 
way. Therefore, the bldJ mutant can accept and respond to the signals sent by any of other 
mutants defined in the cascade to develop aerial mycelium, but bldJ mutant itself is unable to 
provide the signals facilitating the aerial growth of any of other mutants. But the bld gene effect 
is not as simple as this cascade. For instance, bldB and bldN mutants can not be stimulated by 
any other mutant (Nodwell and Losick 1998). The reason for this is still unknown. 
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Figure 1.16: Extracellular signaling cascade involved in aerial mycelia formation in S. coelicolor 
(Adapted from Chater 1998). 
 
1.8 Hormaomycin and its biosynthesis 
Hormaomycin (HRM) was first isolated from a fermentation broth of Streptomyces sp. 
AC-1978 (Omura et al., 1984). The compound has been partially characterized by Omura et al., 
named as takaokamycin (Omura et al., 1984). HRM was isolated again from Streptomyces 
griseoflavus W-384 in the Zähner group (Andres et al., 1990; Andres et al., 1989). Subsequent 
structural elucidation was carried out, revealing an unusual depsipeptide with an extraordinary 
structure (Figure 1.17). It consists of eight building blocks, L-isoleucine [L-Ile] as the only 
proteinogenic amino acid, along with six non-proteinogenic amino acids, two units of 
(2S,3R)-3-methylphenylalanine [(β-Me)Phe], one of D-allo-threonine [D-allo-Thr], two units 
of 3-(trans-2’-nitrocyclopropyl)alanine [(3-Ncp)Ala], one unit of 4-(Z)-propenylproline 
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[(4-Pe)Pro] as well as one residue of 5-chloro-1-hydroxypyrrole-2-carboxylic acid [Chpca] 
(Figure 1.17). The latter three components are to date unique (Andres et al., 1989; Rössner et 
al., 1990).  
 
 
Figure 1.17: The bacterial hormone hormaomycin (HRM) (left) and the antifungal nonnatural analogue 
hormaomycin D2 (right) obtained from feeding 5-nitronorvaline [(NO2)Nva] into the fermentation 
culture of S. griseoflavus W-384. 
 
HRM belongs to the few known signaling metabolites (Figure 1.18) (Recio et al., 2004; Kondo 
et al., 1988; Kitani et al., 2011; Horinouchi 2002; Igarashi et al., 2001) acting as autoregulators 
that are effective in morphological differentiation such as aerial mycelia formation and 
stimulation of antibiotic production in other Streptomyces species (Andres et al., 1990). 
Additionally, HRM itself is an antibiotic with extremely potent activity against coryneform 
actinomycetes at picomolar concentrations (Andres et al., 1990). The HRM antibacterial and 
hormonal mechanism of action is so far unknown. HRM also exhibits high in vitro activity 
against the causative agent of malaria tropica, Plasmodium falciparum (Otoguro et al., 2003).  
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Figure 1.18: Some examples of low-molecular signals from streptomycetes. 
 
Previous feeding studies (Brandl et al., 2005; Höfer et al., 2011) to investigate the precursors 
of the unusual building blocks established the precursors of the moieties in HRM. These are 
L-Pro for Chpca, L-Phe for (β-Me)Phe, L-Tyr for (4-Pe)Pro and L-Lys and 4-hydroxy- L-Lys 
for (3-Ncp)Ala. However, the precise steps during these transformations are so far unknown. 
Some genes involved in the biosynthesis of these building blocks have been identified. For 
example, the hrmQ gene, predicted to encode a halogenase, has been integrated into the 
clorobiocin pathway, resulting in the generation of a novel clorobiocin with a 5-chloro-pyrrole 
moiety analogous to the starter unit of HRM by combinatorial biosynthesis (Heide et al., 
2008). These results established that HrmQ acts as a chlorinase catalyzing the chlorination 
involved in Chpca formation. Another well-studied gene is hrmF, encoding an iron-dependent 
oxidoreductase which performs the cleavage of L-3,4-dihydroxyphenylalanine (L-DOPA). The 
enzyme was kinetically characterized and exhibits a Km of 3.35 μM and a kcat of 57.8 min
-1 
(Höfer et al., 2011) . Interestingly, HrmF was incubated with L-DOPA analogues and able to 
cleave a wide range of catechol derivatives, including unsubstituted catechol, revealed its 
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flexible substrate specificity (Höfer et al., 2011).  
 
In addition, novel HRM analogues were generated by feeding several modified amino acids 
into the fermentation broth of S. griseoflavus W-384 via precursor-directed biosynthesis. The 
resulting analogues possess variations at the positions of (3-Ncp)Ala and (β-Me)Phe 
(Kozhushkov et al., 2005; Zlatopolskiy and de Meijere 2004; Zlatopolskiy et al., 2006). 
Comparison of the bioactivities of these analogues to those of HRM has revealed a HRM 
analogue hormaomycin D2 (Figure 1.17) incorporated (NO2)Nva unit with new antifungal 
activity against Candida albicans with a similar potency as the clinically used fungicide 
nystatin (Radzom 2006). These results have demonstrated that chemical structural variations 
can lead to the generation of novel bioactive peptides and also indicate that the A domains in 
NRPS involved in assembling HRM exhibit considerable substrate flexibility, which is very 
appealing to generate novel bioactive HRM derivatives by metabolic engineering and 
mutasynthesis. 
 
Due to the intriguing structure and diverse bioactivities of HRM, the HRM biosynthetic gene 
cluster was isolated to characterize its biosynthesis (Höfer et al., 2011). A 48,409 bp region of 
23 ORFs (hrmA to hrmW) was identified that could be convincingly attributed to HRM 
biosynthesis. The overall architecture of the gene cluster resembles other nonribosomal 
systems and consists of two giant NRPS genes surrounded by other biosynthetic gene 
candidates involved in amino acid biosynthesis, regulation and transport (Figure 1.19).  
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Figure 1.19: Organization of the hormaomycin (HRM) biosynthetic gene cluster from S. griseoflavus 
W-384. Genes proposed to be involved in precursor biosynthesis are labeled in yellow, green, blue and 
orange. The SCO labels above genes shown in black refer to close homologs present in the S. 
coelicolor genome. 
 
The functions of proteins encoded by hrm genes were deduced, as shown in Table 1.2 (Höfer 
et al., 2011). 
 
Table 1.2: Proposed functions of proteins involved in hormaomycin (HRM) biosynthesis (Höfer et al., 
2011). 
Protein Amino 
Acids 
Proposed Function Sequence Similarity 
(protein, origin) 
Similarity/ 
Identity 
Accession 
Number 
HrmA 
 
HrmB 
 
HrmC 
 
HrmD 
 
HrmE 
HrmF 
 
HrmG 
 
HrmH 
 
321 
 
197 
 
358 
 
298 
 
326 
185 
 
599 
 
132 
 
AraC-type transcriptional  
regulator 
Positive regulator 
 
Methyltransferase 
 
F420-dependent 
oxidoreductase  
Tyrosine hydroxylase 
DOPA-cleaving 
oxidoreductase  
γ-Glutamyl transpeptidase 
Endoribonuclease 
Putative regulator 
 
SCO0287, Streptomyces 
coelicolor  
NovE, Streptomyces 
caeruleus  
LmbW, Streptomyces 
lincolnensis 
SCO3591, S. coelicolor 
 
LmbB2, S. lincolnensis 
TomH, Streptomyces 
achromogenes 
LmbA, S. lincolnensis  
 
YjgH, Kinetococcus 
radiotolerans 
84/75 
 
73/60 
 
72/57 
 
63/52 
 
55/47 
69/61 
 
73/64 
 
80/60 
 
CAB54172 
 
AAF67498 
 
CAA55769 
 
CAA22223 
 
CAA55748 
ACN39014 
 
CAA55746 
 
YP_001362405 
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Protein Amino 
Acids 
Proposed Function Sequence Similarity 
(protein, origin) 
Similarity/ 
Identity 
Accession 
Number 
HrmI 
 
 
HrmJ 
 
HrmK 
 
HrmL 
 
HrmM 
 
HrmN 
 
HrmO 
 
 
HrmP 
 
 
HrmQ 
 
HrmR 
HrmS 
 
HrmT 
 
HrmU 
 
HrmV 
 
HrmW 
350 
 
 
227 
 
527 
 
91 
 
388 
 
389 
 
5252 
 
 
3471 
 
 
448 
 
72 
329 
 
301 
 
427 
 
156 
 
563 
unknown 
 
 
unknown 
 
Acyl-CoA-Synthetase  
 
Type II peptidyl carrier 
protein  
Acyl-CoA dehydrogenase  
 
Acyl-CoA dehydrogenase  
 
NRPS 
(C-A-PCP-C-A-PCP-E-C-
A-PCP-C-A-PCP-E) 
NRPS 
(C-A-PCP-C-A-PCP-C-A-
PCP-TE) 
Halogenase  
 
MbtH Homolog 
Methyltransferase  
 
Diaminopimelate 
epimerase  
Integral membrane 
antitransporter 
ABC transporter ATP 
binding protein  
Intergral membrane 
protein 
PSPTOT1_5436, 
Pseudomonas syringae 
pv. Tomato 
PSPTOT1_5541, P. 
syringae pv. Tomato  
CaiC, Oscillatoria sp. 
PCC 6506 
VinL, Streptomyces 
halstedtii 
MoeH5, Streptomyces 
clavuligerus 
Strop_4265, Salinispora 
tropica 
RHA1_ro00141, 
Rhodococcus sp. RHA 
 
PstC, Streptomyces 
ghanaensis 
 
ChlB4 Streptomyces 
antibioticus 
SCO3218, S. coelicolor 
MppJ, Streptomyces 
hygroscopicus 
DAPF2 (SAV3161), S. 
avermitilis 
CZA382.28, 
Amycolatopsis orientalis 
ABC-transporter, 
Streptomyces cattleya 
JNB_10189, Janibacter 
sp. HTCC2649 
72/57 
 
 
70/51 
 
50/34 
 
59/40 
 
51/33 
 
49/36 
 
40-60% 
domain 
identity 
40-60% 
domain 
identity 
79/64 
 
81/58 
67/52 
 
63/47 
 
68/56 
 
78/66 
 
38/26 
ZP_03398361 
 
 
ZP_03398362 
 
ZP_07113995 
 
BAD08369 
 
YP_002190358 
 
YP_001161071 
 
YP_700135 
 
 
ZP_06575792 
 
 
AAZ77674 
 
CAB38589 
AAU34201 
 
BAB69347 
 
CAB45049 
 
AEW99195 
 
ZP_00994281 
 
Eight homologs of PCP have been identified, which are proposed to covalently bind the eight 
building blocks during HRM biosynthesis. One of them is a free-standing PCP encoded by 
hrmL gene, the others are integrated into each module of NRPSs HrmO and HrmP (Figure 
1.20). 
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Figure 1.20: The assembly of HRM biosynthesis. Numbers represent the start of each individual NRPS 
module (Höfer et al., 2011). 
 
Comparative bioinformatic analysis of NRPSs genes (Crüsemann et al., 2013) have revealed 
that many of the modules exhibit high DNA similarity to each other. Particularly, the regions 
encoding A domains responsible for the activation of amino acids showed more than 90% 
nucleotide identity. For example, in HrmO, the first A domain (HrmO1A) and the fourth A 
domain (HrmO4A) both can activate (3-Ncp)Ala, and the third A domain in HrmO (HrmO3A) 
and the first A domain in HrmP (HrmP1A) are both able to activate (β-Me)Phe (Crüsemann et al., 
2013). Remarkably, even some A domains activating different amino acids also share high 
DNA identity, with the exception of a core region around 400 bp encoding the binding-pocket 
residues to determine the substrate specificity (Stachelhaus et al., 1999). Such phenomenon 
suggested that A domains underwent recombination during evolution, leading to a switch of 
substrate specificity.  
 
All native A domains involved in HRM biosynthesis have been heterologously expressed in E. 
coli, but initially did not exhibit significant activities in vitro. Subsequently, it has been 
demonstrated that many A domains show activities in vitro only when coexpressed with a small 
MbtH-like protein. MbtH-like proteins therefore act as integral components of many NRPSs 
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(Felnagle et al., 2010). Since HrmR is a homolog of MbtH encoded in the hrm gene cluster, 
subsequent coexpression of each A domain with HrmR was carried out. The resulting domains 
were subjected to a γ[18O4]-ATP mass exchange assay to determine and characterize their 
amino acid selectivities (Phelan et al., 2009). Some domains showed substrate flexibility, 
especially HrmP2A, which prefers to activate valine in vitro over the native isoleucine 
(Crüsemann et al., 2013; Crüsemann 2012). 
 
Evolution-guided A domain engineering studies were performed by fusion of the outer regions 
of one A domain with the core of other A domains. This yielded three engineered A domains, 
O2fA, O4fA and P2fA (Crüsemann 2012; Crüsemann et al., 2013). These fused A domains were 
coexpressed with HrmR, and characterized by A domain exchange assay, showing that a swap 
of the core can change the substrate specificity. The results provide insights into the HRM 
biosynthetic pathway, facilitating the generation of novel HRM analogues by mutagenesis. The 
high substrate selectivity of (3-Ncp)Ala and (4-Pe)Pro activating A domains in vitro also 
support that these two unique amino acids are biosynthesized before being loaded onto the PCP 
and assembled by the NRPS. 
 
The studies described above have provided insights into HRM building block selection and 
assembly of this unique peptide. To elucidate the precise HRM biosynthetic pathway, the hrm 
genes had to be studied by gene knock-out, for which no protocol was available, and 
complementation in vivo, as well as by expression of genes for further enzymatic assays in 
vitro. Establishment of a gene knock-out system can also facilitate the generation of HRM 
analogues through mutasynthesis. Furthermore, the HRM antibacterial and hormonal mode of 
action was not known at this stage. 
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Chapter 2   Research Goals 
Hormaomycin (HRM) possesses a remarkable structure with a variety of bioactivities, which 
contains several unique building blocks. The special characteristics of HRM promoted us to 
investigate its unusual biosynthesis and antibacterial and hormonal mechanism of action. The 
HRM biosynthetic gene cluster has been isolated and sequenced recently, which gave us the 
opportunity to study and to genetically modify the biosynthetic pathway. 
 
However, the lack of a genetic manipulation system of the HRM producer has hampered the 
investigation of HRM biosynthetic pathway at the molecular level. The first goal of this work 
was to optimize the genetic manipulation system of HRM wild-type producer S. griseoflavus 
W-384 by establishing efficient conditions for the introduction of foreign DNA via 
PEG-mediated protoplast transformation and conjugation. 
 
HRM production by S. griseoflavus W-384 is very erratic and only provides small amounts of 
compound. Therefore, the second goal of this study was to increase the production of HRM as 
a basis for further investigation of the antibacterial and hormonal mechanism of action. For this 
purpose, two putative pathway-specific positive regulatory genes, hrmA and hrmB were 
individually introduced into S. griseoflavus W-384 or inactivation of the putative negative 
regulatory gene hrmH to test whether this yields HRM overproducers. 
  
The structural variation of a compound often facilitates slight to dramatic shifts in the 
pharmacological profiles of the compound. The analysis of HRM biosynthetic genes was 
supposed to allows us to better understand HRM biosynthesis, which served as the basis for 
the generation of HRM analogues. In this work, several genes involved in biosynthesis of the 
unusual building blocks, hrmQ for Chpca, hrmI, hrmJ for (3-Ncp)Ala, and hrmC, hrmD, 
hrmN for (4-Pe)Pro were analyzed via gene knock-outs as well as genetic and chemical 
complementations. The resulting knock-out mutants were employed to generate HRM 
analogues through mutasynthesis for SAR studies.   
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HRM acts as a bacterial hormone that can induce aerial mycelium formation in other 
Streptomyces. It is well-known that the formation of aerial mycelium in the model strain S. 
coelicolor A3(2) is governed by a regulatory cascade involving products of the bld genes 
(bldJKLAHGCDM). HRM was exposed to the regulatory bald mutants that are defective in 
the formation of aerial mycelium and derived from S. coelicolor A3(2) to test whether this 
peptide could restore aerial mycelium formation. This possibly provided us insights into 
determination of the molecular target in the signaling cascade for HRM to initiate the aerial 
mycelium formation. 
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Chapter 3  Results and Discussion 
3.1 Establishment of genetic manipulation system in S. griseoflavus W-384 
The genetic manipulation of Streptomyces spp. began in the Hopwood`s lab in the early 1970s 
(Chater 1999; Hopwood 1999). Most of work was dealing with the establishment of efficient 
methods for DNA transformation (Bibb et al., 1978; Matsushima and Baltz 1985), conjugation 
(Mazodier et al., 1989; Flett et al., 1997)and transduction as well as construction of DNA 
cloning system and discovery and applications of transposons (Hahn et al., 1991). All the 
previous studies paved the way for modern genetic manipulation in Streptomyces spp.. The 
continuous studies on the genetic features of Streptomyces and the gradual improvement of 
gene cloning techniques have contributed significantly to the rapid development of genetic 
manipulation in Streptomyces spp., such as Red/ET recombination systems. This has allowed 
researchers to modify Streptomyces spp. genetically and to generate its mutants efficiently 
(Datsenko and Wanner 2000; Gust et al., 2003), to establish heterologous expression systems 
making the expression of genes of interest much easier as well as to perform combinatorial 
biosynthesis as a powerful tool in attempts of generating novel “unnatural natural products” 
(Pfeifer et al., 2002; Hopwood et al., 1985). However, Streptomyces is a highly divergent genus. 
Within this genus, there is a major genetic difference between different species. Therefore, 
development of the best genetic manipulation systems is a crucial step towards further studies 
for each individual strain. 
 
In general, the optimization of genetic manipulation system in Streptomyces spp. is 
accomplished by PEG-assisted protoplast fusion and conjugation based on the model strain S. 
coelicolor A3(2). The PEG-assisted protoplast fusion for Streptomyces spp. was firstly 
developed in 1977 and readily applied for foreign DNA transformation, thereby facilitating 
genetic engineering of this commercially important genus (Hopwood et al., 1977; Baltz and 
Matsushima 1981). This includes harvesting of mycelia, removal of cell wall, filtration of 
protoplast and PEG-induced fusion between DNA and protoplasts (Nybo et al., 2010; Zhou et 
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al., 2008). Conjugation is the intergeneric transfer of plasmids from E. coli to Streptomyces 
strains, which was initially reported by Mazodier et al (1989) (Flett et al., 1997). The vectors 
containing the appropriate origin of transfer (oriT) require transfer functions to be supplied by 
E. coli donor strain carrying the plasmid that provides tra gene (Figure 3.1). 
 
 
Figure 3.1: Conjugation system from Escherichia coli to Streptomyces spp.. The plasmid carrying tra 
gene can express a transfer protein for helping the plasmid with oriT get through the tunnel between two 
cells to the side of Streptomyces spp.. 
 
Previous studies indicated that genetic manipulations in S. griseoflavus W-384 was very 
difficult (unpublished data), which hampered functional studies on HRM biosynthetic genes. 
Hence, it was necessary to establish and optimize the genetic manipulation system of this 
strain in order to transform foreign DNA easily for further gene knock-out, expression and 
modification. Furthermore, the efficient transformation system would also provide us with the 
possibility to screen for high-yielding strains. Sequencing the whole genome of S. griseoflavus 
W-384 has enabled the identification of more than fourteen gene clusters involved in the 
biosynthesis of secondary metabolites. Establishment of a genetic manipulation system would 
open up the possibility to investigate the biosynthetic pathways of HRM and other interesting 
metabolites and to generate novel compounds by genetic engineering. 
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3.1.1 Optimization of growth conditions of S. griseoflavus W-384 
3.1.1.1 Antibiotics susceptibility test of S. griseoflavus W-384 
Herein, the sensitivity of S. griseoflavus W-384 was tested to several common antibiotics in 
order to further screen the transformants. S. griseoflavus W-384 was cultivated at 30 °C for 5 
days on MM medium supplemented with antibiotics at the different concentrations ranging 
from 0 g/mL to 100 g/mL (Table 3.1). It was shown that S. griseoflavus W-384 was 
extremely sensitive to apramycin, kanamycin, thiostrepton and streptomycin with the minimal 
inhibitory concentration (MIC) of 10 µg/mL while spectinomycin can be used as an alternative 
for screening with higher concentration.  
 
Table 3.1: Antibiotics susceptibility of S. griseoflavus W-384. +++: growing very well, ++：growing 
well, +/-: growing not so good, -: no growth, NA: not analyzed. 
Antibiotics Concentration (µg/mL) 
 0 10 25 50 100 
Apramycin +++ - - - NA 
NA 
NA 
NA 
- 
Kanamycin  +++ - - - 
Thiostrepton +++ - - - 
Streptomycin +++ - - - 
Spectinomycin +++ ++ +/- - 
 
3.1.1.2 Optimization of sporulation media 
Since a Streptomyces spore suspension at high concentration is required in this work for further 
preparation of protoplasts, screening of transformants as well as fermentation, using  ideal 
media for sporulation are very important and necessary. To obtain the best media for 
sporulation, 10 µL of S. griseoflavus W-384 spore suspension (1 × 10
8
 spores/µL) was spread 
on six different kinds of common agar media (GYM, M2+, GYS, LB, 2CM and MM), 
respectively. The agar plates were incubated at 30 °C for six days.  
 
After cultivation, among six tested media shown in Figure 3.2, GYM was the best sporulation 
medium due to the even distribution of spores to form a gray lawn and the fastest growth 
starting from the third day. S. griseoflavus W-384 also had a good sporulation on M2+ agar 
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plate but slower growth. No sporulation was observed on the other media (2CM, LB and 
MM). In addition, the same plates were incubated at 37 °C to check if this temperature gave 
better sporulation. It was observed that this strain could grow at 37 °C but no sporulation was 
observed. Therefore, the optimal condition for sporulation of S. griseoflavus W-384 was on 
GYM medium at 30 °C for five days. 
 
 
Figure 3.2: Sporulation of S. griseoflavus W-384 on different agar media. 
 
3.1.1.3 Optimization of submerged media for mycelial growth of S. 
griseoflavus W-384 
Mycelial growth of Streptomyces in liquid media is very important for many purposes, for 
example, the production of secondary metabolites and the general genetic manipulation 
including preparation of protoplasts, conjugation, isolation of genomic DNA or plasmid. Here, 
six frequently-used submerged Streptomyces media were tested for the growth of S. 
griseoflavus W-384. 10 µL of S. griseoflavus W-384 spore suspension (1 × 10
8
 spores/µL) 
were added to 20 mL liquid media (YEME, superYEME, SGGP, MS, TSB and MMS) and 
grown at 30 °C, 250 rpm, for two days. Afterwards, the mycelia were harvested and the 
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supernatants were discarded. To compare the mycelial growth in different media, the wet cell 
weights from different media were measured.  
 
Table 3.2: Mycelial growth of S. griseoflavus W-384 in different submerged media. The wet cell weight 
in table is the average value of triplet cultivation. 
Media YEME superYEME  MS SGGP TSB MMS 
Sucrose content 
Wet cell weight (g) 
34% 
 
no growth 
34% 
 
no growth 
- 
 
2.58  
- 
 
0.52 
- 
 
3.74 
- 
 
0.81 
 
As shown in Table 3.2, S. griseoflavus W-384 could not grow in the liquid media containing 
sucrose. The wet weight of the cells growing in TSB was higher than those in other media. 
However, the mycelia grown in TSB sticked together and formed lots of big pellets, which 
made protoplast preparation inefficient. The mycelia in MS not only grew well, but also seemed 
fine morphologically. Therefore, MS medium was considered as the optimal medium for 
mycelial growth of S. griseoflavus W-384. 
 
3.1.2 Efficient conditions for protoplast preparation and regeneration of S. 
griseoflavus W-384 
S. griseoflavus W-384 strain was grown in MS media at 30 °C, 250 rpm, for two days. Then the 
mycelia were harvested, washed with 10.3% sucrose twice and resuspended in P buffer. 
Afterwards, the mycelia were divided into four portions; in which was supplemented with 
lysozyme (50 mg/mL) at the final concentration range of 1 to 3 mg/mL. The incubation time 
was set up at the range from 0 to 2 hours. According to the routine procedure of model strain S. 
coelicolor A3(2), the incubation temperature was set up at 30 °C. After incubation, the 
protoplasts were filtered through sterilized absorbent cotton. The protoplasts were observed by 
microscope (Figure 3.3).  
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Figure 3.3: The protoplast viability micrograph of S. griseoflavus W-384 with 2 mg/mL final 
concentration of lysozyme at 0.5 h and 1.5 h ( × 40). 
 
For protoplast regeneration, protoplasts were diluted serially in 0.1% SDS instead of P buffer to 
eliminate the influence from mycelia. As the control, they were plated on R5 regeneration 
medium with the same sets of dilution in P buffer. Then, the protoplasts were spread on R5 
plates. After incubation of 24 hours at 30 °C, the optimal condition of protoplast formation was 
determined according to the numbers of exact regeneration colonies. The protoplasts treated 
with 0.1% SDS eventually were killed off due to lack of cell wall protection while the mycelia 
were grown as usual on R5 plates. The exact regeneration numbers equal to the numbers of 
regeneration colonies from protoplasts diluted with P buffer minus the numbers of regeneration 
colonies from protoplasts diluted with 0.1% SDS. The result is shown in Figure 3.4. It was 
shown that lysozyme at the final concentration of 2 mg/mL and incubation for 1.5 h was the 
optimal condition for the formation of S. griseoflavus W-384 protoplasts. 
 
 
Figure 3.4: The effect of concentration of lysozyme (mg/mL) and incubation time (h) on the protoplast 
regeneration of S. griseoflavus W-384. 
 
Chapter 3 Results and Discussion 
46 
 
3.1.3 Protoplast transformation in S. griseoflavus W-384 
Integrative and free-replicating plasmids are commonly used in Streptomyces spp.. However, 
the transformation efficiency between these two types of plasmids is different. Generally, the 
transformation of integrative ones was much easier than that of free-replicating ones because 
the integrative ones can be integrated into the Streptomyces genome. In this study, two 
plasmids were chosen from the two different types above for protoplast transformation. 
 
3.1.3.1 Protoplast transformation of integrative plasmid 
pSET152 is a well-known integrative plasmid widely used in Streptomyces spp.(Bierman 1992). 
It carries the gene attP encoding an integrase, which enables it bind to attB site in the 
chromosomes of Streptomyces spp. (Figure 3.5). Therefore, the presence of an attB site in the 
chromosome would allow it to replicate together with the genome of S. griseoflavus W-384.  
 
 
Figure 3.5: Physical map of pSET152. 
 
In general, Streptomyces spp. possess strong restriction systems to inhibit the invasion of 
foreign DNA. Thus, pSET152 was transformed into E. coli ET12567 to obtain non-methylated 
pSET152 before being introduced into S. griseoflavus W-384 through PEG-mediated protoplast 
transformation based on the routine procedure of S. coelicolor A3(2) as described by Kieser et 
al. (2000). 
 
After overlaying apramycin (25 µg/mL) on R5 plate and incubation for five days, plenty of 
pSET152
5715 bp
aac(3)IV
lacZa
phiC31 integrase
phiC31 attP site
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colonies were grown on R5 plates, suggesting that S. griseoflavus W-384 could accept foreign 
demethylated DNA and the efficiency of protoplasts prepared with optimal condition was very 
well (Figure 3.6). 
 
 
Figure 3.6: The transformants of pSET152 in S. griseoflavus W-384. 
 
To test if the resulting transformants were integrated with apramycin resistance gene from 
pSET152, five colonies were picked and plated on GYM agar media supplemented with 
apramycin (25 µg/mL) for sporulation. After incubation for five days, the spores were collected 
from GYM plates and subsequently inoculated into MS liquid media for further isolation of 
genomic DNA. The genomic DNA from the five colonies was used as templates for PCR 
amplification of apramycin resistance gene using the primer pair XF1A and XF1B. The results, 
as shown in Figure 3.7, indicated that all the colonies were resistant to apramycin. 
 
 
Figure 3.7: Agarose gel analysis of transformants of pSET152 in S. griseoflavus W-384. Lane M, l00 
bp DNA ladder; lane 1, PCR products of genomic DNA from the WT strain; lanes 2-6, PCR products 
of genomic DNA from the pSET152 transformants. 
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3.1.3.2 Protoplast transformation of pWHM4*, a free-replicating plasmid 
pWHM4* (Figure 3.8) is a free-replicating plasmid that contains a Streptomyces origin of 
replication and a thiostrepton resistance gene allowing screening transformants.  
 
 
Figure 3.8: Physical map of pWHM4* (Matseliukh 2001). 
 
Before being introduced into S. griseoflavus W-384, pWHM4* from E. coli DH5ɑ was 
transformed into E. coli ET12567 in order to obtain demethylated DNA. After adding 
thiostrepton (12.5 µg/mL) on R5 plate followed by incubating at 30 °C for five days, less 
transformants were grown on the plate relative to that of pSET152 as shown in Figure 3.9. 
 
 
Figure 3.9: The transformants of pWHM4* in S. griseoflavus W-384. 
 
Several transformants were picked, inoculated into GYM supplemented with thiostrepton 
(12.5 µg/mL), and then incubated at 30 °C for seven days. The resulting spores derived from 
the transformants mentioned above were harvested and inoculated into MS liquid medium 
containing thiostrepton (12.5 µg/mL), respectively. After incubation with shaking at 30 °C for 
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two days, genomic DNA was isolated from the mycelia, and then introduced into E. coli 
DH5ɑ. After incubation overnight at 37 °C, a lot of E. coli DH5ɑ colonies with ampicillin 
resistance were grown on LB agar plate supplemented with ampicillin. To confirm if these 
colonies harbor pWHM4* plasmid, they were inoculated into LB liquid media supplemented 
with ampicillin and grown at 37 °C overnight with agitation. The plasmids were extracted 
from the overnight culture and digested with BamHI. As shown in Figure 3.10, all of the 
tested colonies contained the correct plasmid, demonstrating that protoplast transformation of 
S. griseoflavus W-384 with free-replicating plasmids was successful. 
 
 
Figure 3.10: Agarose gel analysis of pWHM4* transformants. Lane M, 1 kb DNA ladder; lanes 1-5, 
digestion of plasmids isolated from the pWHM4* transformants. 
 
3.1.4 Intergeneric conjugation into S. griseoflavus W-384 
Conjugation as an approach of the intergeneric transfer offers some advantages. The 
procedure is not only relatively simple to perform, but also prevents foreign plasmid DNA 
from extracellular nuclease activity. Therefore, it has been considered as a powerful tool for 
gene transfer, which was successfully used in most Streptomyces strains. In this work, the 
donor bacterium was E. coli ET12567/pUZ8002. The pUZ8002 was integrated into the 
chromosome of E. coli ET12567, thereby providing a tra gene encoding an integrase. The 
foreign plasmid DNA used here was pSET152 carrying an origin of transfer, which was 
proved to be integrated into the chromosome of S. griseoflavus W-384 based on the previous 
study on protoplast transformation as described above.  
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3.1.4.1 Transformation of pSET152 into S. griseoflavus W-384 by 
conjugation 
Transformants of E. coli ET12567 containing pSET152 were firstly obtained and cultivated in 
LB liquid media containing chloramphenicol, apramycin and kanamycin at 37 °C until the 
OD600 reached 0.4. Then, the cells were harvested, washed with fresh LB twice to remove the 
residue of antibiotics and finally resuspended in 500 µL fresh LB. Meanwhile, S. griseoflavus 
W-384 spores were heat-shocked in 500 µL of 2 × YT media at 50 °C for 10 min, and cooled 
down at room temperature. Afterwards, these two types of bacteria were mixed up, spread on 
MS agar plates containing 10 mM MgCl2 and incubated at 30 °C for 16-20 hours, then flooded 
with 1.5 mL of sterilized water mixed with 25 µL of apramycin (50 µg/mL) and 20 µL of 
nalidixic acid (25 µg/mL). After incubation for several days, the conjugants grew on the plates. 
A few conjugants were picked and grown on GYM agar plates containing apramycin and 
nalidixic acid for further screening of apramycin resistance (Figure 3.11).  
 
 
Figure 3.11: Conjugants of pSET152 into S. griseoflavus W-384 on MS agar plate. A, Conjugants 
grown on MS plate containing apramycin and nalidixic acid. B, Screening of a few conjugants on GYM 
agar plate supplemented with apramycin and nalidixic acid. 
 
Since these conjugants possess an apramycin resistance, it was deduced that the resistance of 
conjugants came from the plasmid of pSET152, but it also might be caused by spontaneous 
mutation. It is therefore necessary to characterize these exconjugants on a genetic level. 
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3.1.4.2 Confirmation of conjugants on a genetic level 
The spores of above conjugants were harvested from GYM plates. Three of above conjugants 
were inoculated into MS liquid medium containing apramycin while S. griseoflavus W-384 
was considered as a negative control. All the strains were cultivated at 30 °C with shaking for 
two days. The genomic DNA was isolated after incubation, and then taken as a template to 
amplify the apramycin resistance gene by PCR using the primer pair XF1A/1B (Figure 3.12). 
Agarose gel analysis of all the PCR products (Figure 3.12) indicated that the apramycin 
resistance of all the exconjugants was from pSET152 and the conjugation was successful. 
 
 
Figure 3.12: Agarose gel analysis of conjugants of pSET152 in S. griseoflavus W-384. Lane M, l00 
bp DNA ladder; lanes 1-3, PCR products of three conjugants; lane 4, PCR products from the WT 
strain. 
 
3.1.5 Discussion 
In this chapter, a genetic manipulation system of S. griseoflavus W-384 was established via 
optimization of cultivation conditions, protoplast formation and regeneration. Then, two types 
of plasmids were successfully introduced into S. griseoflavus W-384 by either protoplast 
transformation or conjugation. 
 
The integrative plasmid pSET152 used in this study, which contains an attP site derived from 
phage ΦC31 that can be integrated into the chromosome of S. griseoflavus W-384. The results 
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suggested the presence of at least one aatB sites in the S. griseoflavus W-384 genome. Thus, 
the plasmids derived from phage ΦC31 also can be introduced into S. griseoflavus W-384.  
 
Streptomyces spp. often possess strong restriction systems. In many cases, methylated foreign 
DNA is not accepted. Therefore, the foreign DNA is supposed to be demethylated via 
transformation into E. coli ET12567. In the initial study of protoplast transformation, both 
methylated pSET152 and demethylated pSET152 could be individually introduced into S. 
griseoflavus W-384. The results implied that S. griseoflavus W-384 did not have a strong 
restriction system, because it can accept both types of DNA. However, demethylated 
pSET152 showed much higher efficiency of transformation into S. griseoflavus W-384 than 
that of DNA without demethylation. 
 
3.2 Examination of regulatory genes in hormaomycin biosynthesis 
Previous work has provided some insights into the biosynthesis of the unusual building blocks 
and has established that the peptide is assembled by NRPSs (Höfer et al., 2011; Crüsemann et 
al., 2013; Crüsemann 2012). However, a significant challenge during studies on the pathway 
and the as-yet unknown mode of action are the low production titers of S. griseoflavus W-384 
and its propensity to irreversibly lose its biosynthetic capability. The regulation of Streptomyces 
natural products is often complex and commonly involves several layers of pathway-specific 
and/or global regulators. Genetic engineering of these regulatory systems is taken as an 
approach to increase production titers (Bibb 2005). Since HRM itself also acts as a metabolic 
and developmental regulator in Streptomyces spp., an understanding of the factors governing its 
production would also be an important basis to unravel the intricate regulatory network in intra- 
and interspecies HRM signaling. Therefore, in this study, the regulatory genes in HRM 
biosynthesis was investigated to create improved HRM producers and understand the 
regulation during the HRM biosynthesis.  
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3.2.1 Bioinformatic analysis of three candidates for regulatory genes in hrm 
gene cluster 
Previous bioinformatic analysis (Höfer et al., 2011) revealed the existence of three regulatory 
genes, hrmA, hrmB and hrmH, encoded within hormaomycin biosynthetic gene cluster, where 
HrmA and HrmB were predicted as positive regulators. HrmA is homologous to transcriptional 
regulators belonging to the AraC family (Martin and Rosner 2001), showing 35% protein 
sequence identity to TxtR, an AraC/XylS cellobiose-binding protein that induces thaxtomin 
production in S. scabies (Joshi et al., 2007). HrmB is homologous to a small family of 
regulators with poorly understood mechanisms that includes NovE, a transcriptional activator 
of novobiocin biosynthesis (Dangel et al., 2008), and LmbU, a positive regulator of lincomycin 
biosynthesis (Chen et al., 2011). All three homologues contain a TTA codon for leucine that is 
rare in streptomycetes and indicates regulation by the tRNA
UUA
-encoding gene bldA (Leskiw et 
al., 1991). In addition to hrmA and hrmB, hrmH was also tentatively included in the list of 
regulatory gene candidates. Homologues of HrmH belong to the poorly characterized 
YjgF/Yer057p/UK114 family. Members with known function exhibit diverse, often regulatory 
functions. For example, mammalian UK114 (=endoribonuclease L-PSP) is a potent inhibitor of 
cell-free protein synthesis by disintegrating polysomes through fragmentation of polysomal 
mRNA (Oka et al., 1995; Morishita et al., 1999), and Salmonella enterica YjgF (RidA) and the 
human homolog UK114 inhibit threonine dehydratase-dependent phosphoribosylamine 
formation in vitro, apparently by deaminating a biosynthetic intermediate (Lambrecht et al., 
2010). Since these homologues can interact with nucleic acids as well as small molecules, it 
was not clear at this stage whether HrmH might be a regulator or a biosynthetic enzyme. 
 
3.2.2 Overexpression of pathway-specific activators HrmA and HrmB to 
improve hormaomycin production 
Since hrmA and hrmB were candidates for activator genes, it was investigated whether their 
overexpression results in a specific increase of HRM production. To construct the desired 
overproducers, the experiments were carried out according to the strategy depicted in Figure 
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3.13. 
 
 
Figure 3.13: The strategy for construction of HRM overproducers. A, Modification of Streptomyces 
expression plasmid pWHM4*; B, Construction of HrmA and HrmB overexpression strains. 
 
In this study, pWHM4* was modified for further convenience of screening. Firstly, the 
apramycin resistance gene (apr
R
) was amplified from pIJ773 using the primer pair XF9F/9R by 
PCR. The PCR products were purified from an agarose gel and cut with ClaI and EcoRV, 
meanwhile pWHM4* was similarly digested and purified (Figure 3.14A). Subsequently, the 
ligation was performed by mixing the PCR products of apr
R
 with pWHM4* and was 
subsequently transformed into E. coli DH5ɑ. Since the thiostrepton resistance gene (tsr) in 
pWHM4* was disrupted and replaced with apr
R
, the transformants harbored apramycin 
resistance. The transformants were randomly selected and further confirmed by digestion with 
ClaI and EcoRV. The plasmids with the correct bands after digestion were referred to as pXC10, 
a new Streptomyces auto-replicating expression vector. The genes hrmA and hrmB were 
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amplified from S. griseoflavus W-384 genomic DNA using primer pairs XF10F/10R and 
XF11F/11R, then cloned into pBluescript SK-II(+) using EcoRI and XbaI and verified by 
sequencing. The plasmids extracted from the resulting transformants were screened by double 
digestion (Figure 3.14B).  
 
 
Figure 3.14: Agarose gel analysis of pXC11 and pXC12. A, Lane M, 1 kb DNA ladder, lane 1, apr
R
 
with promoter (~1.1 kb), lane 2, pWHM* digested with ClaI+EcoRV (~7.9 kb), lane 3, pBluescript 
SK-II(+) digested with XbaI+EcoRI (~3.0 kb), lane 4, hrmA PCR products (~1.0 kb), lane 5, hrmB PCR 
products (~0.6 kb); B, Lane M1, 1 kb DNA ladder, lanes 7-11, digestion of pXC11 with XbaI+EcoRI, 
lanes 13-18, digestion of pXC12 with XbaI+EcoRI, M2, 100 bp DNA ladder. pXC11, hrmA ligated to 
pBluescript SK-II(+), pXC12, hrmB ligated to pBluescript SK-II(+). Lanes 8 and 16 contain plasmids 
pXC11 and pXC12 used for further study with the correct sequences of hrmA and hrmB, respectively.  
 
The candidate DNA with the correct bands was sequenced. Then, the plasmids with hrmA and 
hrmB based on pBluescript SK-II(+) vector were named as pXC11 and pXC12, respectively. 
The DNA fragments of hrmA and hrmB cut from pXC11 and pXC12 were individually ligated 
into pXC10 under the control of the constitutive promoter ermE* from the erythromycin 
resistance gene (Bibb et al., 1985) to give pXC14 and pXC13 (Figure 3.15).  
 
 
Figure 3.15: Agarose gel analysis of pXC14 and pXC13. A, Lane M, 1 kb DNA ladder, lanes 1-6, 
digestion of pXC13 with XbaI+EcoRI. pXC14, hrmA ligated to pXC10; B, Lane M, 1 kb DNA ladder, 
lanes 1-12, digestion of pXC13 with XbaI+EcoRI (lanes 1-6 are false positives). pXC13, hrmB ligated 
to pXC10. pXC10 is a modified pWHM4* with apramycin resistance. 
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The resulting plasmids were individually introduced into E. coli ET12567 to get 
non-methylated DNA and were then transformed into S. griseoflavus W-384 by PEG-mediated 
protoplast transformation according to the procedures optimized above to give potential 
transformants with apramycin resistance. The genomic DNA was isolated from the potential 
transformants containing pXC14 or pXC13 and independently transformed them into E. coli 
DH5ɑ. The plasmid DNA from the resulting transformants was identified by enzymatic 
digestion with EcoRI and XbaI (Figure 3.15). Finally, the HrmA overexpression strain and 
HrmB overexpression strain were generated and considered as two overproducer candidates. 
To obtain ideal fermentation conditions for HRM production, triplet experiments were 
performed by cultivation of the wild type strain in 50 mL of MMS media in 250 mL flasks 
either baffled with springs or shaken with glass beads. The cell weights, PH value of 
fermentation cultures from flasks either baffled with spring or glass beads were compared 
(Figure 3.16). The results suggested that the optimal condition for HRM production is 
cultivation of the wild type strain in 250 mL flask baffled with spring at pH value of 9 at 27 ºC. 
 
 
Figure 3.16: Comparison of mycelia growth of S. griseoflavus W-384 in different conditions. (S, 
spring-baffled flask; G, flask shaken with glass beads.). 
 
Subsequently, triplet fermentation of the two overproducer candidates and wild-type (WT) was 
carried out in MMS media in the flasks baffled with spring to confirm their constant production 
of HRM. The supernatants from the above cultures were harvested and extracted with 
ethylacetate (EtOAc) three times. The analysis of the culture extracts by HPLC at UV of 273 
nm revealed that HRM production from the HrmA overexpression strain was increased 40-fold 
Chapter 3 Results and Discussion 
57 
 
relative to the WT while HRM production from the HrmB overexpression strain was increased 
135-fold relative to the WT (Figure 3.17). Therefore, the HrmA overexpression strain and 
HrmB overexpression strain were referred as to the HRM overproducers, which were named 
as XC1 and XC2, respectively. These results are consistent with a role as pathway activators 
for both genes.  
 
 
Figure 3.17: Comparison of HPLC traces of extracts from triplet fermentation of WT (WT-1, WT-2, 
WT-3), XC1 (XC1-1, XC1-2, XC1-3) and XC2 (XC2-1, XC2-2, XC2-3). * stands for HRM at retention 
time of 12.8 min at UV of 273 nm. 
 
To test whether these two activators function in an additive way that would allow us to further 
increase HRM titers, a hrmA/hrmB double-expression strain XC3 was created via introducing 
another hrmB-overexpression plasmid pXC31 (hrmB ligated into pWHM4* under control of 
the ermE* promoter with thiostrepton resistance) into XC1. However, analysis of its metabolic 
profile did not indicate up-regulation beyond the level of the previous best producer XC2 
(Figure 3.18).  
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Figure 3.18: HPLC profiles of WT, XC1, XC2 and XC3. HRM A1-A6 are HRM analogues isolated 
from XC2. The detection wavelength was 273 nm. The retention times of HRM and HRM derivatives 
(HRM A1-A6) are: 10.2 min (HRM A1, HRM A2), 13.4 min (HRM), 20.3 min (HRM A3, HRM A4), 23.4 
min (HRM A5) and 38.5 min (HRM A6). 
 
The same amount (20 µL) of supernatants from the two overproducers XC1 and XC2, as well 
as the WT strain were tested against Arthrobacter crystallopoietes ATCC1548. The results 
showed that XC1 and XC2 exhibit much higher bioactivity than the WT strain, with XC2 as the 
apparently best overproducer (Figure 3.19). 
 
 
Figure 3.19: Bioassay of the supernatants from WT, XC1 and XC2 against A. crystallopoietes 
ATCC1548. 
 
Upon closer examination of the HPLC profiles obtained from the regulatory mutants, a series of 
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new compounds were observed in all three strains. Subsequently, these new compounds were 
isolated. The initial analyses of electrospray ionization-liquid chromatography-mass 
spectrometry (ESI-LC-MS) and tandem mass spectrometry (MS/MS) were carried out by Dr. 
Roberta Teta in the Mangoni group in University of Napoli and Dr. Max Crüseman in the Piel 
group. The results indicated that these new compounds were structurally related to HRM. 
Specific search for their ions in LC-MS runs showed that they are also produced by WT, but at 
extremely low amounts. To determine their structures, peptides produced by XC2 were purified. 
The resulting six compounds were subsequently subjected to the MS/MS and NMR analyses 
and characterized by Dr. Roberta Teta and Dr. Max Crüsemann. All tandem mass spectra were 
interpreted by Dr. Roberta Teta using an adapted version of the peptide nomenclature proposed 
by Roepstorff and Fohlman (Roepstorff and Fohlman 1984) as modified by Johnson (Johnson 
et al., 1987). If the charge is retained on the N-terminal fragment, the ion is classified as either a 
or b, if the charge is retained on the C-terminus, the ion type is either x or y. A subscript 
indicates the number of residues in the fragment; d indicates an ion type due to the side chain 
cleavage. The most significant fragments produced by tandem mass analysis for HRM (m/z 
1151.4546 for C55H69N10O14ClNa) are depicted in (Figure 3.20). 
 
 
Figure 3.20: Tandem MS fragmentation of HRM. 
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The most abundant ion in the MS/MS spectrum of HRM is found at m/z 1034.4586
 
and is due to 
the loss of the chlorinated pyrrole ring; it is a C-terminal fragment composed of seven amino 
acids, and is thus called x7. Further fragmentation of this ion in an MS
3
 experiment involves 
ring opening by cleavage of the ester bond between the α-Thr (VI) side chain and (4-Pe)Pro (I) 
carboxyl, yielding the linear peptide d, followed by amide bond cleavages to give the 
N-terminal ions db3, db4, and db5. The pseudomolecular ion undergoes a similar double 
cleavage of the α-Thr ester bond and of an amide bond, but with retention of the charge on the 
C-terminal fragments, giving the linear fragments dy3 (m/z 452.2520) and dy5 (m/z 769.3888). 
Further C-terminal fragmentation of the latter ion (Mangoni 2012) produces ions b4, a4, b3, and 
a3. All the analytical data of HRM A1-HRM A6 including MS/MS and NMR analyses was 
reported in Max Crüsemann’s thesis in 2012. The chemical structures of these six new HRM 
analogues were shown in Figure 3.21. 
 
 
Figure 3.21: The structures of hormaomycin derivatives HRM A1-HRM A6. 
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In comparison to HRM, HRM A1 lacks the chlorine moiety in the Chpca starter unit, and in 
HRM A2, a valine residue is incorporated instead of isoleucine. HRM A3-5 all possess leucine 
substitutions for various (3-Ncp)Ala units. In an effort to further enhance production of HRM 
A3-5, L-leucine was supplemented into the hrmB-overproducing strain, resulting in a modest 
increase in their titers with a concomitant decrease in HRM production (Figure 3.22).  
 
 
Figure 3.22: Chemical feeding of XC2 with L-leucine. 
 
3.2.3 Analysis the role of hrmH, another putative regulatory gene 
HrmH was initially predicted to be a putative negative regulator. To check if HrmH negatively 
regulates the HRM biosynthesis, the hrmH gene was subjected to the inactivation to increase 
HRM production. The hrmH mutant (ΔH) was generated by replacement with an apramycin 
resistance gene cassette according to the strategy of PCR-targeting for mutagenesis in S. 
coelicolor A3(2) (Gust et al., 2003) (Figure 3.23). 
 
Chapter 3 Results and Discussion 
62 
 
 
Figure 3.23: The strategy for construction of the ΔH via a PCR-targeted replacement. Adapted from 
Gust et al., 2003. 
 
A 1.4 kb fragment containing the apramycin resistance cassette amplified from pIJ773 (Gust et 
al., 2003) using the primer pair XF18F/18R was used to disrupt hrmH in pHR6G10. The 
resulting mutants were further confirmed by PCR (Figure 3.24) using the primer pairs 
XF24F/24R, XF26F/29R, XF29F/26R and XF29F/29R (Table 4.6). 
 
 
Figure 3.24: Agarose gel analysis of PCR products amplified from the genomic DNA of S. 
griseoflavus W-384 and ΔH mutant. A, Identification of genomic DNA from S. griseoflavus W-384 
(lane 1) and four different transformants of ΔH (lanes 2-5) by PCR using the primer pair XF24F/24R to 
amplify the hrmH gene. B, Identification of genomic DNA from S. griseoflavus W-384 (lanes 1, 6, 11) 
and four different transformants of ΔH (lanes 2-5, 7-10, 12-15) by PCR using the primer pairs 
XF29F/29R, XF29F/26R, and XF26F/26R, respectively. 
 
Triplet cultivation of the ΔH strain was performed. Unexpectedly, HPLC analysis of the 
corresponding culture extracts showed the same profiles that deletion of hrmH had no obvious 
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effect on HRM production but resulted in the observation of an additional metabolite as 
compared to the WT strain (Figure 3.25).  
 
 
Figure 3.25: Comparison of HPLC traces of the ΔH extracts from triplet cultivation of ΔH (ΔH-1, ΔH-2, 
ΔH-3) with that of the WT strain. HRM is at 13.4 min, an additional metabolite (new peak) appeared in 
ΔH is at 7.2 min. HPLC was carried out at UV of 273 nm. 
 
For genetic complementation of ΔH, the hrmH gene fragment was amplified from S. 
griseoflavus W-384 genomic DNA using primers XF24F/24R and was first inserted into 
pBluescript SK-II(+) to give pXC19. After sequence verification, the correct hrmH gene 
fragment was digested from pXC19 and ligated into pWHM4* to obtain pXC26. Finally, 
non-methylated pXC26 was introduced into the ΔH strain to generate the ΔH complement 
ΔH/HrmH. The required complements (ΔH/HrmH) were further identified by enzymatic 
digestion of plasmid DNA from transformants of E. coli DH5ɑ (Figure 3.26).  
 
 
Figure 3.26: Agarose gel analysis of ΔH/HrmB and ΔH/HrmH. Lane M, 1 kb DNA ladder; lanes 1-6, 
digestions of plasmids with XbaI and EcoRI isolated from transformants after introducing plasmid DNA 
from ΔH/HrmB into E. coli DH5ɑ; lanes 7-8, digestions of plasmids with XbaI and EcoRI isolated from 
transformants after introducing plasmid DNA from ΔH/HrmH into E. coli DH5ɑ. 
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HPLC analysis of ΔH/HrmH showed the additional metabolite in ΔH decreased (Figure 3.27A). 
MS analysis of the HPLC-purified peak revealed a mass of 1103.464 Da for the [M+H]
+ 
ion 
(Figure 3.27B), which corresponds to a compound with 26 mass units less than HRM. This 
additional metabolite observed in ΔH was designated as HRM A7. 
 
 
Figure 3.27: LC-MS analysis of extracts from the WT and the ΔH and ΔH/HrmH mutants. A, 
Comparison of HPLC traces from the WT, the ΔH and ΔH/HrmH. The retention time of HRM A7 (a 
seventh HRM analogue) and HRM are at 7.2 min and 13.4 min, respectively. UV, 273 nm. B, Observed 
exact mass of HRM A7. 
 
Based on the molecular formula of C55H69O14N10Cl for HRM with an exact mass of 1129.476 
Da for [M+H]
+
, the molecular formula of this new compound, HRM A7, was estimated as 
C53H67N10O14Cl with loss of C2H2 (calcd. Mass 1103.460 Da for [M+H]
+
). Since the titers were 
too low for NMR analysis, the compound was initially analyzed by MS/MS analysis after 
isolation by HPLC. According to the tandem MS fragmentation of HRM (Figure 3.20), all the 
fragmentations of HRM A7 showed the consistance with those of HRM except for 426.225 
[M+Na]
+
 (Table 3.3), corresponding to a modified tripeptide normally including (4-Me)Phe, 
L-isoleucine, and (4-Pe)Pro. Methanolysis to open the depsipeptide ring followed by MS/MS 
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analysis of the isolated peak narrowed down the modified fragment to L-isoleucine and 
(4-Pe)Pro, suggesting the non-natural amino acid (4-Pe)Pro was modified in HRM A7. 
 
Table 3.3: ESI tandem MS fragmentation pattern of hormaomycin (HRM) and HRM A7. 
Ion HRM (Theoretical) HRM A7 HRM A7 (Methanolysis) 
[M+Na]
+ 
1151.458  
C55H69N10O14ClNa
+ 
1125.433 
C53H67N10O14ClNa
+
 
1157.454 
C54H71N10O15ClNa
+
 
Cl 
1117.489 
C55H70N10O14Na
+
 
1090.438 
C53H68N10O14Na
+
 
1121.481 
C54H70N10O15Na
+
 
x7 
1034.468 
C51H65N9O13Na
+
 
1008.443 
C49H63N9O13Na
+
 
1040.453 
C50H67N9O14Na
+
 
y7 
1008.473 
C50H67N9O12Na
+
 
982.441 
C48H65N9O12Na
+
 
1014.477 
C49H69N9O13Na
+
 
x6 
878.414 
C45H57N7O10Na
+
 
852.382 
C43H55N7O10Na
+
 
884.402 
C44H59N7O11Na
+
 
y6 
852.427 
C44H59N7O9Na
+
 
826.392 
C42H57N7O9Na
+
 
858.431 
C43H61N7O10Na
+
 
dy5 
769.390 
C40H54N6O8Na
+
 
743.381 
C38H52N6O8Na
+
 
757.375 
C39H54N6O8Na
+
 
dy4 
608.306 
C30H43N5O7Na
+
 
582.242 
C28H41N5O7Na
+
 
596.294 
C29H43N5O7Na
+
 
dy3 
452.253 
C24H35N3O4Na
+
 
426.225 
C22H33N3O5Na
+
 
440.249 
C23H35N3O4Na
+
 
dy3→b3 
291.168 
C14H24N2O3Na
+
 
- 279.170 
C13H24N2O3Na
+
 
   
Based on this hypothesis, a series of feeding studies were carried out to determine the structure 
of the newly incorporated residue. In addition to supplementing fermentations of the WT, ΔH, 
and ΔH/HrmH strains with (4-Pe)Pro in control experiments, cultures were fed the 
commercially available L-pipecolic acid and (2S,4R)-4-methylpyrrolidine-2-carboxylic acid 
[trans-(4-Me)Pro] as precursor amino acid candidates with a matching mass and known 
occurrence in nonribosomal peptides (He 2006; Katz et al., 1977). As a control, (3-Ncp)Ala was 
also independently fed into the strains. As shown in Figure 3.28A, feeding with 
trans-(4-Me)Pro resulted in the appearance of a 10-fold enhanced peak in the HPLC trace as 
compared to the unsupplemented ΔH strain, and the retention time was identical to that of HRM 
A7. In contrast, feeding of pipecolic acid did not change the metabolic profile, suggesting that 
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this compound is not incorporated. These results show that the presence or absence of HrmH 
has an effect on the fidelity of HRM biosynthesis. To further characterize the new peptide, it 
was isolated from the trans-(4-Me)Pro enrichment culture. The subsequent NMR analysis of 
this new peptide was carried out by Dr. Roberta Teta in the Mangoni group. 
 
 
Figure 3.28: Chemical and genetic complementation of the ΔH. A, HPLC traces of the WT, ΔH, ΔH fed 
with trans-(4-Me)Pro [ΔH + trans-(4-Me)Pro], ΔH fed with L-pipecolic acid (ΔH+ Pipecolic acid), ΔH 
fed with (4-Pe)Pro [ΔH + (4-Pe)Pro], ΔH/HrmH, ΔH fed with (3-Ncp)Ala [ΔH + (3-Ncp)Ala], WT fed 
with (3-Ncp)Ala [WT + (3-Ncp)Ala], ΔH/HrmH fed with (4-Pe)Pro [ΔH/HrmH + (4-Pe)Pro]. The 
retention time of HRM A7 and HRM are at 7.2 min and 13.4 min, respectively. UV, 273 nm. B, The 
structure of HRM A7. 
 
The following NMR analytical data were interpreted by Dr. Roberta Teta. The absence in the 
1
H NMR spectrum (Figure 3.29) of HRM A7 of the olefinic protons signals at δ 5.63 and 5.33, 
and the correlation in the correlation spectroscopy (COSY) spectrum (Figure 3.30) between 
H-4 at δ 2.57 with the methyl group at δ 1.07 (H3-1’) suggested that in HRM A7, a methyl group 
at position 4 replaces the moiety present in HRM.  
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Figure 3.29:
 1
H NMR spectrum (700MHz, CD3OD) of HRM A7. 
 
 
Figure 3.30: COSY spectrum (700MHz, CD3OD) of HRM A7 high field expansion. 
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This was confirmed by analysis of the total correlation spectroscopy (TOCSY) and 
heteronuclear single-quantum correlation spectroscopy (HSQC) spectra, which allowed 
assignment of all the protons and carbon atoms of 4-methylproline (Table 3.4).  
 
Table 3.4: NMR signals of HRM A7. 
Aa Position  H [mult., J (Hz)]  C [mult.] 
(4-Me)Pro (I) 1  - 174.4 I 
(4-Me)Pro (I) 2  4.07 (t, 7.5) 61.1 (CH) 
(4-Me)Pro (I) 3 a 2.06 (ddd, 12.8, 7.5, 7.5) 36.9 (CH2) 
(4-Me)Pro (I) 3 b 1.90 (ddd, 12.8, 7.5, 6.2)  
(4-Me)Pro (I) 4  2.57 (octet, 6.2) 34.3 (CH) 
(4-Me)Pro (I) 5 a 3.84 (dd, 10.4, 6.2) 55.6 (CH2) 
(4-Me)Pro (I) 5 b 3.58 (dd, 10.4, 5.0)  
(4-Me)Pro (I) 1’  1.07 (d, 7.0) 18.1 (CH3) 
Ile (II) 1  - 172.2 I 
Ile (II) 2  4.64 (d, 10.6) 56.2 (CH) 
Ile (II) 3  2.17 (m) 36.1 (CH) 
Ile (II) 4 a 1.61 (m) 25.6 (CH2) 
Ile (II) 4 b 1.18 (dq, 8.3, 7.6)  
Ile (II) 5  0.89 (br. T, 7.0) 10.7 (CH3) 
Ile (II) 1’  0.98 (d, 6.7) 16.5 (CH3) 
(β-Me)Phe (III) 1  - 172.5 I 
(β-Me)Phe (III) 2  4.44 (d, 5.4) 61.5 (CH) 
(β-Me)Phe (III) 3  3.63 (dddd, 7.3, 7.3, 7.3, 5.4) 40.6 (CH) 
(β-Me)Phe (III) 4  1.35 (d, 7.3) 14.3 (CH3) 
(β-Me)Phe (III) 1’  - 143.4 I 
(β-Me)Phe (III) 2’  7.29 (ovl) 128.6 (CH) 
(β-Me)Phe (III) 3’  7.19 (m) 128.0 (CH) 
(β-Me)Phe (III) 4’  7.28 (ovl) 129.4 (CH) 
(3-Ncp)Ala (IV) 1  - 174.2 I 
(3-Ncp)Ala (IV) 2  3.89 (ovl) 54.5 (CH) 
(3-Ncp)Ala (IV) 3 a 1.10 (ddd, 14.4, 6.8, 6.8) 33.3 (CH2) 
(3-Ncp)Ala (IV) 3 b 0.90 (ddd,14.4, 7.6, 7.6)  
(3-Ncp)Ala (IV) 1’  1.34 (ovl) 22.8 (CH)    
(3-Ncp)Ala (IV) 2’  3.90 (br. D , 4.8) 60.2 (CH)    
(3-Ncp)Ala (IV) 3’ a 1.51 (ddd, 10.3, 6.8, 4.8) 18.4 (CH2) 
(3-Ncp)Ala (IV) 3’ b 0.67 (q, 6.8)  
(β-Me)Phe (V) 1  - 171.5 I 
(β-Me)Phe (V) 2  4.62 (d, 8.7) 59.7 (CH) 
(β-Me)Phe (V) 3  3.08 (dq, 8.7, 7.2) 45.2 (CH) 
(β-Me)Phe (V) 4  1.21 (d, 7.2) 18.4 (CH3) 
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Aa Position  H [mult., J (Hz)]  C [mult.] 
(β-Me)Phe (V) 1’  - 143.3 I 
(β-Me)Phe (V) 2’  7.10 (d, 7.5) 129.2 (CH) 
(β-Me)Phe (V) 3’  7.14 (t, 7.5) 129.0 (CH) 
(β-Me)Phe (V) 4’  7.00 (t, 7.5) 127.7 (CH) 
α-Thr (VI) 1  - 169.5 I 
α-Thr (VI) 2  4.77 (br. S) 59.1 (CH) 
α-Thr (VI) 3  5.44 (dq, 7.0, 2.5) 73.1 (CH) 
α-Thr (VI) 4  1.58 (d, 7.0) 18.5 (CH3) 
(3-Ncp)Ala (VII) 1  - 171.9 I 
(3-Ncp)Ala (VII) 2  4.47 (br. D, 5.6  ) 54.5 (CH) 
(3-Ncp)Ala (VII) 3 a 2.04 (ddd,, 13.2, 5.6, 5.6) 34.2 (CH2) 
(3-Ncp)Ala (VII) 3 b 1.72 (ddd, 13.2, 7.6, 7.6)  
(3-Ncp)Ala (VII) 1’  2.01 (ovl) 22.9 (CH)    
(3-Ncp)Ala (VII) 2’  4.36 (ddd, 7.2, 3.6, 3.6) 60.4 (CH)    
(3-Ncp)Ala (VII) 3’ a 1.82 (ddd, 10.2, 5.8, 3.6) 17.8 (CH2) 
(3-Ncp)Ala (VII) 3’ b 1.14 (ovl)  
Chpca (VIII) 1  - 161.6 I 
Chpca (VIII) 2  - 118.6 I 
Chpca (VIII) 3  6.80 (d, 4.8) 110.4 (CH) 
Chpca (VIII) 4  6.06 (d, 4.8) 104.1 (CH) 
Chpca (VIII) 5  - 120.5 I 
 
A rotating frame nuclear overhauser effect spectroscopy (ROESY) spectrum allowed us to 
establish the relative configuration of (4-Me)Pro (I) as trans (in contrast, HRM contains a 
cis-4-Z-propenylproline) (Figure 3.31). The spectrum showed diagnostic dipolar couplings 
between H-2 and H3-1’, which are in the 1,3-relationship in a five-membered ring, and 
therefore must be cis oriented. This stereochemical assignment was corroborated by several 
other NOEs (Figure 3.32). Trans-(4-Me)Pro is much less common than cis-(4-Me)Pro, and has 
been found only in two closely related depsipeptides from the plant Pterula sp. (Chen et al., 
2006) and in monamycin D1 from Streptomyces jamaicensis (Hassall et al., 1971), compared to 
the ~19 known natural products containing cis-(4-Me)Pro. All the other configurations were 
assumed to be the same as in HRM because the NMR data were very similar.  
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Figure 3.31: ROESY spectrum (700MHz, CD3OD) of HRM A7 high field expansion. 
 
 
Figure 3.32: ROESY correlations in the (4-Me)Pro residue (I) of HRM A7. Only 1,3 NOEs are reported. 
NOEs between cis vicinal protons are consistently much stronger than those between trans vicinal 
protons. 
 
3.2.4 Inactivation of hrmD involved in the biosynthesis of (4-Pe)Pro  
The unexpected metabolic phenotype observed for the ΔH mutant raised new questions about 
the role of HrmH. Since trans-(4-Me)Pro replaced (4-Pe)Pro in HRM A7, the biosynthesis of 
(4-Pe)Pro was further investigated. Current knowledge about this complex sub-pathway comes 
from functional analysis of the HRM pathway and other routes that involve 4-alkyl-substituted 
Pro building blocks and homologous genes, i.e., lincomycin and pyrrolo[1,4]benzodiazepine 
antibiotics (Hu et al., 2007; Li et al., 2009a; Li et al., 2009b; Peschke et al., 1995). All these 
subpathways are initiated by extradiol cleavage of L-DOPA, which is generated by 
hydroxylation of L-tyrosine, and subsequent recyclization to form an unstable pyrroline 
intermediate. In contrast to HrmH, which is unique to the (4-Pe)Pro pathway, HrmD has close 
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homologs in the related pathways. The proteins are predicted to be F420-dependent 
oxidoreductases likely involved in reducing and/or rearranging olefinic double bonds at a later 
stage of biosynthesis (Höfer et al., 2011). To investigate which influence the inactivation of a 
(4-Pe)Pro biosynthetic enzyme has on HRM production, an insertional hrmD mutant (ΔD) was 
created in a similar manner to ΔH (Figure 3.23).  
 
Fermentation of the ΔD and ΔD/HrmD revealed a biosynthetic role of HrmD in HRM 
biosynthesis through complete abolishment of HRM, while genetic complementation with 
hrmD restored HRM production. Chemical complementation with (4-Pe)Pro also restored 
production and thus confirmed the direct role of HrmD in (4-Pe)Pro biosynthesis (Figure 3.33). 
Instead of HRM, the trans-(4-Me)Pro variant HRM A7 was detected in extracts of ΔD 
fermentations. Upon addition of trans-(4-Me)Pro, the production of HRM A7 increased in ΔD, 
paralleling the phenotype of the ΔH strain. These observations show that, similar to HrmD, 
HrmH influences the (4-Pe)Pro subroute of hormaomycin biosynthesis, but in contrast to HrmD 
is not absolutely required for the production of this residue. 
 
 
Figure 3.33: Genetic complementation and chemical feeding studies of the ΔD. A, HPLC traces of the 
ΔD, ΔD fed with (4-Me)Pro [ΔD + (4-Me)Pro], ΔD fed with L-pipecolic acid (ΔD + Pipecolic acid), and 
ΔD fed with (4-Pe)Pro [ΔD + (4-Pe)Pro], ΔD/HrmD, as well as the WT. B, MS analysis of HRM in ΔD 
fed with (4-Pe)Pro and ΔD/HrmD. The retention time of HRM A7 and HRM are at 7.2 min and 13.4 min, 
respectively. UV, 273 nm.  
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3.2.5 Analysis of the origin of (4-Me)Pro  
The function of HrmH was further interrogated by studying the biosynthetic origin of 
(4-Me)Pro. To test whether it is an intermediate or shunt product of the (4-Pe)Pro route or 
comes from a different source, a trideuterated form of the (4-Pe)Pro precursor L-DOPA 
[L-DOPA-(ring-d3)] was fed into the WT and ΔH strains. In the WT and ΔH strains, the label 
was successfully incorporated into HRM (Figure 3.34).  
 
 
Figure 3.34: Comparison of the extracted ion chromatogram (EIC) from LC-MS analysis of the 
extracts from the WT and ΔH fed with L-DOPA-(ring-d3). A, EIC of 1132.495 Da [M+H]
+
 from the 
WT without feeding. B, EIC of 1132.495 Da [M+H]
+
 from the WT fed with L-DOPA-(ring-d3). C, EIC 
of 1132.495 Da [M+H]
+
 from the ΔH without feeding. D, EIC of 1132.495 Da [M+H]+ from the ΔH fed 
with L-DOPA-(ring-d3). E, EIC of 1103.460 Da [M+H]
+
 from the ΔH strain without feeding. F, EIC of 
1103.460 Da [M+H]
+
 from the ΔH fed with L-DOPA-(ring-d3). HRM with D3 [M+H]
+
 (1132.495) is the 
exact mass of deuterate-labeled HRM; HRM A7 [M+H]
+
 (1103.460) is the exact mass that HRM A7 was 
not be deuterate-labeled. 
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In contrast, MS analysis revealed no detectable labeling of HRM A7 in both the WT and ΔH 
strains, and further supported that L-DOPA, as a precursor of HRM, is involved in HRM 
biosynthesis. This result suggested that (4-Me)Pro is not an intermediate in (4-Pe)Pro 
biosynthesis but rather originates from a source other than the HRM pathway. To identify a 
possible (4-Me)Pro pathway, the available genome sequence (GenBank: NZ_GG657758.1) of 
the HRM producer was searched for genes that might be involved in (4-Me)Pro biosynthesis or 
incorporation. However, no convincing gene candidate was identified. 
 
3.2.6 Antibacterial assays for HRM A1-A7 
HRM and its analogues were tested at five different concentrations (1, 0.1, 0.01, 0.001, and 
0.0001 µg/mL) against Arthrobacter crystallopoietes ATCC15481 in liquid-based 
antimicrobial activity assays. The MIC values of these compounds are listed in Table 3.5.  
 
Table 3.5: Bioassay test of HRM and HRM analogues against A. crystallopoietes ATCC15481. 
HRM & HRM Analogues MIC [ µg/mL ] 
HRM 0.001 
HRM A1 0.01 
HRM A2 0.01 
HRM A3 0.001 
HRM A4 0.1 
HRM A5 
HRM A6 
1 
1 
HRM A7 0.001 
 
All of the HRM analogues exhibited antibiotic activity against the test strain. HRM A3 and 
HRM A7 have similar activity to HRM, suggesting that there is the structural variability in the 
(4-Pe)Pro and the endocyclic (3-Ncp)Ala residues. In contrast, the exocyclic (3-Ncp)Ala 
moiety has a stronger influence on activity, since HRM A4 and A5 lacking this unit exhibit 
decreased activity. Similarly important but not absolutely required seem to be the chlorine atom 
and the leucine residue replaced in HRM A1 and A2. 
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3.2.7 Discussion 
To study the many unusual biosynthetic and biological features of HRM, the limitations of 
inconsistent and low production had to be overcome. One aim of this study was therefore to 
exploit regulatory components in the HRM pathway to modify titers through metabolic 
engineering. Among the identified genes hrmA, hrmB and hrmH, individual overexpression of 
hrmA and hrmB resulted in significant increases in HRM production, with a maximal increase 
of 135-fold in the hrmB overexpression strain relative to WT. In numerous growth experiments, 
strains exhibited excellent stability. These results established HrmA and HrmB as 
pathway-specific positive regulators for HRM biosynthesis. The ability to significantly 
increase HRM production with trans-acting plasmids provides an effective and reproducible 
platform to study HRM biosynthesis in both WT and mutant strains.  
 
A third gene, hrmH, was initially proposed to be a negative regulator in HRM biosynthesis 
(Höfer et al., 2011), yet disruption of hrmH had no detectable effect on HRM production. The 
peculiar phenotype observed with the ΔH strain, i.e., formation of the additional congener 
HRM A7, allows for several possibilities of HrmH’s role in HRM biosynthesis. Scenarios 
including a catalytic role in (4-Pe)Pro biosynthesis, down-regulation of trans-(4-Me)Pro 
biosynthesis or an alternative protection against its interference with the HRM pathway, 
up-regulation of (4-Pe)Pro biosynthesis, and down-regulation of other sub-pathways in HRM 
biosynthesis are all consistent with these data. However, some of these possibilities are 
incompatible when taken into context with our results for the (4-Pe)Pro-biosynthetic knockout 
strain ΔD. For instance, since HRM production was eliminated in ΔD while retained in ΔH, it is 
unlikely that HrmH is involved in the supplementation of (4-Pe)Pro in HRM biosynthesis. 
However, it should be taken into account that (4-Pe)Pro biosynthesis in S. griseoflavus W-384 
has not been fully elucidated and that the HRM producer lacks a key enzyme present in 
homologous pathways (Höfer et al., 2011). All in all, our results reveal HrmH influences 
(4-Pe)Pro production and/or fidelity in HRM biosynthesis. Defining the precise mechanism for 
HrmH as transcriptional, translational, or small-molecule-mediated regulation in HRM 
biosynthesis will be the focus of future studies. 
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The complexities of regulatory mechanisms involved in antibiotic biosynthesis, hallmarked by 
Streptomyces secondary metabolism, are still poorly understood. Combined with our current 
excess of genetic information encoding proteins that are largely unverified and uncharacterized, 
manipulation of regulatory genes within secondary metabolic clusters often have unforeseen 
consequences. Unexpected changes in the timing, production, and metabolic profiles of 
secondary metabolites are often reported (Wang et al., 2011; Stratigopoulos et al., 2002; 
Matsuno et al., 2004; Gottelt et al., 2010; D'Alia et al., 2011; de la Fuente et al., 2002). Even 
genes initially labeled to have biosynthetic or unknown activities have been shown to harbor 
regulatory functions (Volokhan et al., 2005; Hwang et al., 2003). Manipulation of the 
previously proposed negative regulator hrmH revealed the unanticipated discovery of HRM A7, 
which was shown to have (4-Pe)Pro replaced with trans-(4-Me)Pro (Figure 3.28). Interestingly, 
the source of trans-(4-Me)Pro remains undefined. The proposed biosynthetic routes for 
(4-Pe)Pro biosynthesis do not include trans-(4-Me)Pro as an intermediate (Höfer et al., 2011). 
Previous biochemical validation of the L-DOPA-cleaving activity of HrmF and its homolog in 
lincomycin biosynthesis did, however, highly suggest L-DOPA as an early intermediate in 
(4-Pe)Pro biosynthesis (Höfer et al., 2011; Colabroy et al., 2008). Feedings of deuterated 
L-DOPA in WT and ΔH cultures clearly showed trans-(4-Me)Pro production was independent 
from (4-Pe)Pro biosynthesis in S. griseoflavus W-384 (Figure 3.34).  
 
Variants of (4-Me)Pro are known for a small number of other natural products, including 
nostopeptolide (Luesch et al., 2003) and echinocandins (Cacho et al., 2012), for which the 
biosynthetic genes are reported. To identify a candidate for a (4-Me)Pro pathway in the HRM 
producer, its genome (GeneBank: NZ_GG657758.1) was searched for homologues of genes 
present in the gene clusters. In addition, the genome was scanned for NRPS A domains with 
similar predicted substrate specificities as the 4-methylproline-accepting domain of the 
nostopeptolide NRPS, as well as for methyltransferases of the radical S-adenosylmethionine 
superfamily (Frey et al., 2008; Atta et al., 2010; Crone et al., 2012; Huo et al., 2012; Freeman et 
al., 2012) that might methylate proline. However, all bioinformatic analyses failed to reveal 
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strong candidates. It should be noted that free trans-(4-Me)Pro has been previously observed in 
Nature and therefore could be supplied by the complex fermentation medium (Hulme and 
Arthington 1954). 
 
In addition to HRM A7, six new, HRM analogues (HRM A1-6) were discovered through 
overexpression of hrmB in the WT strain (Figure 3.21), of which HRM A6 is likely an artifact. 
With the exception of HRM A1 and HRM A6, all of the analogues had one or more residues 
replaced with L-leucine or L-valine. Recently, the specificities of all adenylation domains (A 
domains) responsible for the activation and selection of amino acids in the HRM NRPS were 
probed using a γ[18O4]–ATP mass exchange assay (Crüsemann et al., 2013; Phelan et al., 2009). 
In disagreement with the leucine substitutions observed in HRM A3-5, the A domains 
corresponding to the substituted positions did not show high substrate tolerance for leucine. 
Moreover, the A domain responsible for isoleucine incorporation in HRM revealed in vitro 
selectivity for valine in these studies, correlating with in silico predictions and the structure of 
the minor metabolite HRM A2. Thus, unknown downstream constraints for residues 
incorporated into HRM might be present in this system. Our data therefore highlight the 
potential benefits of in vivo manipulation of regulatory genes over in vitro or in silico 
predictions towards the production of accepted and bioactive NRPS-derived natural product 
congeners. 
 
Analogues HRM A1-6 also uncovered a previously unseen natural plasticity in HRM 
biosynthesis and provided useful SAR data that can aid in the design of non-natural active 
analogues. Replacement of L-isoleucine with L-valine had a modest 10-fold reduction in 
bactericidal activity against A. crystallopoietes ATCC15481 (Table 3.5). Previous feedings of 
various (3-Ncp)Ala analogues revealed flexible substrate tolerances for these substitutions in 
HRM biosynthesis, while often retaining partial antibiotic activity (Kozhushkov et al., 2005; 
Zlatopolskiy et al., 2006). From these experiments, it was hypothesized that terminal 
electron-withdrawing groups like NO2 and CO2Me were necessary at these positions for 
incorporation into HRM. However, acceptance of L-leucine in place of (3-Ncp)Ala in HRM 
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A3-5 expands and refines the SARs and profiles of accepted amino acids in HRM determined in 
those studies. Of note, HRM A3 retained full antimicrobial activity compared to HRM, 
therefore revealing the D-configured (3-Ncp)Ala unit flanked by (β-Me)Phe as an especially 
promising candidate for future derivatization. Furthermore, the epimerase domain of this 
module was able to tolerate L-leucine and invert its configuration. Lastly, as seen with HRM A6, 
previous experiments identified the N-hydroxy group of Chpca as essential for HRM activity; 
however, the effect of the chloro functionality remained unclear (Zlatopolskiy et al., 2006). Our 
data show that the dechlorinated analogue HRM A1 retains potent, yet slightly reduced 
antibacterial activity compared to HRM. With these insights, HRM residues that show 
flexibility for incorporation with retention of activity can subsequently be modified through 
mutasynthesis to act as ‘molecular handles’ to pull-down and identify HRM’s currently 
unknown cellular target. Together with the significant increase in stable HRM titers, research 
concerning HRM biosynthesis will be more tractable and tolerant to further manipulation and 
discovery.  
 
3.3 Molecular analysis of genes involved in biosynthesis of the unusual 
building blocks in HRM 
HRM is a nonribosomal peptide containing several nonproteinogenic amino acids, such as 
Chpca, (β-Me)Phe, (4-Pe)Pro, and in particular, (3-Ncp)Ala, which occurs in two diasteromeric 
forms. Previous feeding studies established the biosynthetic origin of all amino acids (Brandl et 
al., 2005). Chpca and (β-Me)Phe are derived from Pro and Phe, respectively. 4-Pe-Pro is 
biosynthesized from L-Tyr involving extensive skeletal reorganization, while L-Lys and 
4-hydroxy-L-Lys are precursors of (3-Ncp)Ala (Höfer et al., 2011). However, the precise steps 
during these transformations are so far unknown.  
 
With the optimized manipulation system of S. griseoflavus W-384 available and two cosmids 
containing the hrm gene cluster, pHR6G10 (hrmA to part of hrmO), and pHR1F4 (part of hrmO 
to hrmW), knock-out experiments would be a powerful and general strategy to allocate genes to 
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building block sub-pathways. The genes hrmQ (Chpca), hrmD [(4-Pe)Pro], as well as hrmI and 
hrmJ [(3-Ncp)Ala] were disrupted via homologous recombination. The culture extracts from 
resulting mutants were analyzed by LC-MS to detect the production of intermediates. The 
corresponding complements for these mutants were also prepared for restoring HRM 
production. These results along with bioassay tests and chemical feeding experiments, 
provided the deeper insights into the biosynthesis of HRM. 
  
3.3.1 Chpca biosynthesis 
The biosynthesis of pyrrole carboxylic acid derivatives is well understood and typically 
involves attachment of Pro to a free-standing PCP, followed by four-electron reduction by a 
dehydrogenase to produce the aromatic ring (Walsh et al., 2006). In certain cases, chlorine 
atoms are attached to the ring by FAD-dependent halogenases (Dorrestein et al., 2005; Zhang 
and Parry 2007). The homologs to all these enzymes are HrmK, HrmL, HrmM and HrmN 
encoded in the hrm cluster. In vitro studies of HrmK suggested that it acts as a free-standing A 
domain activating Pro that is subsequently attached to PCP encoded by hrmL (Figure 3.35) 
(Crüsemann 2012). HrmM is predicted to be a dehydrogenase catalyzing the four-electron 
oxidation of prolyl-PCP to form 2-pyrroloyl-PCP (Garneau-Tsodikova et al., 2006; Garneau et 
al., 2005) (Figure 3.35). Location of hrmN in the gene cluster suggests a role of HrmN in 
Chpca formation, and HrmN was suspected to be an oxygenase that introduces the hydroxy 
group to Chcpa. HrmQ has been identified to be a chlorinase involved in chlorination of Chpca 
by combinatorial expression of hrmQ integrated into the clorobiocin biosynthetic gene cluster 
(Heide et al., 2008). In this study, the genes hrmN and hrmQ were analyzed to check their 
roles in Chcpa formation by gene knock-outs and complementations. 
 
 
Figure 3.35: Proposed biosynthesis of Chpca. 
 
A PCR-targeted gene replacement strategy was initiated by transforming two cosmids 
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(pHR6G10 containing hrmA-hrmO, and pHR1F4 containing hrmO-hrmW) into E. coli 
BW25113/pIJ790, respectively. Two extended apramycin resistance cassettes were individually 
generated by PCR using long primer pairs XF16F/16R for hrmN gene replacement and 
XF17F/17R for hrmQ disruption (Figure 3.36), and then separately introduced into E. coli 
BW25113/pIJ790 containing cosmid pHR6G10 and E. coli BW25113/pIJ790 harboring cosmid 
pHR1F4 via electroporation.  
 
 
Figure 3.36: Agarose gel analysis of the PCR products of the apramycin resistance gene cassette. Lane 
M, 100 bp DNA ladder; lanes 1-7, 1.4 kb apr
R
 cassettes for knocking out of hrmC, hrmD, hrmI, hrmJ, 
hrmH, hrmN, and hrmQ, respectively. 
 
Homologous recombinations occurred, and the resulting apramycin resistants were screened by 
PCR analysis using the test primer pairs in Table 4.6. The results showed that all mutant 
cosmids contained the apr
R
 gene (Figure 3.37A) and lost the genes that were expected to be 
replaced. 
 
 
Figure 3.37: Agarose gel analysis of the PCR products from the mutant cosmids (I). A, Lane M, 1 kb 
DNA ladder; lane 1, no PCR product from pHR6G10 using the primer pair XF1F/XF1R (as a negative 
control); lanes 2-7 and 9, the apramycin resistance gene products amplified from the hrmC, hrmD, hrmI, 
hrmJ, hrmH and hrmQ mutant cosmids using the same primer pair; 8, no PCR product from pHR1F4 (as 
a negative control of hrmQ mutant cosmid). B, Lane M, 1 kb DNA ladder; lanes 1, 3, 5, 7, 9, and 11 are 
PCR products of hrmC, hrmD, hrmI, hrmJ, and hrmN amplified from the cosmid pHR6G10 using the 
corresponding primer pairs; lanes 2, 4, 6, 8, 10,12, no PCR product from the mutant cosmids of hrmC, 
hrmD, hrmI, hrmJ, and hrmN; lane 13, PCR products of hrmQ amplified from pHR1F4; lane 14, no 
PCR product from the hrmQ mutant cosmid. 
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To identify whether homologous recombination occurred in the correct position, primer pairs of 
XF32F/32R and XF33F/33R were individually designed from ~200 bp upstream and 
downstream of the apramycin resistance cassette in the hrmN mutant gene cluster and hrmQ 
mutant gene cluster. For further confirmation of mutant cosmids, a sub-primer pair XF26F/26R 
was generated from the middle part of the apramycin resistance gene. The DNA sizes amplified 
from the hrmN and hrmQ mutant cosmids were both ~1.85 kb using the primer pairs 
XF32F/32R and XF33F/33R, respectively (Figure 3.38, Lanes 12 and 14). The cosmids of 
pHR6G10 and pHR1F4 were also used for amplification as negative controls, and the PCR 
products showed the expected sizes (Figure 3.38, Lanes 11 and 13). 
 
 
Figure 3.38: Agarose gel analysis of the PCR products from the mutant cosmids (II). Lanes M1 and M2, 
1 kb DNA ladders; lanes 1, 3, 5, 7, 9 and 11, PCR products from pHR6G10 using the primer pairs 
XF27F/27R, XF28F/28R, XF29F/29R, XF30F/30R, XF31F/31R, XF32F/32R, respectively; lanes 2, 4, 
6, 8, 10 and 12, PCR products from the hrmC, hrmD, hrmH, hrmI, hrmJ, hrmN mutant cosmids using 
the same primer pairs; lane 13, PCR products amplified from pHR1F4 using the primer pair XF33F/33R; 
lane 14, PCR products from the hrmQ mutant cosmid using the same primers with lane 13. 
 
Since the DNA sizes amplified from the both mutant cosmids and original cosmids were nearly 
same using the primer pairs XF32F/32R and XF33F/33R, additional amplifications were 
conducted using primer pairs XF32F/26R, XF26F/26R and XF33F/26R, XF26F/26R, and the 
wild type cosmids were also used as negative controls The fragments obtained from mutant 
cosmids were designed to be ~1.0 kb while no product was expected from the original cosmids 
when correct replacement occurs (Figure 3.39, Lanes 21-28). 
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Figure 3.39: Agarose gel analysis of the PCR products from the mutant cosmids (III). Lanes M1 and 
M2, 1 kb DNA ladders. The following primer pairs were used to detect mutant cosmids: lanes 1-4, hrmC 
mutant cosmid with pairs XF26F/27R and XF27F/26R; lanes 5-8, hrmD cosmid with pairs XF26F/28R 
and XF28F/26R; lanes 9-12, hrmH mutant cosmid with pairs XF26F/29R and XF29F/26R; lanes 13-16, 
hrmI mutant cosmid with pairs XF26F/30R and XF30F/26R; lanes 17-20, hrmJ mutant with pairs 
XF26F/31R and XF31F/26R,; lanes 21-24, hrmN mutant cosmid with pairs XF26F/32R and 
XF32F/26R; lanes 25-28, hrmQ mutant cosmid with pairs XF26F/33R and XF33F/26R; lanes 1, 3, 5, 7, 
9, 11, 13, 15, 17, 19, 21, and 23, no DNA product amplified from pHR6G10 (as negative controls); 
lanes 25 and 27, no DNA product amplified from pHR1F4 (as negative controls). 
 
The mutant cosmids were confirmed based on step-wise PCR analysis and subsequently 
transformed into methylation-deficient E. coli ET12567/pUZ8002 to create demethylated 
mutant cosmids for further protoplast transformation. The demethylated hrmN and hrmQ 
mutant cosmids were individually introduced into S. griseoflavus W-384 through either 
protoplast transformation or conjugation. Unfortunately, multiple attempts failed to generate 
hrmN mutant strain. Only one potential hrmQ mutant strain was obtained. For further 
confirmation, the genomic DNA isolated from this strain were analyzed by PCR using the same 
primer pairs applied in the previous screening of the hrmQ mutant cosmid (Figure 3.40A, lane 
3; Figure 3.40B, lanes 9-16). 
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Figure 3.40: Agarose gel analysis of the PCR products from the ΔI and ΔQ. A, M, 1 kb DNA ladder; 1, 
no PCR product from the WT (as a negative control); 2, and 3, the apr
R
 from the ΔI and the ΔQ. B, 
Lanes M1 and M2, 1 kb DNA ladders; lanes 1-8, PCR analysis of the ΔI; lanes 1 and 2, PCR products 
from the WT and ΔI using the primer pair XF21F/21R for the hrmI; lanes 3 and 4, PCR products from 
the WT and ΔI using the primer pair XF30F/30R for the DNA fragment containing the aprR cassette 
(~1.85 kb); lanes 5 and 6, PCR products from the WT and ΔI using the primer pair XF26F/30R for the 
DNA fragment containing one part of apr
R
 (~1.0 kb); lanes 7 and 8, PCR products from WT and ΔI 
using the primer pair XF30F/26R for the DNA fragment containing the other part of apr
R
 (~1.0 kb). 
Lanes 9-16, PCR analysis of the ΔQ, which was similar to that of the ΔI using the different primer paris 
XF22F/22R, XF33F/33R, XF26F/33R and XF33F/26R. Lanes 9, 10, 11, 13 and 16, PCR products 
from the WT, as negative controls. 
 
The genotype of the ΔQ generated was verified based on the results of PCR analysis. 
Subsequent cultivation of the ΔQ and WT strains was carried out for further analyzing the 
secondary metabolites. After five days of fermentation, the culture supernatants were extracted 
with EtOAc, evaporated, and redissolved in 500 µL methanol. The extracts from the ΔQ and 
WT strains were analyzed first by HPLC, but the results did not show an obvious difference 
between the two cultures at UV of 273 nm. Since the wild type strain only provides a small 
amount of HRM, a more sensitive detection method (LC-MS) was employed to identify the 
metabolites and to make sure that the disruption of hrmQ was successful. The NRPS can accept 
and incorporate other metabolites instead of the missing building blocks. Therefore, even if the 
ΔQ mutant abolished the production of HRM, it is still able to accumulate the HRM A1 with a 
loss of chlorine (described in 3.2.2). The exact mass of HRM A1 is 1095.515 Da [M+H]
+
, 
which is present in the WT. LC-MS analysis of the extracts from the WT and ΔQ strains 
showed that the EIC of 1129.476 Da [M+H]
+
 (HRM) was not detected in the ΔQ, relative to 
that of the WT (Figure 3.41).  
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Figure 3.41: LC-MS analysis of the extracts from the WT, ΔQ and ΔQ/HrmQ strains. A, Comparison of 
the EICs of 1129.476 Da [M+H]
+
 (HRM) from the WT, ΔQ and ΔQ/HrmQ strains. B, Observed exact 
mass of HRM at 12.8 min. 
 
To check if the ΔQ mutant can accumulate HRM A1, the exact mass of 1095.515 Da [M+H]
+
 
was extracted from the LC-MS data of the both strains. The results showed that the EIC of 
1095.515 Da [M+H]
+
 was observed in the WT and ΔQ strains (Figure 3.42). 
 
 
Figure 3.42: LC-MS analysis of the extracts from the WT, ΔQ and ΔQ/HrmB strains. A, Comparison of 
EICs of 1095.515 Da [M+H]
+
 (HRM A1) from the WT, ΔQ, and ΔQ/HrmB strains. B, Observed exact 
mass of HRM A1 at 9.5 min. 
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To further identify the essential role of HrmQ in the biosynthesis of HRM, the complement of 
ΔQ, ΔQ/HrmQ, was generated by introducing the hrmQ expression plasmid back into ΔQ. To 
construct this mutant, the hrmQ gene was amplified from the genomic DNA of WT using a 
primer pair of XF22F/22R, then ligated into pBluescript SK(II)+ giving plasmid pXC23 for 
sequencing. The hrmQ fragment was purified from digestion of pXC23 with XbaI and PstI, and 
then inserted into pWHM4* to obtain pXC30 (Figure 3.43). 
 
 
Figure 3.43: Agarose gel analysis of the mutant complements. A, Lane M1, 100 bp DNA ladder; lanes 
1-7, purified PCR products of hrmC, hrmD, hrmH, hrmI, hrmJ, hrmN and hrmQ, respectively; lane 8, 
purified pBluescript SK(II)+ after digestion by EcoRI and XbaI; lane 9, purified PCR product of hrmB; 
lane 10, purified pBluescript SK(II)+ after digestion by PstI and XbaI; lane 11, purified pWHM4* after 
digestion by EcoRI and XbaI; lane 12, purified pWHM4* after digestion by PstI and XbaI; lane M2, 1 kb 
DNA ladder. B, Lanes 1-3, digestion of pXC17; 4-6, digestion of pXC18; lanes 7-9, digestion of pXC19; 
lanes 10-12, digestion of pXC20; lanes 13-15, digestion of pXC21; lanes 16-18, digestion of pXC22; 
lanes 19-21, digestion of pXC23; lane M, 100 bp DNA ladder. C, Lane M, 1 kb DNA ladder; lanes 1-3, 
digestion of pXC24; lanes 4-6, digestion of pXC25; lanes 7-9, digestion of pXC26; lanes 10-12, 
digestion of pXC27; lanes 13-15, digestion of pXC28; lanes 16-18, digestion of pXC29. D, Lane M, 1 
kb DNA ladder; lanes 1-3, digestion of pXC30. F, Lane M, 1 kb DNA ladder; lanes 1-4, digestion of 
plasmids isolated from transformants of genomic DNA from ΔQ/HrmQ into E. coli DH5ɑ.  
 
pXC30 was introduced into E. coli/ET12567 yielding the non-methylated DNA. The resulting 
demethylated pXC30 was finally transformed into the hrmQ mutant to obtain the complement 
of ΔQ, ΔQ/HrmQ (Figure 3.43). LC-MS analysis showed that ΔQ/HrmQ restored HRM 
production (Figure 3.41). Since HRM production was significantly increased in the WT via 
overexpression of HrmB (described in chapter 4), the hrmB overexpression plasmid was also 
transformed into the ΔQ to give ΔQ/HrmB in order to improve the production of HRM A1. In 
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Figure 3.42, it was shown that the ion peak of 1095.515 Da [M+H]
+
 was
 
increased, but the 
production of this compound was still very low, which was insufficient for further isolation 
and structural characterization. The failure in significant increase of expected compound in ΔQ 
is probably because of the complex regulation system in Streptomyces spp..  
 
Based on these results along with previous combinatorial biosynthesis of hrmQ, it is further 
confirmed that HrmQ acts as a chlorinase catalyzing the chloration of HRM. 
 
3.3.2 (3-Ncp)Ala biosynthesis 
Previous feeding experiments have revealed that the two units of (3-Ncp)Ala in HRM are 
derived from lysine (Brandl et al., 2005), which are biosynthesized before assembly of the 
peptide lactone (Kozhushkov et al., 2005). However, the biosynthetic pathway of ΔQ is still 
unknown. Only few examples of peptides are known containing nitro groups or cyclopropyl 
building blocks (Winkler and Hertweck 2007; Kelly et al., 2007; Grogan and Cronan 1997), but 
no homologs for these building blocks are encoded in the hrm cluster. All the hrm genes were 
analyzed to predict their functions during the HRM biosynthesis. However, three hrm genes 
remain unassigned. One is the hrmT gene encoding a protein that resembles diaminopimelate 
epimerases catalyzing the penultimate step in lysine biosynthesis (Scapin and Blanchard 1998). 
As lysine is a precursor of (3-Ncp)Ala, HrmT presumably serves to provide lysine for the HRM 
biosynthesis. The additional remaining genes hrmI and hrmJ have no closer similarity to 
characterized proteins, but their closest relatives are clustered together with a hrmT homolog in 
S. avermitilis, suggesting a role in lysine transformation. It is known that only few examples of 
proteins are involved in the generation of nitro groups or cyclopropyl units (Gu et al., 2009; 
Kelly et al., 2007; Vaillancourt et al., 2005). However, none of their homologs were found 
encoded in HRM biosynthetic gene cluster. In this study, the possible roles of hrmI and hrmJ 
were investigated in the (3-Ncp)Ala biosynthesis in vivo via gene knock-outs and complements. 
In addition, HrmI was heterologously expressed for further enzymatic assay in vitro to assess its 
role of biosynthesis of (3-Ncp)Ala. 
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5.2.2.1 Functional analysis of hrmI and hrmJ in vivo 
The cosmid pHR6G10 containing hrmI and hrmJ, was used for generation of hrmI and hrmJ 
mutants via PCR-targeted gene replacement, in a similar method described for hrmQ mutant. 
The initial amplification of apramycin resistance cassette is shown in Figure 3.36. The hrmI 
and hrmJ mutant cosmids were confirmed by PCR analysis, shown in Figure 3.37-Figure 3.39, 
then transformed into E. coli ET12567/pUZ8002 to obtain demethylated DNA. The resulting 
mutant cosmids were individually introduced into S. griseoflavus W-384 through protoplast 
transformation. Screening of apramycin resistant transformants was performed via 
identification of their genomic DNA by amplification (Figure 3.44). 
 
 
Figure 3.44: Agarose gel analysis of the ΔI and ΔJ strains. Lanes 1-8, Identification of the ΔI. Lanes 2, 
4, 6 and 8, PCR products from the ΔI genomic DNA using the primer pairs XF21F/21R (hrmI gene), 
XF30F/30R (DNA fragments containing apr
R
 cassette), XF26F/30R (DNA fragments containing one 
part of apr
R
 cassette) and XF30F/26R (DNA fragments containing the other part of apr
R
 cassette); lanes 
1, 3, 5 and 7, PCR products from the WT genomic DNA, as negative controls. Lanes 9-16, 
Identification of the ΔJ. Lanes 10, 12, 14, and 16, PCR products from the ΔJ genomic DNA using the 
primer pairs XF23F/23R (hrmJ gene), XF31F/31R (DNA fragments containing apr
R
 cassette), 
XF26F/31R (DNA fragments containing one part of apr
R
 cassette) and XF31F/26R (DNA fragments 
containing the other part of apr
R
 cassette); lanes 9, 11, 13 and 15, PCR products from the WT genomic 
DNA; lane M, 1 kb DNA ladder.  
 
The PCR results showed that hrmI and hrmJ could not be amplified from ΔI and ΔJ, 
respectively. The DNA fragments amplified from both mutants were about 1.85 kb that 
contains the apr
R
 cassette, while the ones from the WT using the same primer pairs carried hrmI 
and hrmJ, with corresponding sizes of ~1.55 kb and 1.15 kb, respectively. Therefore, the DNA 
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fragments amplified from the mutants were larger than those from the WT. Based on the sizes 
of DNA fragments amplified shown in Figure 3.44, it is proposed that the genotypes of these 
two mutants were correct, and were used for further experiments. 
 
Similar to ΔQ, it was difficult to recognize the difference between ΔI, ΔJ and WT by HPLC. 
Therefore, LC-MS was employed to analyze their extracts. The EICs of 1129.476 Da [M+H]
+ 
(HRM) extracted from LC-MS analysis of the ΔI and WT were compared (Figure 3.45).  
 
 
Figure 3.45: LC-MS analysis of the WT, ΔI, ΔI/HrmI and ΔI/HrmB fed with (3-Ncp)Ala. A, 
Comparison of the EICs of 1129.476 Da [M+H]
+ 
from the WT, ΔI, ΔI/HrmI and ΔI/HrmB fed with 
(3-Ncp)Ala. B, Observed exact mass of HRM at 13.1 min. 
 
The results showed that ΔI lost the ability to produce HRM completely, and accumulated 
compound with the exact mass of 1043.540 Da [M+H]
+
, observed in the WT (Figure 3.46). 
This exact mass was identical to that of HRM A5 possessing two units of leucine instead of 
(3-Ncp)Ala. Therefore, it was postulated that hrmI was involved in the biosynthesis of 
(3-Ncp)Ala.  
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Figure 3.46: LC-MS analysis of the WT, ΔI, ΔI/HrmI, ΔI/HrmB and ΔI/HrmB fed with (3-Ncp)Ala. A, 
Comparison of the EICs of 1045.537 Da [M+H]
+
 (HRM A5)
 
from the WT, ΔI, ΔI/HrmI, ΔI/HrmB and 
ΔI/HrmB fed with (3-Ncp)Ala. B, Observed exact mass of HRM A5 at 23.5 min. 
 
The expression plasmid carrying additional copy of hrmB was transformed into ΔI yielding 
mutant strain ΔI/HrmB, to obtain a sufficient amount of HRM A5 in ΔI for further analysis. To 
investigate the essential role of HrmI, the complement of ΔI was constructed by introducing 
HrmI expression plasmid back to ΔI, assigned as ΔI/HrmI to restore the HRM production. The 
identification of these constructs was carried out by digestions of plasmids from transformants 
generated from introducing genomic DNA of corresponding mutants into E. coli DH5ɑ (Figure 
3.47).  
 
 
Figure 3.47: Agarose gel analysis of the ΔI/HrmB, ΔI/HrmI, ΔJ/HrmJ and ΔJ/HrmB by digestions. 
Lanes M1 and M2, 1 kb DNA ladders; lanes 1-4, digestions of plasmids from ΔI/HrmB by XbaI and 
EcoRI; lanes 5-8, digestions of plasmids from ΔI/HrmI by XbaI and PstI; lanes 9-12, digestions of 
plasmids from ΔJ/HrmJ by XbaI and EcoRI; lanes 13-16, digestions of plasmids from ΔJ/HrmB by XbaI 
and EcoRI.  
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Subsequently, these resulting mutants were individually cultivated. The extracts from the 
fermentation cultures were analyzed by LC-MS (Figure 3.45 and Figure 3.46). The EIC of 
1129.476 Da [M+H]
+ 
(HRM) from ΔI/HrmI in Figure 3.45 revealed that HRM production was 
restored, while the intensity of the ion belonging to HRM A5, as seen in the EIC of 1043.537 Da 
[M+H]
+
,
 
 (Figure 3.46) was reduced. The increased intensity of ΔI/HrmB in the EIC of 
1043.537 Da [M+H]
+ 
suggested that HrmB overexpression upregulated the production. 
However, yields were still insufficient for MS/MS and NMR analysis. Based on these results, it 
was proposed that hrmI is involved in the biosynthesis of (3-Ncp)Ala. To test whether 
supplement of (3-Ncp)Ala in the ΔI/HrmB can restore HRM production, ΔI/HrmB was fed 
with (3-Ncp)Ala gradually during fermentation with final concentration of 0.3 mg/mL. The 
extracts from the resulting culture was analyzed by LC-MS. LC-MS data showed that HRM 
production was restored by supplementation of (3-Ncp)Ala (Figure 3.45).  
 
A series of experiments similar to those of hrmI were also conducted to analyze the function of 
hrmJ. The construction of the hrmJ knock-out mutant started with amplification of a 1.4 kb 
apr
R
 cassette (Figure 3.35). The initial hrmJ mutant cosmid was constructed and identified by 
PCR analysis shown in Figure 3.37-Figure 3.39. Then the hrmJ mutant cosmid was 
transformed into E. coli ET12567/pUZ8002 to obtain the demethylated DNA. The hrmJ mutant 
was grown on R5 plate with apramycin after introducing the demethylated hrmJ mutant cosmid 
into S. griseoflavus W-384 by PEG-mediated protoplast transformation. Identification of the 
resulting hrmJ mutant (ΔJ) was carried out by PCR analysis of genomic DNA from the mutant 
using appropriate primer pairs (Figure 3.44, lanes 9-16).  
 
The EIC of 1129.476 Da [M+H]
+ 
from LC-MS analysis of the ΔJ suggested that HRM 
production was abolished in the ΔJ completely (Figure 3.48), while a compound with the exact 
mass of 1043.537 [M+H]
+ 
was accumulated, which was also detected in the WT (Figure 3.49). 
Since this accumulated compound with the exact mass of 1043.537 in the WT is HRM A5 with 
two leucine instead of two (3-Ncp)Ala units, it was proposed that HrmJ, along with HrmI, play 
an essential role in the biosynthesis of (3-Ncp)Ala. 
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Figure 3.48: LC-MS analysis of the WT, ΔJ, ΔJ/HrmJ and ΔJ/HrmB fed with (3-Ncp)Ala. A, 
Comparison of the EICs of 1129.476 Da [M+H]
+  
from the WT, ΔJ, ΔJ/HrmJ and ΔJ/HrmB fed with 
(3-Ncp)Ala. B, Observed exact mass of HRM at 13.2 min. 
 
To further determine the essential role of HrmJ, the ΔJ complement (ΔJ/HrmJ) was generated 
by introducing the hrmJ expression plasmid into the ΔJ. The additional copy of hrmB was also 
introduced into ΔJ, yielding the ΔJ/HrmB to increase the production of accumulated compound 
in the ΔJ. These two resulting mutants were analyzed by enzymatic digestions shown in Figure 
3.47. Subsequent cultivation of these mutants were carried out, and the extracts from which 
supernatants were analyzed by LC-MS. 
 
The EIC of 1129.476 Da [M+H]
+
 from the LC-MS data of ΔJ/HrmJ showed that HRM 
production was restored by introducing HrmJ back to ΔJ, but the intensity was less than 
observed for the WT (Figure 3.48). The EIC of 1043.537 Da [M+H]
+ 
(HRM A5) from the 
LC-MS analysis of ΔJ/HrmB suggested that introduction of HrmB did not significantly 
upregulate the production of this compound again indicating the presence of a complex 
regulation system in this strain (Figure 3.49). 
 
Chapter 3 Results and Discussion 
91 
 
 
Figure 3.49: LC-MS analysis of the WT, ΔJ, ΔJ/HrmJ, ΔJ/HrmB and ΔJ/HrmB fed with (3-Ncp)Ala. A, 
Comparison of the EICs of 1045.537 Da [M+H]
+
 from the WT, ΔJ, ΔJ/HrmJ, ΔJ/HrmB and ΔJ/HrmB 
fed with (3-Ncp)Ala. B, Observed exact mass of HRM A5 at 23.3 min. 
 
To investigate the role of HrmJ in the biosynthesis of (3-Ncp)Ala, chemical feeding of 
(3-Ncp)Ala into the ΔJ/HrmB mutant was performed (Figure 3.49). As expected, HRM 
production was restored.  
 
Based on all functional studies of hrmI and hrmJ in vivo, it is suggested that HrmI and HrmJ 
directly participate in the biosynthesis of (3-Ncp)Ala. Previous characterization of HRM 
analogues revealed that HRM A5 exhibits the same exact mass as compounds produced by ΔI 
and ΔJ. HRM A5 possesses a structure with both (3-Ncp)Ala residues replaced by leucine. It 
was suspected that the substance accumulated in ΔI and ΔJ are identical to HRM A5. Given 
this hypothesis, leucine was fed into ΔI/HrmB and ΔJ/HrmB during the fermentation, 
respectively, to increase the production. Afterwards, the supernatants were extracted from 
their cultures independently, then applied to HPLC to analyze the peptide profiles. The results 
showed that the substance can only be detected by UV in ΔI/HrmB and ΔI/HrmB fed with 
leucine. As expected, after feeding leucine, the substance in ΔI/HrmB was increased about 
three times as compared to that in ΔI/HrmB without feeding (Figure 3.50).  
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Figure 3.50: LC-MS analysis of the extracts from the ΔI/HrmB and ΔI/HrmB fed with leucine. A, 
Comparison of UV spectra from the ΔI/HrmB and ΔI/HrmB fed with leucine at 24.2 min UV 273 nm. 
B, Observed exact mass of the substance in theΔI/HrmB and ΔI/HrmB fed with leucine at 24.2 min. 
 
However, HPLC analysis of the extracts from ΔJ/HrmB and ΔJ/HrmB fed with leucine 
showed that the substance in both scenarios was not observed from the UV spectra. Therefore, 
all of these extracts were further analyzed by LC-MS. The EIC of 1045.537 Da [M+H]
+
 was 
detected
 
in the LC-MS data from both ΔJ/HrmB and ΔJ/HrmB fed with leucine (Figure 3.51). 
 
 
Figure 3.51: LC-MS analysis of the extracts from the ΔJ/HrmB and ΔJ/HrmB fed with leucine. A, 
Comparison of EICs of 1043.537 Da [M+H]
+ 
from the ΔJ/HrmB and ΔJ/HrmB fed with leucine. B, 
Observed exact mass of HRM A5 at 24.3 min. 
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Results from the feeding experiments, along with those of previously feeding leucine into the 
HrmB overproducer, indicated that leucine can be readily incorporated by the hrm NRPS, 
which was also verified by adenylation domain studies in vitro (Crüsemann 2012).  
 
5.2.2.2 Heterologous expression of HrmI in vitro 
From the above experiments of hrmI and hrmJ in vivo, it was demenstrated that these two genes 
are involved in the biosynthesis of (3-Ncp)Ala. Previous feeding experiments suggested that 
(3-Ncp)Ala originating from lysine (Brandl et al., 2005), leading to the proposal of 
cyclopropanation in (3-Ncp)Ala (Figure 3.52). However, it is still unknown how these two 
proteins function during this process. Previous bioinformatic analysis based on standard 
BLAST and motif searches revealed that there are no obvious characterized homologs of these 
two proteins (Höfer et al., 2011). Therefore, PSI-BLAST was employed to search for more 
distant homologues. The results showed that HrmI shares homology to a distant homologue that 
is the characterized pyrroloquinoline quinone biosynthesis protein C (PqqC). PqqC is a 
well-known cofactorless oxidase catalyzing an eight-electron ring-closure oxidation reaction at 
the final step of PQQ biosynthesis (Magnusson et al., 2004) (Figure 3.52). The PSI-BLAST 
search also revealed that HrmJ is distantly similar to an α-ketoglutarate-dependent L-isoleucine 
dioxygenase found in Bacillus thuringiensis, catalyzing the hydroxylation of L-isoleucine to 
4-hydroxyisoleucine (Hibi et al., 2011). Based on the characterized functions of their 
corresponding homologs and previous feeding experiments (Brandl et al., 2005), the step-wise 
biosynthetic pathway of (3-Ncp)Ala was postulated, which assigned possible roles of HrmI and 
HrmJ (Figure 3.52). 
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Figure 3.52: A, Final step of PQQ biosynthesis catalyzed by PqqC. B, Postulated biosynthetic pathway 
of (3-Ncp)Ala from feeding studies. HrmI and HrmJ are proposed to be involved in this pathway. 
 
To investigate the precise steps of biosynthesis of (3-Ncp)Ala, these two proteins were 
heterologously expressed in the Piel group for in vitro enzymatic assays. In this study, the 
focus was heterologous expression of HrmI. 
 
The hrmI gene was amplified from genomic DNA of S. griseoflavus W-384 using primer pairs 
of HrmI-F/HrmI-R (for hrmI with its stop codon) and HrmI-F/HrmI-chis-R (for hrmI without  
a stop codon), respectively. The resulting PCR products were purified and then independently 
inserted into p-GEM easy for sequence analysis. The plasmids isolated from their 
corresponding transformants were identified by enzymatic digestion with HindIII and NdeI 
(Figure 3.53A). DNA sequencing revealed that the plasmids of clone 1-3 carried the correct 
complete hrmI gene. This plasmid was referred to as pXC35A. Clone 11, 12 and 14 all 
contained the correct hrmI gene without a stop codon, the plasmid from which was referred to 
as pXC35B. The hrmI gene fragments were subsequently purified after digestion of pXC35A 
and pXC35B by HindIII and NdeI, respectively. The expression vectors used here were 
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pET28b(+) (Figure 4.4) carrying both N and C terminal His-tags and pET29b(+) with only a C 
terminal His-tag. The hrmI gene with a stop codon was subcloned into pET28b (+) to obtain 
pXC36 for expression of HrmI contain N terminal His-tag. As an alternative, the hrmI gene 
without stop codon was ligated into pET29b (+) to get pXC37 for expressing HrmI protein 
carrying only a C terminal His-tag. After identification of these two expression plasmids 
(Figure 3.53B), they were transformed into E. coli BL21(DE) to obtain two heterologous 
expression strains of HrmI, respectively. 
 
 
Figure 3.53: Agarose gel analysis of the plasmids, pXC35A, pXC35B, pXC36 and pXC37 by 
enzymatic digestion. A, Lane M, 1 kb DNA ladder; lanes 1-7, screening for pXC35A by digestion with 
NdeI and HindIII; lanes 8-14, screening for pXC35B by digestion with NdeI and HindIII. B, Lane M, 1 
kb DNA ladder; lanes 1-4, screening for pXC36 by digestion with NdeI and HindIII; lanes 5-8, 
Screening for pXC37 by digestion with NdeI and HindIII.  
 
The resulting strains were grown in TB media supplemented with kanamycin at 37 °C to an 
OD600 of 1.5-2.0. Then the cultures were cooled down, and IPTG was added to induce protein 
expression. The cultures were kept shaking at 16 °C overnight. Afterwards, cell pellets were 
harvested and protein purification was carried out according to the procedure described in 
Chapter 4. The purified proteins were concentrated via trichloroacetic acid (TCA) precipitation. 
Roti
®
-Nanoquant solution was used to determine protein concentration. The identification of 
proteins was carried out by SDS-PAGE analysis (Figure 3.54).  
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Figure 3.54: SDS-PAGE (9%) of initial protein expression of HrmI. Lanes 1-5, the culture pellets after 
lysis. Lane 1, culture without induction; lanes 2-5, cultures for expression of, Nhis-HrmI (HrmI with a 
N terminal His-tag), Nonhis-HrmI (HrmI without any His-tag), (N+C)his-HrmI (HrmI with both C and 
N terminal His-tags) and Chis-HrmI (HrmI with a C terminal His-tag). Lane M, protein marker; lanes 
6-10, culture pellets of samples 1-5 diluted in 1:10; lanes 11-15, supernatants of samples 1-5 after lysis. 
Lanes 16-20, the proteins from samples 1-5 eluted with 250 mM elution buffer, respectively. 
 
To maintain the activity of HrmI for further storage, the protein stability assay of HrmI with N 
terminal His-tag (Nhis-HrmI) was conducted by exchanging buffers for this protein into 
different buffers with a range of pH 6.0-8.0 described in detail in Chapter 4. The SDS-PAGE 
suggested that the most stable buffer for this protein is 50 mM MES buffer (pH 6.0) (Figure 
3.55). 
 
 
Figure 3.55: SDS-PAGE (12%) of Nhis-HrmI stability assays. Lane 1, HrmI in 50 mM MES, pH 6.0, 
with 10% (v/v) glycerol; lane M, PageRuler™ Unstained Protein Ladder (molecular weights of 
pertinent standards labeled on the gel); lane 2, HrmI in 50 mM MES, pH 6.5, with 10% (v/v) glycerol; 
lane 3, HrmI in 50 mM potassium phosphate buffer at pH 7.0 with 10% (v/v) glycerol; lane 4, HrmI in 
50 mM potassium phosphate buffer at pH 7.5 with 10% (v/v) glycerol; lane 5, HrmI in 50 mM 
potassium phosphate buffer at pH 8.0 with 10% (v/v) glycerol; lane 6, HrmI in 50 mM potassium 
phosphate buffer at pH 8.5 with 10% (v/v) glycerol; lane 7, HrmI in 50 mM Tris buffer at pH 6.5 with 10% 
(v/v) glycerol; lane 8, HrmI in 50 mM Tris buffer at pH 7.0 with 10% (v/v) glycerol; lane 9, HrmI in 50 
mM Tris buffer at pH 7.5 with 10% (v/v) glycerol; lane 10, HrmI in 50 mM Tris buffer at pH 8.0 with 10% 
(v/v) glycerol. 
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The protein samples from stability assay were also tested to determin the protein concentration 
using Roti
®
-Nanoquant solution. After incubation of proteins in different buffers at 37 °C 
overnight, the protein concentration in MES buffer (pH 6.0 and 6.5) remained stable as before, 
while those in the other two buffers were less stable (Figure 3.56).  
 
 
Figure 3.56: Determination of Nhis-HrmI protein concentration and stability by using 
Roti
®
-Nanoquant. A, Nhis-HrmI in different buffers before incubation. B, Nhis-HrmI in different 
buffers after incubation. 
 
In the present study, functional analysis of hrmI and hrmJ by gene knock-outs, genetic 
complementations and chemical feeding studies demonstrated the essential role of these genes 
in the biosynthesis of (3-Ncp)Ala. The soluble HrmI protein was successfully expressed and 
the most stable buffer for this protein was established, which is 50 mM MES at pH 6.0, with 10% 
(v/v) glycerol. Further enzymatic studies will be carried out with the postulated substrate for 
HrmI or starting with L-Lys for both HrmI and HrmJ. 
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3.3.3 (4-Pe)Pro biosynthesis 
Previous feeding experiments have revealed that (4-Pe)Pro is generated from L-tyrosine via a 
similar pathway found in lincomycin (Hu et al., 2007) and pyrrolo[1,4]benzodiazepine 
(anthramycin, tomaymycin and sibiromycin) biosynthesis (Höfer et al., 2011; Hurley 1980; Li 
et al., 2009a; Li et al., 2009b). Bioinformatic analysis suggested that the hrm system contains 
the clustered genes hrmCDEFG, which are homologs found correspondingly in the gene clustes 
of these compounds (Figure 3.57) (Hu et al., 2007; Li et al., 2009a; Li et al., 2009b; Peschke et 
al., 1995). HrmF, homologous to the characterized LmbB1, has been identified to as a 
dioxygenase from the linconmycin biosynthetic pathway performing the cleavage of a 
L-DOPA to the pyrroline intermediate (Colabroy et al., 2008; Höfer et al., 2011). HrmE shows 
similarity to LmbB2 in lincomycin biosynthesis. Studies on LmbB2 provide indirect evidence 
that it hydroxylates L-Tyr to give L-DOPA (Neusser et al., 1998). The next steps in (4-Pe)Pro 
formation likely consist of a methylation catalyzed by HrmC and another carbon-carbon bond 
cleavage performed by HrmD (Figure 3.57). Both enzymes have homologs in the lincomycin 
pathway, which generates 4-propylproline (Peschke et al., 1995). HrmG encoding a putative 
γ-glutamyltransferase, is likely involved in biosynthesis of the unusual cytochrome F420-like 
cofactor (Peschke et al., 1995). Unexpectedly, among the gene cluster generating 
(4-Pe)Pro-related residues, only the hrm system does not encode LmbX-homolog that is 
proposed to catalyze the cleavage of pyrroline intermediate (Li et al., 2009a; Li et al., 2009b). 
In this study, Southern hybridization was conducted to search for the gene related to lmbX in the 
genomic DNA of HRM producer. In addition, the roles of hrmC and hrmD in HRM 
biosynthesis were analyzed via gene knock-outs and complementations.  
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Figure 3.57: Postulated biosynthetic pathway of (4-Pe)Pro. Enzyme homologs from the lincomycin 
(Lmb), anthramycin (ORFxy), sibiromycin (Sib), tomaymycin (Tom) pathways are also shown. Proteins 
in parentheses were proposed to convert variants of the substrates shown (Höfer et al., 2011). 
 
3.3.3.1 Screening for an lmbX homolog  
LmbX has been shown to be essential in the biosynthesis of propylproline moiety in lincomycin 
(Ulanova et al., 2010).Therefore it was wondered whether an LmbX homolog might be 
encoded on an unclustered part in the genome of S. griseoflavus W-384. To search for this gene, 
the genomic DNA of HRM producer was initially tested using the degenerated primers derived 
from an alignment of lmbX with all known homologs (sibS, tomK, and ORF15 from 
anthramycin) by amplification. However, no PCR product was observed. To test whether this is 
a false-negative result generated by non-matching primers, an lmbX hybridization probe was 
generated to further detect its homolog in the genomic DNA by Southern blotting. Likewise, the 
arrayed library of HRM was screened using the same probe by colony in situ hybridization.  
 
The lmbX gene fragment was amplified from the genomic DNA of lincomycin producer 
Streptomyces lincolnensis NRRL 2936 using the primer pair of XF6F/6R. The PCR products 
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were ligated into pBluescript SK(+) to give pXC7 and end sequenced. The lmbX gene fragment 
was digested with HindIII and EcoRI from pXC7and labeled using the DIG-High Prime DNA 
Labeling Kit, which was used as a probe for hybridization. 
 
 
Figure 3.58: Screening for lmbX-like gene in the genomic DNA of S. griseoflavus W-384 by Southern 
blotting using lmbX as a probe derived from S. lincolnensis NRRL 2936. A, DNA agarose gel before 
hybridization. Lane M1, 100 bp DNA ladder; lane 1, lmbX gene; 2, genomic DNA digested by BamHI; 
lane 3, genomic DNA digested by BglII; lane 4, genomic DNA digested by EcoRI; lane 5, genomic 
DNA digested by HindIII; lane 6, genomic DNA digested by PstI; lane M2, 1 kb DNA ladder. B, Lane 1, 
labeled lmbX after hybridization; lanes 2-6, no DNA fragment is labeled from any digestion of genomic 
DNA after hybridization. 
 
Unfortunately, Southern hybridization using an lmbX-derived probe together with either 
genomic DNA (Figure 3.58) or the arrayed library was unsuccessful. During the later course of 
our studies, a draft genome sequence of S. griseoflavus Tü 4000, which is identical to the HRM 
producer, became available (GenBank: NZ_GG657758.1). Investigation of the genome 
revealed the presence of the hrm cluster. In agreement with the PCR and Southern studies, the 
draft genome lacked an lmbX homolog. 
 
3.3.3.2 Functional analysis of hrmC and hrmD in vivo 
To knockout hrmC and hrmD, the initial apr
R
 cassettes for hrmC and hrmD mutations were 
amplified using the primers XF12F/12R and XF13F/13R, respectively (Figure 3.36). The 
hrmC and hrmD mutant cosmids were derived from pHR6G10, both of which were identified 
by PCR analysis before transformation into E. coli ET12567 to obtain demethylated DNA 
(Figure 3.37-Figure 3.39). The candidates for hrmD mutant were successfully grown on an R5 
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plate containing apramycin after protoplast transformation with demethylated hrmD mutant 
cosmid into S. griseoflavus W-384. In contrast, many attempts to introduce the hrmC mutant 
cosmid into S. griseoflavus W-384 failed to generate the hrmC mutant. The genotype of hrmD 
mutant was verified by PCR analysis of its genomic DNA (Figure 3.59).  
 
 
Figure 3.59: Agarose gel analysis of ΔD by PCR. Lane M, 100 bp DNA ladder; lanes 2, 4, 6, 8 and 10, 
PCR products amplified from the genomic DNA of ΔD using the primer pairs XF1F/1R for aprR (~800 
bp), XF20F/20R for the hrmD gene (~900 bp), XF28F/28R for the DNA fragment containing the apr
R
 
cassette (~1.85 kb), XF28F/26R for the DNA fragment containing a half of the apr
R
 cassette (~1.0 kb) 
and XF26F/28R for the other half of the apr
R
 cassette (~1.0 kb), respectively; lanes 1, 3, 5, 7 and 9, 
PCR products amplified from the genomic DNA of WT using the same primer pairs, respectively (as 
negative controls).  
 
Similar to previous experiments, the ΔD complement (ΔD/HrmD) was constructed by 
expression of HrmD in ΔD. In addition, a HrmB overexpression plasmid was introduced into 
ΔD to obtain ΔD/HrmB for improving the production of substance. Both strains were identified 
by enzymatic digestions of plasmids from transformants of their genomic DNA into E .coli 
DH5ɑ (Figure 3.60). Subsequently, all the strains including the WT, ΔD, ΔD/HrmD and 
ΔD/HrmB were individually cultivated in the fermentation media for analyzing the secondary 
metabolites. As shown in Figure 3.33, it was identified that HrmD is involved the biosynthesis 
of (4-Pe)Pro residue in HRM. 
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Figure 3.60: Agarose gel analysis of ΔD/HrmD and ΔD/HrmB by enzymatic digestions. Lane M, 1 kb 
DNA ladder; lanes 1-4, digestions of plasmids by XbaI and EcoRI isolated from the transformants after 
introducing genomic DNA of ΔD/HrmD into E. coli DH5ɑ; lanes 5-8, digestions of plasmids by XbaI 
and EcoRI isolated from the transformants after introducing genomic DNA of ΔD/HrmB into E. coli 
DH5ɑ. 
 
In this section, it was demonstrated that the LmbX-homolog is not needed for the biosynthesis 
of (4-Pe)Pro by hybridization. Functional analysis of hrmD by gene knock-out, 
complementation and chemical feeding experiments revealed its essential role in (4-Pe)Pro 
biosynthesis.  
 
3.3.4 Generation of hormaomycin analogues by mutasynthesis 
Many HRM analogues have been generated by precursor-directed biosynthesis. Since the 
supplemented amino acids compete with the natural precursors, the peptide analogs were 
always obtained in low yields as side products together with authentic HRM, and purification of 
new compounds has also been a problem (Radzom 2006). These disadvantages can be 
eliminated by, prior to feeding, genetically inactivating the production of the amino acid that is 
to be replaced, referred to as mutasynthesis. This strategy was employed to investigate and 
exploit the hrm pathway for analogue production more efficiently. 
 
Click chemistry serves as a practical chemical approach for generating a specific substance 
quickly and reliably by joining two small units together (Kolb et al., 2001). It has become a 
powerful tool applied in many areas, such as, drug discovery, combinatorial chemistry, 
bioconjugation, and radiolabeling. The azide-alkyne cycloaddition catalyzed by copper (I) 
Chapter 3 Results and Discussion 
103 
 
(Figure 3.61A) is a particularly powerful linking reaction, due to its high quantitative yields, 
efficiency and specificity (Sekhon 2012). Bioconjugation using the cycloaddition of azides and 
acetylenes has been successfully applied in tagging living organisms (Deiters et al., 2003; Link 
and Tirrell 2003), profiling activity-based proteins (Speers et al., 2003) for drug development 
and labeling DNA for sequencing (Seo et al., 2003).  
 
 
Figure 3.61: Classic click chemistry and its application. A, Copper(I)-catalyzed azide–alkyne 
cycloaddition. B, Putative bioconjugation using the cycloaddition of biotin azide and ethinyl-HRM 
analogue to determine the HRM cellular target.  
 
The cellular targets of HRM hormonal and antibacterial activities were hoped to be 
investigated (Figure 3.61B) via bioconjugation using the cycloaddition of azides and 
acetylenes and eventually to investigate their corresponding mechanism of action. To employ 
this reaction, an alkyne-based HRM analogue is required. Since chemical synthesis of this 
compound is very complex and time-consuming, this compound was expected to be generated 
via mutagenesis by feeding 4-ethinylproline [(4-Et)Pro] into ΔD. 
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Approximately 25 mg of (2S, 4S)-4-ethinylproline [(4-Et)Pro] was synthesized initially by 
Christoph Kohlhaas. The chemical feeding experiment of ΔD/HrmB with (4-Et)Pro was firstly 
conducted at a small scale. 50 mL of ΔD/HrmB production media was supplemented with 10 
mL (4-Et)Pro (2 mg/mL) every 12 h for 5 times to a final concentration of 0.33 mg/mL. The 
resulting culture supernatant was extracted and analyzed by LC-MS (Figure 3.62). The data 
revealed a new compound designated as HRM A8 with a mass of 1113.456 Da [M+H]
+
 
matching to the calculated mass of 1113.445 Da [M+H]
+
. 
 
 
Figure 3.62: LC-MS analysis of the extracts from the ΔD/HrmB and ΔD/HrmB fed with (4-Et)Pro. A, 
Comparison of UV spectra of ΔD/HrmB and ΔD/HrmB fed with (4-Et)Pro at 273 nm. B, Observed 
exact mass of HRM A8 at 8.9 min. 
 
To test the bioactivity of this new compound for further studies, very small amount of HRM 
A8 was isolated by preparative HPLC and applied to bioassay against A. crystallopoietes 
ATCC15481. The inhibition zone suggested HRM A8 was antibacterially active (Figure 3.63), 
and encouraged us to obtain more of this compound for further structural characterization and 
bioassay tests. 
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Figure 3.63: Bioassay test of HRM A8 against A. crystallopoietes ATCC15481. 
 
To obtain sufficient amounts of required compound for structural elucidation, 100 mg 
(4-Et)Pro was synthesized by Pia Schmidt. Subsequent cultivation was carried out at multiple 
small scales in parallel because S. griseoflavus W-384 produces very small amounts of 
metabolites in large scale fermentation. 100 mg (4-Et)Pro was dissolved in 50 mL sterilized 
distilled water to a final concentration of 2 mg/mL. 250 mL production medium of ΔD/HrmB 
was devided into 5 flasks. Each 50 mL production medium was fed with 10 mL of (4-Et)Pro 
as described above. After feeding, the supernatant from the resulting fermentation culture was 
combined and extracted with EtOAc. The extracts were applied to preparative HPLC. 
Unexpectedly, the UV chromatography of the HPLC showed that one more peak adjacent to 
HRM A8 was observed. To obtain good separation of these two compounds, the HPLC method 
was optimized by Andeas Schneider, and eventually obtained 1.8 mg of fraction 1 (Frac. 1) at 
11.42 min and 1.9 mg of fraction 2 (Frac. 2) at 12.41 min (Figure 3.64). These two fractions 
were further analyzed using MS/MS and NMR by Dr. Roberta Teta. 
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Figure 3.64: Preparative HPLC analysis of extracts from chemical feeding ΔD/HrmB with (4-Et)Pro. 
 
MS/MS spectra of these two compounds were analyzed by Dr. Roberta Teta according to the 
pattern of tandem MS fragmentation of HRM A8-1, derived from that of HRM (Figure 3.65).  
 
 
Figure 3.65: Fragmentation of HRM A8-1 as observed in the ESI MS
2
 and MS
3
 spectra. 
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The fragmentations of HRM A8-1 and HRM A8-2 were summarized in Table 3.6. All the 
MS/MS and NMR analysis of these two compounds were conducted by Dr. Roberta Teta. 
 
Table 3.6: Most significant fragment ions observed in the ESI-MS
2
 and –MS3 spectra of hormaomycin, 
HRM A8-1, and HRM A8-2. 
Fragment HRM HRM A8-1 HRM A8-2 
[M+Na]
+
 
1151.4546 
C55H69N10O14Na
+
 
1135.4260 
C54H65N10O14Na
+
 
1135.4237 
C54H65N10O14Na
+
 
x7 
1034.4586 
C51H65N9O13Na
+
 
1018.4281 
C50H61N9O13Na
+
 
1018.4261 
C50H61N9O13Na
+
 
x7 → db5 
897.3749 
C43H54N8O12Na
+
 
897.3715 
C43H54N8O12Na
+
 
897.3732 
C43H54N8O12Na
+
 
x7 → da5 
851.3697 
C42H52N8O10Na
+
 
851.3662 
C42H52N8O10Na
+
 
851.3679 
C42H52N8O10Na
+
 
x7 → db4 
784.2915 
C37H43N7O11Na
+
 
784.2879 
C37H43N7O11Na
+
 
784.2894 
C37H43N7O11Na
+
 
x7 → da4 
738.2852 
C36H41N7O9Na
+
 
738.2826 
C36H41N7O9Na
+
 
738.2849 
C36H41N7O9Na
+
 
x7 → db3 
623.2069 
C27H32N6O10Na
+
 
623.2044 
C27H32N6O10Na
+
 
623.2055 
C27H32N6O10Na
+
 
x7 → da3 
577.2011 
C26H30N6O8Na
+
 
577.1990 
C26H30N6O8Na
+
 
577.2002 
C26H30N6O8Na
+
 
y7 
1008.4798 
C50H67N9O12Na
+
 
992.4492 
C49H63N9O12Na
+
 
992.4469 
C49H63N9O12Na
+
 
x6 
878.4059 
C45H57N7O10Na
+
 
862.3750 
C44H53N7O10Na
+
 
862.3729 
C44H53N7O10Na
+
 
y6 
852.4266 
C44H59N7O9Na
+
 
836.3957 
C44H59N7O9Na
+
 
836.3936 
C44H59N7O9Na
+
 
dy5 
769.3888 
C40H54N6O8Na
+
 
753.3585 
C39H5oN6O8Na
+
 
753.3567 
C39H5oN6O8Na
+
 
dy5 → b4 
632.3046 
C32H43N5O7Na
+
 
632.3048 
C32H43N5O7Na
+
 
632.3039 
C32H43N5O7Na
+
 
dy5 → a4 
586.2992 
C31H41N5O5Na
+
 
586.2992 
C31H41N5O5Na
+
 
586.2984 
C31H41N5O5Na
+
 
dy5 → b3 
519.2206 
C26H32N4O6Na
+
 
519.2206 
C26H32N4O6Na
+
 
519.2199 
C26H32N4O6Na
+
 
dy5 → a3 
473.2153 
C25H30N4O4Na
+
 
473.2153 
C25H30N4O4Na
+
 
473.2146 
C25H30N4O4Na
+
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HRM A8-1. The [M+Na]
+
 pseudomolecular ion peak of HRM A8-1 observed at m/z 1135.4260 
in the high-resolution ESI mass spectrum indicated the molecular formula C54H65N10O16Cl 
(calcd. m/z 1135.4262 for C54H65N10O16ClNa), differing from HRM by one less carbon atom 
and one more degree of unsaturation. This corresponds to the expected formula from replacing 
the (4-Pe)Pro of HRM with a (4-Et)Pro residue. The MS
2
 and MS
3
 spectra confirmed that the 
difference of HRM A8-1 from HRM is located in the proline residue. Because the fragmentation 
of HRM has been studied in detail, the assignment of the observed fragments was 
straightforward. All the fragment ions containing the proline residue (x7, y7, x6, y7, and dy7) 
were less than the respective fragments of HRM by 16 amu, while the remaining fragment ions 
were identical (Figure 3.65 and Table 3.6).  
 
HRM A8-2. The [M+Na]
+
 pseudomolecular ion peak of HRM A8-2 at m/z 1135.4237 suggested 
the same molecular formula C54H65N10O16Cl as for HRM A8-1, and the fragments obtained 
from MS
2
 and MS
3
 were also identical. Full 
1
H and 
13
C NMR assignment of HRM A8-2 was 
achieved through 1D and 2D spectra, which also showed that all the planar structure of the 
compound is the same as HRM A8-1. Therefore, the two compounds are stereoisomers. The 
most remarkable differences in the 
1
H NMR signals were the signals of (4-Et)Pro (Table 3.7), 
suggesting a different configuration at (4-Et)Pro-C4, i.e. a different orientation of the ethinyl 
group. The ROESY spectrum displayed an intense NOE between (4-Et)Pro-H2 and -H4, 
demonstrating that these two protons are on the same side of the proline five-membered ring. 
This established the R configuration at (4-Et)Pro-C4. 
 
Full NMR characterization of HRM A8-1 (Figure 3.66) was achieved using the usual set of 2D 
NMR experiments, including COSY, TOCSY, ROESY, HSQC, and HMBC (Table 3.7 and 
Figure 3.67-Figure 3.73). The 
1
H NMR spectrum was similar to that of HRM, except for the 
absence of the signals of the propenyl side chain and the presence of a singlet at δ 2.56 
attributable to a terminal alkyne proton. This showed correlation peaks in the HMBC spectrum 
with (4-Et)Pro-C4 (δ 30.9) and -C1’ (δ 83.5). The latter correlation peak was characterized by a 
very large 
2
JCH (49.5 Hz), which is peculiar of terminal alkynes. The HMBC spectrum also 
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displayed the one-bond correlation between (4-Et)Pro-H2’ and -C2’, which was important for 
the assignment of (4-Et)Pro-C2’ because the relevant correlation peak was not visible in the 
HSQC spectrum (probably because the 
1
JCH between the two nuclei, 250.0 Hz, was very 
different from the value for which the experiment was optimized, 155 Hz). The location of the 
ethinyl group was confirmed by the long range coupling (2.4 Hz) of the alkyne proton 
(4-Et)Pro-H2’ with (4-Et)Pro-H4 evidenced by the COSY spectrum. The stereochemistry at 
(4-Et)Pro-C4 was determined as S on the basis of the weak NOE between (4-Et)Pro-H2’ and 
-H2 observed in the ROESY spectrum, and of the absence of any NOE between (4-Et)Pro-H2 
and –H4 (which on the contrary was evident in the stereomeric HRM A8-2 (Figure 3.66), see 
Table 3.7 and Figure 3.74-Figure 3.80.  
 
 
Figure 3.66: The structure of HRM A8-1 and HRM A8-2. 
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Table 3.7: NMR spectroscopic data for compounds HRM A8-1 and HRM A8-2 (700 MHz, CD3OD) 
   HRM A8-1 HRM A8-2 
AA Pos.  H [mult., J (Hz)]  C [mult.] H [mult., J (Hz)]  C [mult.] 
(4-Etynyl)Pro 
(I) 
1  - 173.7 I - 173.5 I 
(4-Etynyl)Pro 
(I) 
2  4.14 (t, 7.6) 61.0 (CH) 4.00 (dd, 11.2, 6.2) 61.9 (CH) 
(4-Etynyl)Pro 
(I) 
3 a 2.25 (ddd, 12.8, 
7.6, 5.4) 
36.1 (CH2) 2.53 (ddd, 12.2, 6.1, 6.1) 36.6 (CH2) 
(4-Etynyl)Pro 
(I) 
3 b 2.19 (ddd, 12.8, 
7.6, 6.3) 
 1.95 (q, 12.0)  
(4-Etynyl)Pro 
(I) 
4  3.30 (m) 30.9 (CH) 3.18 (m) 30.4 (CH) 
(4-Etynyl)Pro 
(I) 
5 a 3.96 (dd, 10.1, 6.3) 54.3 (CH2) 4.41 (m) 53.5 (CH2) 
(4-Etynyl)Pro 
(I) 
5 b 3.92 (t, 10.1, 5.0)  3.49 (t, 10.4)  
(4-Etynyl)Pro 
(I) 
1’  - 83.5 I - 82.1 I 
(4-Etynyl)Pro 
(I) 
2’  2.57 (d, 2.4) 72.4 (CH) 2.61 (d, 2.3) 72.4 (CH) 
Ile (II) 1  - 172.0 I - 172.0 I 
Ile (II) 2  4.64 (ovl) 56.2 (CH) 4.57 (dd, 10.5, 1.9) 56.2 (CH) 
Ile (II) 3  2.16 (m) 36.4 (CH) 2.18 (m) 36.2 (CH) 
Ile (II) 4 a 1.60 (m) 25.5 (CH2) 1.60 (m) 25.6 (CH2) 
Ile (II) 4 b 1.17 (m)  1.16 (m)  
Ile (II) 5  0.89 (t, 7.5) 10.8 (CH3) 0.88 (t, 7.4) 10.7 (CH3) 
Ile (II) 1’  0.98 (d, 6.7) 16.4 (CH3) 0.97 (d, 6.8) 16.4 (CH3) 
(β-Me)Phe (III) 1  - 172.5 I - 172.6 I 
(β-Me)Phe (III) 2  4.52 (dd, 8.6, 4.7) 61.2 (CH) 4.44 (ovl) 61.5 (CH) 
(β-Me)Phe (III) 3  3.66 (dq, 4.7, 7.3) 40.5 (CH) 3.62 (dq, 4.8, 7.3) 40.6 (CH) 
(β-Me)Phe (III) 4  1.34 (d, 7.3) 14.2 (CH3) 1.35 (d, 7.3) 14.4 (CH3) 
(β-Me)Phe (III) 1’  - 143.4 I - 143.3 I 
(β-Me)Phe (III) 2’  7.28 (ovl) 128.6 (CH) 7.29 (ovl) 128.6 (CH) 
(β-Me)Phe (III) 3’  7.28 (ovl) 129.5 (CH) 7.29 (ovl) 129.6 (CH) 
(β-Me)Phe (III) 4’  7.18 (m) 128.0 (CH) 7.19 (m) 128.1 (CH) 
(3-Ncp)Ala 
(IV) 
1  - 174.0 I - 174.4 I 
(3-Ncp)Ala 
(IV) 
2  3.89 (ovl) 54.5 (CH) 3.84 (d, 7.9) 54.5 (CH) 
(3-Ncp)Ala 
(IV) 
3 a 1.11 (ddd, 14.0, 
7.5, 7.5) 
33.3 (CH2) 1.13 (ovl) 33.2 (CH2) 
(3-Ncp)Ala 3 b 0.82 (ddd, 14.0,  0.86 (ovl)  
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   HRM A8-1 HRM A8-2 
(IV) 7.5, 7.5) 
(3-Ncp)Ala 
(IV) 
1’  1.29 (m) 22.9 (CH) 1.31 (m) 22.8 (CH) 
(3-Ncp)Ala 
(IV) 
2’  3.89 (ovl) 60.2 (CH)    3.90 (ddd, 7.1, 3.4, 3.4) 60.2 (CH) 
(3-Ncp)Ala 
(IV) 
3’ a 1.51 (ddd, 10.0, 
5.6, 3.7) 
18.5 (CH2) 1.50 (ddd, 9.9, 5.7, 3.4) 18.4 (CH2) 
(3-Ncp)Ala 
(IV) 
3’ b 0.66 (m)  0.69 (m)  
(β-Me)Phe (V) 1  - 171.5 I - 171.5 I 
(β-Me)Phe (V) 2  4.64 (d, 8.6) 59.7 (CH) 4.60 (d, 8.8) 59.7 (CH) 
(β-Me)Phe (V) 3  3.05 (dq, 8.6, 7.2) 45.2 (CH) 3.05 (dq, 8.6, 7.2) 45.2 (CH) 
(β-Me)Phe (V) 4  1.21 (d, 7.2) 18.4 (CH3) 1.21 (d, 7.2) 18.4 (CH3) 
(β-Me)Phe (V) 1’  - 143.2 I - 143.2 I 
(β-Me)Phe (V) 2’  7.12 (d, 7.5) 129.2 (CH) 7.12 (d, 7.5) 129.1 (CH) 
(β-Me)Phe (V) 3’  7.15 (t, 7.5) 129.3 (CH) 7.16 (t, 7.5) 129.3 (CH) 
(β-Me)Phe (V) 4’  7.01 (t, 7.5) 127.9 (CH) 7.01 (t, 7.5) 127.9 (CH) 
α-Thr (VI) 1  - 169.5 I - 169.5 I 
α-Thr (VI) 2  4.77 (d, 2.2) 59.1 (CH) 4.77 (d, 2.1) 59.2 (CH) 
α-Thr (VI) 3  5.43 (dq, 2.2, 6.9) 73.3 (CH) 5.47 (dq, 2.1, 6.8) 73.4 (CH) 
α-Thr (VI) 4  1.58 (d, 6.9) 18.6 (CH3) 1.59 (d, 6.9) 18.6 (CH3) 
(3-Ncp)Ala 
(VII) 
1  - 172.0 I  172.0 I 
(3-Ncp)Ala 
(VII) 
2  4.44 (t, 5.5) 54.6 (CH) 4.44 (ovl) 54.7 (CH) 
(3-Ncp)Ala 
(VII) 
3 a 2.03 (m) 34.2 (CH2) 2.04 (m) 34.1 (CH2) 
(3-Ncp)Ala 
(VII) 
3 b 1.73 (m)  1.76 (m)  
(3-Ncp)Ala 
(VII) 
1’  2.01 (m) 22.9 (CH)    2.02 (m) 22.9 (CH)    
(3-Ncp)Ala 
(VII) 
2’  4.36 (ddd, 7.0, 3.6, 
2.6) 
60.4 (CH)    4.37 (ddd, 7.0. 3.6, 2.6) 60.5 (CH)    
(3-Ncp)Ala 
(VII) 
3’ a 1.82 (ddd, 10.0, 
5.6, 3.6) 
18.0 (CH2) 1.82 (ddd, 9.8, 5.9, 3.6) 17.9 (CH2) 
(3-Ncp)Ala 
(VII) 
3’ b 1.15 (m)  1.17 (m)  
Chpca (VIII) 1  - 161.8 I  161.9 I 
Chpca (VIII) 2  - 118.5 I  118.4 I 
Chpca (VIII) 3  6.82 (d, 4.8) 110.4 (CH) 6.82 (d, 4.8) 110.4 (CH) 
Chpca (VIII) 4  6.07 (d, 4.8) 104.1 (CH) 6.06 (d, 4.8) 104.1 (CH) 
Chpca (VIII) 5  - 120.6 I  120.5 I 
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Figure 3.67: 
1
H NMR spectrum (700MHz, CD3OD) of HRM A8-1. 
 
 
Figure 3.68: COSY spectrum (700MHz, CD3OD) of HRM A8-1. 
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Figure 3.69: HSQC spectrum (700MHz, CD3OD) of HRM A8-1 high field expansion. 
 
 
Figure 3.70: HSQC spectrum (700MHz, CD3OD) of HRM A8-1 low field expansion. 
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Figure 3.71: HMBC spectrum (700MHz, CD3OD) of HRM A8-1. 
 
 
Figure 3.72: HMBC spectrum (700MHz, CD3OD) of HRM A8-1 high field expansion. 
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Figure 3.73: ROESY spectrum (700MHz, CD3OD) of HRM A8-1. 
 
 
Figure 3.74:
 1
H NMR spectrum (700MHz, CD3OD) of HRM A8-2. 
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Figure 3.75: COSY spectrum (700MHz, CD3OD) of HRM A8-2. 
 
 
Figure 3.76: HSQC spectrum (700MHz, CD3OD) of HRM A8-2 high field expansion. 
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Figure 3.77: HSQC spectrum (700MHz, CD3OD) of HRM A8-2 low field expansion. 
 
 
Figure 3.78: HMBC spectrum (700MHz, CD3OD) of HRM A8-2. 
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Figure 3.79: HMBC spectrum (700MHz, CD3OD) of HRM A8-2 high field expansion. 
 
 
Figure 3.80: ROESY spectrum (700MHz, CD3OD) of HRM A8-2 high field expansion. 
 
Finally, HRM A8-1 and HRMA8-2 were tested individually against A. crystallopoietes 
ATCC15481, both of which showed potent activities with MICs of 0.01 µg/mL and 0.001 
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µg/mL, respectively. However, HRM A8-2 appeared to be more active than HRM A8-1 (Figure 
3.81). 
 
 
Figure 3.81: Bioassay test of HRM A8-1 and HRM A8-2 against A. crystallopoietes ATCC15481 with 
0.01 µg of two compounds per disc. 
 
In addition, these two compounds were applied to S. coelicolor A(3)2 and one of its bald 
mutant ΔBldK to see whether they could induce the aerial mycelia formation for preliminary 
test. As shown in Figure 3.82, the aerial mycelia formed a circle around the filter paper disk 
after incubation for 5 ~7 d. The results indicated that these two compounds exhibit hormonal 
activity similar to HRM. However, HRM A8-2 did not show more obvious effects on aerial 
mycelia formation than HRM A8-1, relative to their antibacterial test.  
 
 
Figure 3.82: Preliminary bioassay test of HRM A8-1 and HRM A8-2 on S. coelicolor A3(2) and 
ΔBldK. 
 
In this section, the ethinyl-HRM analogues (HRM A8-1 and HRM A8-2) were successfully 
generated by feeding (4-Et)Pro into the ΔD/HrmB mutant via mutasynthesis, which exhibit 
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antibacterial and hormonal activities like what HRM possesses. These two compounds will be 
further applied to bioconjugation using the cycloaddition of azides and acetylenes.  
 
3.3.5 Discussion 
HRM acts as a bacterial hormone that induces morphological differentiation and increases 
antibiotic production in other Streptomyces spp. (Andres et al., 1989; Andres et al., 1990). In 
addition, it is an extremely potent antibiotic against coryneform actinomycetes (Andres et al., 
1990). Except for these diverse activities, HRM possesses a remarkable structure (Höfer et al., 
2011), which motivated us to exploit and elucidate the biosynthetic machinery of HRM, 
especially the biosynthesis of unique building blocks existing in HRM, such as Chpca, 
(3-Ncp)Ala, and (4-Pe)Pro. Previous study has assigned the hrm genes suspected to be 
involved in the biosynthesis of these residues (Höfer et al., 2011), hrmQ and hrmN for Chpca, 
hrmI and hrmJ for (3-Ncp)Ala, as well as hrmC and hrmD for (4-Pe)Pro. In present study, all 
these genes were investigated to analyze their roles during HRM biosynthesis by gene 
knockout, genetic complementation and feeding studies. The results established that hrmQ 
encoding a chlorinase is responsible for catalyzing the chlorination of Chpca, hrmI and hrmJ 
are involved in the biosynthesis of (3-Ncp)Ala, and hrmD plays an essential role in the 
biosynthesis of (4-Pe)Pro. HrmI was successfully heterologously expressed, and future 
enzymatic assays will allow us characterize its function in biosynthesis of (3-Ncp)Ala. In 
addition, PCR and Southern studies failed to identify a lmbX homolog in genomic DNA of 
HRM producer. The data therefore indicate that this enzyme is not needed for (4-Pe)Pro 
biosynthesis and that the terminal two-carbon unit of the first pyrroline intermediate is cleaved 
off by another enzyme.  
 
Overexpression of HrmB led to a significant increase of HRM, suggesting a positive regulatory 
role of HrmB. Therefore, a HrmB overexpression plasmid was individually introduced into the 
mutants generated to improve the production of substances as initially applied in S. griseoflavus 
W-384 for increasing HRM production. Unexpectedly, the results showed no obvious change. 
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The reason for this difference is probably due to the complex regulation system in Streptomyces 
and special physiological properties of HRM. It has been suggested that ~60% Streptomyces 
can produce γ-butyrolactone autoregulators to control their own cellular morphogenesis and 
secondary metabolism (Yamada 1995). Little is known whether such compounds can act as the 
signaling bacterial hormone to stimulate the production of antibiotics in other Streptomyces 
spp., such as hormaomycin, goadsporin and avenolide (Andres et al., 1990; Onaka et al., 2001; 
Kitani et al., 2011). HRM may act as an autoregulator, and bind to its own cellular receptor, and 
then activate its pathway-specific regulator HrmB to induce the transcription of biosynthetic 
hrm genes and eventually upregulate HRM biosynthesis. Therefore, overexpression of HrmB 
in S. griseoflavus W-384 led to a significant increase of HRM as well as its analogues. However, 
overexpression of HrmB in the mutants failed to increase the production of substances, which 
was possibly caused by the complex regulation system in Streptomyces spp. and absence of 
HRM. To examine the role of HRM, additional experiments should be performed by adding 
HRM to the mutant production culture to see whether HRM can stimulate the production of 
substances in these mutants. In addition, to investigate the exact regulation role of HrmB, the 
biosynthetic hrm genes should be identified in transcriptional level by RT-PCR analysis in the 
future.  
 
Mutagenesis is a powerful means to generation of specific substances. In this study, the aim 
was to obtain one hormaomycin analogue HRM A8 with (4-Pe)Pro substituted by (4-Et)Pro via 
feeding of (4-Et)Pro into ΔD. Unexpectedly, two HRM A8 with different stereochemistry of 
(4-Et)Pro was generated. These two compounds probably result from feeding a mixture of 
(4-Et)Pro with different configurations into the ΔD mutant. This mixture might come from 
changes made in the protocol during the second synthesis of cis-(4-Et)Pro, yielding a 
diastereomeric mixture of the building block. Nevertheless, it was shown that these 
ethinyl-based HRM analogues possess potent bioactivities against A. crystallopoietes 
ATCC15481 with MIC of 0.01 and 0.001 µg/mL, respectively. SAR studies suggested that 
change of (4-Pe)Pro residue in HRM has no obvious effect on the antibacterial activity. These 
two HRM A8 analogues were individually applied to S. coelicolor A3(2) and some of its bald 
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mutants that previously showed clear aerial mycelia formation by HRM, such as ΔBldC, 
ΔBldD and ΔBldK for initial test. Although it was observed that HRM A8-2 was more active 
than HRM A8-1 against A. crystallopoietes ATCC15481 (Figure 3.81), the preliminary 
hormonal activities induced by these two compounds showed no much difference (Figure 
3.82). Therefore, they can be further applied to determination of HRM antibacterial and 
hormonal cellular targets by “Click chemistry”. 
 
3.4 Investigation of HRM hormonal activity  
Actinomycetes commonly produce low-molecular signals, which act like bacterial hormones 
called autoregulators by inducing aerial mycelia formation, sporulation and antibiotic 
production (Beppu 1992; Barabas et al., 1994). These autoregulators are usually active at very 
low (nM) concentrations and belong to diverse natural product families. The best-characterized 
autoregulator is butyrolactone A-factor discovered in S. griseus in the 1960s (Khokhlov et al., 
1967), which triggers sporulation and production of streptomycin, grixazones and polyketides 
(Horinouchi 2002). But little was known that γ-butyrolactone–type autoregulator can induce 
the antibiotic production in other species. 
 
Unlike butyrolactone autoregulators, HRM not only induces aerial mycelia formation in 
various Streptomyces species at concentrations as low as 50 ng/mL, but also increases antibiotic 
production in other Streptomyces spp. (Andres et al., 1990). In this study, HRM was applied to 
a series of bald mutants derived from S. coelicolor A3(2) and S. griseus IFO 13350 to obtain 
the first insights into the regulatory mechanism of action and provide the basis for further 
determination of the as-of-yet unknown molecular target of HRM. 
 
3.4.1 Hormaomycin hormonal assay against S. coelicolor A3(2) 
Streptomycetes possess a complex life cycle. S. coelicolor A3(2) is the genetically 
best-characterized and first fully sequenced Streptomyces strain (Bentley et al., 2002). It has 
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been revealed that morphological differentiation in S. coelicolor involves three major protein 
families, SapB family, chaplins and rodlins family, and the protein family encoded by bld 
genes. SapB, a surfactant peptide secreted on rich media that coats aerial mycelia to allow the 
growth of aerial hyphae into the atmosphere. The chaplins and rodlins, are produced around 
aerial mycelia to form hydrophobic sheaths, facilitating aerial mycelia escape into the air 
(Flärdh and Buttner 2009). The Bld proteins determine production of SapB and chaplins, 
which are required for initiation of aerial hyphae formation (Kelemen and Buttner 1998; 
Claessen et al., 2006). Numerous bald (bld) mutants that are defective in aerial mycelia 
formation  have been generated to discover the factors (Chater 2001). Most bld genes encode 
regulatory proteins involved in an extracellular signaling cascade that controls the initiation of 
morphogenesis. The bld mutants are blocked in the earlier stage of development, which are 
defective in erecting aerial hyphae (Pope et al., 1996). A series of bld mutants have been 
created genetically and characterized, such as bldA (Leskiw et al., 1991), bldB (Pope et al., 
1998), bldD (Elliot 1998), bldH (Champness 1988), bldK (Nodwell et al., 1996), bldC (Hunt 
et al., 2005), and bldM (Molle and Buttner 2000). A hierarchy of bld genes has been proposed 
based on extracellular complementation studies, in which each mutant can complement the 
aerial mycelia formation in mutants to the left (Willey et al., 1991; Willey et al., 1993; 
Nodwell and Losick 1998; Molle and Buttner 2000; Elliot et al., 2001):  
 
[bldJ (formerly bld261)] < [bldK, bldL] < [bldA, bldH] < [bldG]< [bldC] < [bldD, bldM] 
 
However, the bld genes do not always conform to this linear cascade. For instance, the bldB 
mutant cannot be complemented by any other mutants or growth on minimal medium 
supplemented with mannitol (Pope et al., 1996). It has been suggested that this hierarchal 
signaling cascade involves at least five extracellular signals. Each signal induces the 
production and release of the next signal, eventually leading to the production of 
bldD-dependent SapB and other morphogens, which result in aerial mycelia formation 
(Kelemen and Buttner 1998). In this study, the bldA, B, C, D, H, K, and M mutants obtained 
from the John Innes Center were tested to check whether HRM can restore their aerial mycelia 
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formation to analyze the regulation mechanism of HRM. It was hoped that insights from these 
studies can help to narrow down the celluar targets of HRM in the aerial mycelia formation. 
 
It has been shown previously that HRM was effective in inducing aerial mycelia formation in 
five strains of Streptomyces (Andres et al., 1990). However, none of them was S. coelicolor 
A3(2). Therefore, S. coelicolor A3(2) was exposed to HRM to test whether morphological 
differentiation can be induced. The strain was assayed by an agar diffusion method at HRM 
concentrations of 0.01 µg per paper disc on Gauze I solid medium. After three days of 
incubation at 30 ºC, it was observed that white aerial mycelia were produced around the paper 
disc along with a blue pigment (Figure 3.83). However, after five days of growth, the aerial 
mycelia formed a lawn and covered the whole plate and started producing gray spores. This 
result suggested that HRM can accelerate aerial mycelia formation in S. coelicolor A3(2). To 
understand the HRM regulatory hierarchy, HRM was subsequently applied to the bld mutants 
derived from S. coelicolor A3(2) in a similar manner.  
 
 
Figure 3.83: HRM hormonal activity assay against S. coelicolor A3(2) and its bald mutant derivatives 
on Gauze I medium plates with 0.01 µg HRM added to each paper disc. J2166 (ΔBldC), NS17 (ΔBldK), 
bldM mutant (ΔBldK), bldD mutant (ΔBldD), J1700 (ΔBldA), J669 (ΔBldB), and WC109 (ΔBldH) are 
the bald mutants derived from S. coelicolor A3(2). 
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Unexpectedly, the results showed that HRM only induced sporulation or pigment formation in 
J2166 (ΔBldC), NS17 (ΔBldK), and the bldM mutant (ΔBldM) and bldD mutant (ΔBldD) but 
not J1700 (ΔbldA), J669 (ΔBldB) and WC109 (ΔBldH) (Figure 3.83). 
 
It has been shown previously that goadsporin (GS), a 19-amino-acid polypeptide discovered in 
Streptomyces sp. TP-A0584, could induce sporulation and/or secondary metabolite in 36 
Streptomyces strains. However, the regulatory mode of action for this compound has not been 
demonstrated yet. For comparison, GS obtained from Prof. Hiroyasu Onaka at the University of 
Tokyo was applied to the above mentioned S. coelicolor strains in the same way. After 
incubation for three days, similar results to that of HRM were observed (Figure 3.84). The only 
difference was the speed of aerial mycelia formation, where after three days of growth, the 
aerial mycelia covered the entire plate, and the surrounding area of the paper disc displayed 
larger density of aerial mycelia.  
 
 
Figure 3.84: GS hormonal activity assay against S. coelicolor A3(2) on Gauze I medium plates with 
0.01 µg GS added to each paper disc. ΔBldC, K, M, D, A, B, H are bald mutants derived from S. 
coelicolorA3(2). 
 
Aerial mycelium formation in Streptomyces spp. commonly relies on the composition of media. 
Previous studies suggested that Streptomyces strains used in the HRM hormonal assay could 
produce aerial mycelia on poor SY agar abundantly, but nearly failed to form aerial mycelia on 
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rich SYC agar (Andres et al., 1990). To investigate the HRM hormonal activity, HRM was 
applied to its own producer, S. griseoflavus W-384, grown on SYC agar. It was shown that the 
aerial mycelia formation of S. griseoflavus W-384 was induced by HRM at concentration of 1 
µg (Figure 3.85). This showed that HRM can induce aerial mycelia formation in not only its 
producing strain but also the other Streptomyces spp., while GS only had such an effect on 
other Streptomyces spp., but not its own producer S. sp. TP-A0584 (Onaka et al., 2001). 
 
 
Figure 3.85: Aerial mycelia formation induced by HRM in its own producer, S. griseoflavus W-384. 
The paper discs contained 0.01, 0.1 and 1 µg HRM. 
 
Subsequently, S. coelicolor A3(2) along with its mutants were spread on rich SYC plates, and 
then exposed to HRM and GS with concentrations of 1 µg per disc, respectively. The plates 
were incubated at 30 °C for 7-10 days. It was observed that both HRM and GS could induce 
aerial mycelia formation and/or secondary metabolites in some of the test strains (Figure 3.86 
and Figure 3.87). 
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Figure 3.86: Aerial mycelium-inducing activity of HRM in S. coelicolor A3(2) and its related mutants 
on SYC agar plates with 1 µg of HRM added to each paper disc. 
 
 
Figure 3.87: Aerial mycelium-inducing activity of GS in S. coelicolor A3(2) and its related mutants on 
SYC agar plates with 1 µg of GS added to each paper disc. 
 
Comparing aerial mycelia-inducing activities of GS and HRM on SYC media with that on 
Gauze’s media, J1700 (ΔbldA), J669 (ΔBldB) and WC109 (ΔBldH) exhibited ring-shaped 
zones of aerial mycelia surrounding paper discs on SYC plates. However, inhibition zones were 
shown near the paper discs in several S. coelicolor mutant strains with the addition of both GS 
and HRM, such as J669 (ΔBldB), J2166 (ΔBldC), the bldD and M null mutants (ΔBldD and M) 
derived from S. coelicolor M600. The results further supported previous observations that 
formation of aerial mycelia by GS was dose-dependent, effective at less than 1.8 µM (Onaka et 
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al., 2001). It has been shown that GS inhibited the growth of S. coelicolor A3(2) at an MIC of 
3.2 µg/mL on Bennett’s agar medium (Onaka et al., 2001), while GS induced mycelia formation 
of S. coelicolor A3(2) on an SYC plate at concentration of 1 µg (~60 µM) in the present study. 
These results indicated that aerial mycelia formation induced by HRM and GS in Streptomyces 
spp. depends on the composition of media as well as the concentrations of HRM and GS.  
 
3.4.2 HRM hormonal assay against S. griseus DSM 40236 and bld mutants 
derived from S. griseus IFO 13350  
Relative to S. coelicolor, the signaling pathway involved in aerial mycelia formation in S. 
griseus is well-studied, designated as the A-factor signaling cascade. In this pathway, the 
hormone-like signaling molecule A-factor binds to its own receptor ArpA, which leads to the 
activation of AdpA, a global regulator governing the expression of downstream genes 
responsible for morphological differentiation and secondary metabolism (Horinouchi 2002). 
Several bald mutants derived from S. griseus IFO 13350 were generated in the group of Prof. 
Horinouchi (Yamazaki 2000; 2003b; 2003a; 2004). In this study, to understand HRM and GS 
hormonal regulation mechanism, three of these mutants, ΔAdpA, ΔAdsA, and ΔAfsA, obtained 
from Prof. Horinouchi were assayed along with the wild type strain S. griseus DSM 40236. 
ΔAfsA is unable to synthesize A-factor, which fails to initiate the A-factor signaling cascade 
for morphogenesis and streptomycin or pigment production. ΔAdpA is a mutant of a global 
transcriptional activator with an inability to produce aerial mycelia and streptomycin. ΔAdsA 
is a mutant of AdsA that is required for the formation of aerial mycelia. 
 
Before application of HRM to the mutants derived from S. griseus IFO 13350, the 
concentration of HRM was tested for inducing aerial mycelia formation in S. griseus DSM 
40236 in a range from 0.1–10 µg per paper disc. After incubation of plates at 30 °C for almost 
20 days, it was shown that a white aerial mycelia zone was produced around the paper discs at 1 
µg and 10 µg (Figure 3.88). Compared with the hormonal assay employed with S. coelicolor, 
more HRM was required for inducing aerial mycelia formation in S. griseus. 
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Figure 3.88: Aerial mycelia-inducing activity of HRM in S. griseus DSM 40236 on SYC agar medium. 
The paper discs contained 0.1 µg, 1 µg and 10 µg hormaomycin. 
 
Thus, to obtain distinguishable effects, the mutants related to S. griseus IFO 13350 were 
assayed by application of HRM and GS at concentrations of 10 µg per disc, respectively. After 
growth of these strains at 30 °C for 20 days, it was observed that both HRM and GS could 
stimulate the ring-shaped aerial mycelia formation in the wild type strain (Figure 3.89). During 
incubation, aerial mycelia zone firstly showed up in S. griseus induced by HRM, the density of 
which was the largest. It seems that HRM is more active than GS in this strain. Moreover, HRM 
only had effect on one mutant, ΔAdsA, while GS had no influence on any of the mutants. 
 
 
Figure 3.89: Aerial mycelium-inducing activity of HRM and GS in S. griseus DSM 40236 and ΔadsA 
derived from S. griseus IFO 13350 with 10 µg of HRM or GS added to each paper disc. 
 
3.4.3 Discussion 
The formation of aerial mycelia in S. coelicolor is controlled by a regulatory cascade involving 
products of the bld genes (bldJKLAHGCDM), which ultimately result in transcription of the 
ram cluster encoding the biosynthesis of SapB. SapB is a biosurfactant lantipeptide that 
facilitates the emergence of aerial hyphae into the atmosphere from the vegetative mycelium on 
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rich media. In addition, the hydrophobic chaplins and rodlins secreted around the aerial hyphae 
play a crucial role in helping aerial hyphae escape into the air (Flärdh and Buttner 2009). 
 
In this study, the regulation mechanism of HRM was investigated to understand the effects of 
this signal on the morphological differentiation in Streptomyces via an aerial 
mycelium-inducing assay. For the assay applied to S. coelicolor A3(2) and its bld mutants, 
HRM was able to induce the aerial mycelia formation in S. coelicolor A3(2) and some of its 
mutants, J2166, K, D, and M on Gauze I medium plates, but failed to stimulate mycelia 
formation in J1700 (ΔBldA), J669 (ΔBldB) and WC109 (ΔBldH). According to the published 
hierarchy, if HRM can complement the mycelia formation of ΔBldD or M, the production of 
aerial mycelia should have been restored in all the other mutants except for ΔBldB. However, 
HRM showed no effect on formation of aerial hyphae in ΔBldA/H. It has been suggested that 
ΔBldB results in a global defect in the regulation of carbon utilization, which fails to erect 
aerial mycelia formation (Pope et al., 1996). This is in partial agreement with the result that 
HRM cannot induce morphogenesis in ΔBldB. Previous studies illustrated that GS possesses 
hormone-like activity by promoting aerial mycelia formation in various Streptomyces. GS was 
applied to S. coelicolor and its mutants to test whether GS had the same effect as HRM. After 
cultivation, the assay showed similar results to that of HRM, which indicated that HRM and 
GS played a similar role in the regulation of aerial mycelia formation although they possess 
different chemical structures. Nevertheless, how they function in this pathway is still unclear. 
Since the nutritional status often affects differentiation in Streptomyces, rich SYC agar 
medium was employed to perform the same assay with HRM or GS for inducing aerial 
mycelium formation. The results showed again that HRM and GS had similar effects on S. 
coelicolor as well as its mutants on SYC agar plates. However, compared to the assay 
performed on Gauze I media, it was shown that both HRM and GS could induce the aerial 
mycelia formation or pigment production in all the test strains. The difference between these 
two media is that SYC contains a rich nitrogen source, like yeast extract and casamino acids. 
Interestingly, under sufficient nutrition conditions, the synthesis of (p)ppGpp (an intracellular 
metabolic signal) is induced in the wild type strain that would directly activate the expression 
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of genes involved in morphological differentiation and antibiotic production. (Hesketh et al., 
2007; Hesketh et al., 2001). Therefore, SYC media might have provided sufficient nutrition of 
nitrogen, amino acids and carbon sources to induce the accumulation of (p)ppGpp and lead to 
aerial mycelia formation and/or pigment production in all the mutants on some level. When 
HRM or GS was applied to these mutants at an earlier stage of growth, they promoted rapid 
growth of aerial mycelia around the paper disc to form an observable zone. Additionally, GS 
and HRM inhibited the growth of ΔBldB, H, D and M at 1 µg per disc, which suggested that 
GS and HRM act as a bacterial hormone to promote morphological differentiation and 
secondary metabolism at very low doses. Previous extracellular complementation studies on 
the S. colicolor mutants were carried out on R2YE. To obtain comparable results and to 
continue to analyze the regulation mechanisms of HRM and GS in this signaling cascade, the 
same assay should be performed on R2YE plates in the future. 
 
The morphological differentiation and secondary metabolism in Streptomyces spp. is regulated 
by a complex network involving multiple environmental, intracellular and extracellular factors 
taking place at different levels. Sometimes, cross-talk occurs between different signaling 
systems (Galperin 2004; Huang et al., 2005). The present studies provide a basis for further 
studying HRM’s hormonal activity. To deeply understand and elucidate HRM’s hormonal 
mechanism of action, “Click chemistry” will be employed via cycloaddition of azides and 
acetylenes catalyzed by copper(I). This method has been successfully applied to probe targeted 
biomolecules of drugs in living organisms (Willand et al., 2010; Deiters et al., 2003; Hong et al., 
2010; Anderson et al., 2012). This could allow us to determine the cellular target of HRM using 
the mutasynthesized alkyne-labeled HRM, HRM A8, generated in this study. This could be 
achieved by incubating HRM A8 with protein extracts from S. coelicolor A3(2) or S. griseus 
(hormonal activity), both of which have been completely sequenced (Bentley et al., 2002; 
Ohnishi et al., 2008). After labeling, HRM-binding proteins can be enriched by conjugating the 
alkyne moiety to a biotinylated probe, followed by binding to streptavidin beads.  
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3.5 Investigation for a trans-AT PKS-derived polyketide in S. griseoflavus 
W-384 
With the growing number of microbial genome sequences available in the public databases, 
genome mining has been considered as a promising and efficient tool for unraveling the new 
bioactive metabolites that are encoded by orphan gene clusters or overlooked under standard 
detection conditions (Winter et al., 2011). This approach has been successfully employed to 
discover the bioactive natural products in many different organisms, such as, terrequinone A in 
fungi (Bok et al., 2006), orfamides in pseudomonads (Gross et al., 2007), avermitilol in 
streptomycetes (Chou et al., 2010), thailandamides in Burkholderia thailandensis (Nguyen et 
al., 2008), and onnamides in yet unculturable bacteria from the complex metagenome of the 
marine sponge (Piel et al., 2004) (Figure 1.13).  
 
The draft genome sequence of S. griseoflavus Tü 4000, which is identical to the HRM 
producer S. griseoflavus W-384, was performed by the Broad Institute of MIT and Harvard and 
is accessible in GenBank (NZ_GG657758.1). In the present study, this genome sequence was 
further analyzed to search for the product of a newly discovered trans-AT PKS gene cluster 
with unknown function in order to identify the corresponding polyketide via gene 
inactivation. 
 
3.5.1 Completing the gene sequence of the trans-AT PKS gene cluster 
An automated antibiotic and Secondary Metabolite Analysis SHell (antiSMASH) search was 
employed to analyze the secondary metabolite biosynthesis gene clusters (Medema et al., 2011). 
The results revealed 23 gene clusters, one of which is a putative trans-AT PKS gene cluster 
with 10 sequence gaps (Figure 3.91).  
 
Primers were designed starting 50-200 bp away from both sides of these gaps to amplify DNA 
fragments covering gaps. The PCR products were purified and sequenced (Figure 3.90).  
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Figure 3.90: Agarose gel analysis of PCR products of ten gaps in trans-AT PKS gene cluster for 
sequencing. Lane M, 100 bp DNA ladder, lanes 1-10, PCR products of gaps 1-10, respectively. 
 
Finally, the complete DNA sequence of this trans-AT PKS gene cluster was obtained (Figure 
3.91), measuring 111.165 kb in length. The entire gene cluster contains 50 open reading 
frames (ORFs) that were designated as orf1-orf50.  
 
 
Figure 3.91: The complete genetic map of trans-AT PKS gene cluster (~111 kb) from S. griseoflavus 
Tü 4000. The gene cluster contains 50 ORFs from orf1-orf50. 
  
All the domains in this trans-AT PKS were initially analyzed manually and the biosynthetic 
pathway of the putative polyketide was predicted by Prof. Piel. The data revealed 16 KS 
domains, 9 KR domains, 14 ACP domains, 2 MT domains, 5 DH domains and one ER domain 
(Figure 3.92). Neither of the PKS modules harbors integral AT domains. The orf28 gene was 
predicted to encode discrete AT domain. The complete gene cluster was analyzed again after 
covering ten sequence gaps, which resulted in an additional gene that possibly encode a KR 
domain in Orf21 (Figure 3.92). 
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Figure 3.92: The module architecture of the trans-AT PKS proteins with their domains and substrate 
specificity and configuration predicted manually based on phylogenetic analysis by Prof. Piel. The 
shown intermediates are hypothetical structures based on the predicted substrate specificity of KS 
domains. L-OH, L-configuration of β-OH functionally installed on modules 1, 3 and 10; D-OH, 
D-configuration of β-OH functionally installed on module 5; D, KRs contain D configuration motifs. 
MT, responsible for ɑ-methyl branch at the substrate attached to modules 4 and 5; KS0, a KS that is 
unable to elongate the polyketide chain; db, double bond formation; db + beta, double bond + 
beta-branch. 
 
3.5.2 Generation of a trans-AT PKS mutant to isolate the potential 
polyketide  
In order to identify the potential trans-AT PKS product and assign the functions of genes 
involved in its biosynthesis, the genes encoding KS domains were chosen to be targets for 
generation of gene-disruption mutants by a single cross-over strategy.  
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To increase the efficiency of a single cross-over for attaining potential mutants, the orf20 gene 
encoding two PKS modules were targeted to be disrupted. The orf20 gene was amplified from 
the genomic DNA of S. griseoflavus W-384 using the corresponding primer pair of 
MFF1-RE/MFR1-RE listed in Table 4.6. The resulting DNA fragment was ~8.4 kb, encoding 
two DH, two ACP and two KS and one KR domains. The PCR fragments were digested with 
HindIII and subsequently inserted into pBluescript SK II(+) treated with the same restriction 
enzyme and end-sequenced. The resulting plasmid was named pXC15. The PKS gene was 
purified from digestion of pXC15 and ligated into pHZ199 (Hu et al., 1994) to yield pXC16 
(Figure 3.93).  
 
 
Figure 3.93: The strategy for construction of pXC15 and pXC16 for generation of a trans-AT PKS 
knock-out mutant of S. griseoflavus W-384. The ~8.4 kb PCR product was cloned into pBluescript SK 
II(+) vector to yield pXC15. After verification by sequencing, the PKS gene was purified following 
digestion of pXC15 with HindIII and inserted into pHZ199 treated with the same enzyme to obtain 
pXC16. 
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The plasmids pXC15 and pXC16 were confirmed by enzymatic digestion before conjugation 
(Figure 3.94). 
 
 
Figure 3.94: Agarose gel analysis of pXC15 and pXC16 by digestion with HindIII. A, screening of E. 
coli DH5ɑ transformants with pXC15; lane M, 1 kb Plus DNA ladder; Clones 14 and 16 were identified 
with the desired inserts. PKS gene was ~8.4 kb, vector pBluescript SK II(+) was ~3.0 kb. B, screening of 
E. coli DH5ɑ transformants of pXC16. Lane M, 1 kb Plus DNA ladder, Clones 7, 8, 9, 14, 19, 20 and 21 
were transformants with the expected inserts. pHZ199 is the suicide vector, ~6.6 kb. 
 
The suicide plasmid pXC16 was introduced into E. coli ET12567/pUZ8002 for further 
conjugation into S. griseoflavus W-384. Once single cross-over occurs, the suicide plasmid will 
be integrated into the genome, so that the conjugants will show thiostrepton resistance (Figure 
3.95). After multiple attempts, a single conjugant was obtained and grown on MS agar plate 
supplemented with 12.5 µg/mL thiostrepton.  
 
 
Figure 3.95: The single cross-over strategy. ‘PKS’ indicates the PKS gene inserted into suicide plasmid 
pXC16. Once single cross over occurs, the suicide plasmid will integrate into the chromosome of wild 
type to interrupt the expression of PKS gene and generate two copies of PKS gene. The resulting mutant 
will exhibit thiostrepton resistance. 
 
The genomic DNA was isolated from the culture of this conjugant and identified by PCR 
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using the primer pairs XF38F/38R and XF39F/39R for the hygromycin resistance gene (Hyg
R
) 
and thiostrepton resistance gene (Thio
R
), respectively (Figure 3.96). Based on the PCR results, 
it was suspected that the conjugant obtained was the trans-AT PKS mutant.  
 
 
Figure 3.96: Identification of the Δtrans-AT PKS candidate by PCR amplification. Lane M, 1 kb DNA 
ladder; lane 1, Hyg
R 
(~1.0 kb)amplified from genomic DNA of the Δtrans-AT PKS candidate using the 
primer pair XF38F/38R; lane 3, Thio
R
 (~0.8 kb) amplified from genomic DNA of the Δtrans-AT PKS 
candidate using the primer pair XF39F/39R; lanes 2 and 4, absence of the PCR product amplified from 
genomic DNA of the WT using the same primer pairs (as negative controls). 
 
The putative trans-AT mutant (Δtrans-AT PKS) and WT strains were cultivated according to 
the general fermentation procedure used for S. griseoflavus W-384 described in Chapter 4. 
The culture supernatants from both strains were extracted and analyzed by HPLC. In principle, 
if the targeted PKS is inactivated, the potential polyketide will be absent in the mutant strain 
compared to the WT strain. Comparison of HPLC traces from the extracts of Δtrans-AT PKS 
and WT strains showed that one peak (a) in the WT strain disappeared (Figure 3.97). 
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Figure 3.97: Comparison of HPLC traces from extracts of the Δtrans-AT PKS and WT. Compound a, 
was present in the the WT strain and absent in the Δtrans-AT PKS; HRM, produced in both the 
Δtrans-AT PKS and WT. The mass of a is 1037.4 Da [M+H]+. 
 
The extracts from the WT and Δtrans-AT PKS were also subjected to LC/MS analysis. The 
result showed compound a with a mass of 1037.4 Da [M+H]
+
. To characterize the structure of 
compound a, 0.5 mg of compound a was purified from 1 L fermentation culture of WT by 
Reiko Ueoka and further structurally elucidated by Dr. Roberta Teta in University of Napoli. 
The NMR analysis revealed a known cyclic depsipeptide, termed WS9326A, which was also 
previously isolated from Streptomyces violaceusniger No. 9326. WS9326A is a potent 
tachykinin antagonist and exhibits weak antimicrobial activity (Hashimoto et al., 1992). Its 
chemical structure is similar to skyllamycin (Pohle et al., 2011) (Figure 3.98). The isolation of 
a peptide based on a presumed PKS knock-out was surprising. It was suspected that the 
putative Δtrans-AT PKS mutant obtained might have been a false positive resulting from the 
coincidental high sequence similarity with the suicide plasmid. Therefore, the genomic DNA of 
this putative Δtrans-AT PKS was investigated by PCR analysis using the specific primers and 
Southern blotting. However, neither of these studies showed the expected results. Since the 
sequence of suicide vector pHZ199 is not available, the position of the integrated region could 
not be detected in the genomic DNA by sequencing.  
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Figure 3.98: The structure of WS9326 and skyllamycins. 
 
As described above, the PKS gene (orf20) targeted in this study encodes two KS, two DH and 
one KR domains (Figure 3.92). To inactive the function of this PKS, four gene fragments were 
targeted instead of the entire PKS gene. The gene fragments consisted of the DH, ACP in 
module 6 and KS in module 7 domain-coding regions (~2.1 kb), one (~4.1 kb) encoding the 
DH, ACP in module 6, and the KS and DH in module 7, one (~1.9 kb) encoding the KR in 
module 7, and ACP and KS
0
 in module 8, the last one (~4.1 kb) encoding the DH and KR in 
module 7, and the ACP and KS
0
 in module 8. These four gene fragments were amplified, 
referred to as KS1, KS1’, KS2 and KS2’, and purified and digested with HindIII. Then, all of 
these fragments were individually ligated into pBluescript SK II(+) to obtain pXC32, pXC38, 
pXC39, pXC40 and end-sequenced independently. Since thiostrepton is not as sensitive as 
apramycin during screening of Streptomyces mutants, the Thio
R
 of pHZ199 was replaced by the 
apr
R
. The resulting suicide vector was assigned as pXC41 (Figure 3.99).  
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Figure 3.99: The strategy for construction of the new suicide vector pXC41. The plasmid pHZ199 (Hu 
et al., 1994) was digested with EcoRI and EcoRV, then the resulting ~3.39 kb DNA fragment was 
harvested as a new vector backbone with essential functional elements, bla, oriT, and ori. The 
apramycin resistance cassette (~1.4 kb) was amplified from pIJ733 (Gust et al., 2003), digested by 
EcoRI and EcoRV and subsequently inserted into the 3.39 kb vector backbone to give the new suicide 
vector pXC41 with apr
R
 instead of Thio
R
. 
 
The four gene fragments from the corresponding plasmids with correct sequences were purified 
(Figure 3.100A) and inserted into pXC41 to give pXC42, pXC43, pXC44 and pXC45, 
respectively. These newly obtained suicide plasmids were confirmed by enzymatic digestion 
with EcoRI and XbaI. The results showed the expected sizes (Figure 3.100B and C), 
suggesting the plasmids were ready for further conjugation. 
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Figure 3.100: Agarose gel analysis of the suicide plasmids by enzymatic digestion. A, Lane M, 1 kb 
Plus DNA ladder; lanes 1-4, The DNA fragments of KS1, KS1’, KS2, and KS2’ purified from pXC32, 
pXC38, pXC39, and pXC40, respectively. B, Identification of suicide plasmids by enzymatic digestion 
with EcoRI and XbaI. Lane M, 1 kb Plus DNA ladder; lanes 1-3, digestion of pXC42; lanes 4-5, 
digestion of pXC43; lanes 6-7, digestion of pXC44. C, Lane M, 1 kb Plus DNA ladder; lanes 1-3, 
digestion of pXC45 by EcoRI and XbaI. After digestion, all the suicide plasmids share the same DNA 
fragment of ~2.13 kb. 
 
The four suicide plasmids from E. coli DH5ɑ were individually transformed into E. coli 
ET12567/pUZ8002. The resulting strains were used for conjugation with S. griseoflavus W-384. 
The conjugation was performed according to the standard procedure. After several days of 
incubation, a few transformants from pXC42, pXC43 and pXC45 were observed on a MS agar 
plate supplemented with apramycin and nalidixic acid. A few apramycin resistant 
transformants were independently inoculated into MS liquid medium with appropriate 
antibiotics and grown for two days. Their genomic DNA was extracted and analyzed by PCR 
using specific primers, and that of the WT as a negative control. The specific primers were 
designed based on the model of expected mutant genome after single cross-over occurring 
(Figure 3.101). For example, one primer pair of KSF2/XCKSR2, the forward primer KSF2 
started from upstream of the target KS gene in the WT genomic DNA and the reverse primer 
XCKSR2 started from the plasmid pXC41; for the other pair, forward primer XCKSF1 started 
from the plasmid pXC41 and reverse primer XCKSR1 started from downstream of the target 
KS gene in the WT genomic DNA.  
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Figure 3.101: The putative trans-AT PKS mutant genome derived from pXC45 generated after single 
cross-over. The plasmid carrying the ‘KS’ gene which was identical with the target KS gene in the WT 
genome was integrated into the genome of the WT after single cross-over recombination. The trans-AT 
PKS gene cluster is in green. The pXC41 integrated into the genome is in black with the essential 
functional elements. The target KS gene in the WT genome was disrupted by pXC45 to bring an 
additional copy of KS gene.  
 
Unfortunately, there was no expected PCR product amplified from the transformants derived 
from pXC42, pXC43, except for the apramycin resistance gene. However, there was one 
transformant generated from pXC45, named W-384/pXC45, which was promising. The PCR 
products suggested the expected genotype (Figure 3.102). To confirm this mutant, the PCR 
products amplified using the primer pair of XCKSF1/R1 were sequenced. Comparison of the 
resulting DNA sequence and trans-AT gene cluster sequence, revealed that the recombination 
occurred in the beginning position of the gene for the DH in module 7. 
 
 
Figure 3.102: Agarose gel analysis of the W-384/pXC45 by PCR amplification. Lane M, 1 kb Plus 
DNA ladder; lanes 1 and 2, PCR products amplified from the genomic DNA of the WT and 
W-384/pXC45 using the primer pair XF1F/1R (for the apr
R
); lanes 3 and 4, PCR products amplified 
from the genomic DNA of the WT and W-384/pXC45 using the primer pair KSF2/XCKSR2 for the 
KS2’ gene fragment (~4.1 kb); lanes 5 and 6, PCR products amplified from the genomic DNA of the WT 
and W-384/pXC45 using the primer pair XCKSF1/R1 for the KS2’ gene fragment (~4.1 kb). 
 
The W-384/pXC45 mutant was cultivated along with the WT strain in the MMS media. After 
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five days of fermentation, the supernatants from their cultures were extracted and analyzed by 
LC-MS.  
 
 
Figure 3.103: Comparison of HPLC traces of the WT and W-384/pXC45 at UV of 273 nm. Compounds 
1, 2 and 3, were present in the WT at 40.2 min, 42 min and 42.2 min, but absent in W-384/pXC45; 
HRM, was present in the both strains at 42.6 min. 
 
Comparison of the HPLC profiles from LC-MS analysis of the WT and W-384/pXC45 mutant 
showed that compounds 1, 2 and 3 were absent in W-384/pXC45, which were suspected as 
putative trans-AT PKS-derived polyketides (Figure 3.103). The corresponding exact masses of 
the three compounds were detected. Based on previous structural prediction of this compound 
by Prof. Piel, the calculated mass of one structural proposal (Figure 3.92) or the potential 
polyketide is ~477.321 Da [M+H]
+
. Comparison of the exact masses for these three 
compounds between the WT and W-384/pXC45 showed that the exact masses of 409.210 Da 
[M+H]
+
 for compound 2 and 414.273 Da [M+H]
+
 for compound 3 were obviously observed 
only in the WT (Figure 3.104). Since the exact mass of 414.273 Da [M+H]
+
 was closer to the 
mass of the predicted polyketide, compound 3 might be the potential trans-AT PKS-derived 
polyketide. However, these results are still based on preliminary analysis. Further studies need 
to be carried out to identify the structures. 
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Figure 3.104: Comparison of the exact masses of compounds 1, 2 and 3 from the LC-MS data of the 
WT and W-384/pXC45 extracts. A, comparison of the exact mass of the compound 1 at 40.2 min in 
the WT and W-384/pXC45; B, comparison of the exact mass of the compound 2 at 42.0 min in the WT 
and W-384/pXC45; C, comparison of the exact mass of the compound 3 at 42.2 min in the WT and 
W-384/pXC45. 
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3.5.3 Discussion 
Bioinformatic analysis revealed a trans-AT PKS gene cluster in the genome of the HRM 
producer S. griseoflavus W-384. In this study, the aim was to identify its corresponding 
polyketide via a combination of gene knockouts with comparative metabolic profiling. Firstly, 
ten sequence gaps were closed in the putative trans-AT PKS gene cluster in NCBI database by 
PCR amplification and sequencing. The modular architecture and the substrate specificity and 
configuration were predicted previously by Prof. Piel via manual basic local alignment search 
tool (BLAST) search. After completing the entire gene cluster, the PKS genes were further 
analyzed using the automated antiSMASH to predict the essential functional domains. 
Compared to previous modular construction predicted by Prof. Piel (Figure 3.92), one missing 
KR domain encoded by orf21 was found in the module 9.  
 
To isolate the putative polyketide, a PKS gene, orf20 encoding two KS, two DH, two ACP and 
one KR was targeted to create trans-AT PKS mutant. The results showed that the expected 
trans-AT PKS-derived polyketide was not discovered and a skyllamycin-like cyclic 
depsipeptide was observed. To further confirm if this mutant possessed the correct genotype, 
the genomic DNA of this initial trans-AT PKS mutant was analyzed by Southern blotting and 
PCR amplification using the specific primers. Although this mutant exhibits thiostrepton 
resistance, the single cross-over may have occurred somewhere else in the chromosome of wild 
type strain, perhaps due to coincidental high sequence similarity with the suicide plasmid. 
  
Many successful examples for construction of gene disrupted mutants via single cross-over 
were published with less than 1 kb of the internal region of target gene (Sioud et al., 2007; 
Xiang and Moore 2003), which can make screening work much easier. Therefore, the target 
PKS gene coding region was reduced from 8.4 kb to 4 kb and 2 kb, respectively. Moreover, 
given that thiostrepton was not as sensitive as apramycin in previous studies during screening 
of S. griseoflavus W-384 mutants, the suicide vector pHZ199 was modified by replacing the 
Thio
R
 with an apr
R
 to generate the new suicide vector pXC41. Similar conjugations were 
carried out with the newly constructed suicide plasmids, which led to the generation of one 
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potential trans-AT PKS mutant W-384/pXC45. The genotype of this mutant was confirmed by 
PCR analysis. The metabolic profile of this mutant was compared to that of wild type strain by 
HPLC, resulting in the detection of three potential candidate compounds. Comparison of the 
exact masses of the compounds 1, 2, and 3 from LC-MS analysis of the WT and W-384/pXC45 
extracts indicated that the compound 3 with the exact mass of 414.273 Da [M+H]
+ 
, which was 
only detected in the WT, might be the potential trans-AT PKS-derived polyketide due to its 
mass relatively close to the predicted mass. Since these results were observed in the positive 
mode for the first LC-ESI MS analysis, to confirm these results, these three compounds need to 
be isolated and detected by ESI-MS in both positive and negative modes. In addition, the 
current UV chromatogram was detected at UV of 273 nm which is the optimal wave-length for 
HRM detection. Therefore, these extracts should be also scanned in a full wave-length range to 
optimize the UV conditions for better separation of the putative polyketides and to obtain first 
insights into their chromophore. To further identify and characterize these three candidates, 
large scale of fermentation of the WT needs to be carried out to obtain sufficient amounts of 
these three peaks for structural elucidation directly via NMR analysis. Once the polyketide is 
structurally characterized, not only its biosynthetic pathway can be predicted based on the 
structure, but also its corresponding biosynthetic gene cluster can be annotated more precisely. 
Moreover, its bioactivity will be tested further for drug discovery.  
 
3.6 Summary and outlook 
HRM is a depsipeptide produced by S. griseoflavus W-384. It possesses a remarkable structure 
bearing chlorine, nitro or cyclopropyl moieties (Andres et al., 1989). HRM exhibits a variety of 
bioactivities including anticorynebacterial (Andres et al., 1990) and antimalarial (Otoguro et 
al., 2003). Additionally, it acts as a signaling metabolite that can induce morphological 
differentiation and increase antibiotic production in other Streptomyces spp. (Andres et al., 
1990). However, the biosynthetic pathway of HRM and its antibacterial and hormonal 
mechanism were still largely unknown and were the major interest of this project.  
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The hrm gene cluster was isolated in previous studies (Höfer et al., 2011), allowing us to 
bioinformatically analyze genes involved in the HRM biosynthesis. However, studies of HRM 
biosynthesis have been hampered by genetically inefficient manipulation of its producing 
strain S. griseoflavus W-384. In addition, the inconsistent and low production of HRM in the 
wild type strain has prevented us from investigation of its antibacterial and hormonal 
mechanism of action.  
 
To solve the problems mentioned above, the first achievement of this project was the 
establishment of an optimal genetic manipulation system of S. griseoflavus W-384 for further 
molecular analysis of hrm genes. With the optimized system in hand, three putative regulatory 
genes, hrmA, hrmB and hrmH were genetically manipulated, which resulted in the generation 
of two HRM overproducers. HRM production was increased as much as 135-fold for HrmB 
overexpression strain. Additionally, six more HRM analogues were obtained from the HrmB 
overproducer. However, manipulation of hrmH by gene knockout, a putative negative 
regulatory gene, did not increase and abolish HRM production, but led to the isolation of an 
additional HRM analogue containing a (4-Me)Pro residue instead of (4-Pe)Pro. 
Overexpression of hrmH in S. griseoflavus W-384 also did not have an influence on HRM 
production. It was postulated that HrmH may act as an unusual regulator governing the 
biosynthesis of (4-Pe)Pro. Investigation of the origin of (4-Me)Pro suggested that (4-Me)Pro 
was not an intermediate in (4-Pe)Pro biosynthesis and there was no convincing gene 
candidate from the genome sequence for this building block. Thus, (4-Me)Pro would rather 
originate from the fermentation medium. Defining the precise mechanism for HrmH as 
transcriptional, translational, or small-molecule-mediated regulation in HRM biosynthesis will 
be the focus of future studies. 
 
HRM consists of eight building blocks, some of which are unusual, such as Chpca, 
(3-Ncp)Ala and (4-Pe)Pro. In this work, to elucidate the HRM biosynthesis, the aim was to 
identify and analyze the biosynthetic genes involved in these unusual building blocks by gene 
knock-outs as well as genetic and chemical complementations. The gene knock-out and 
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genetic complementation of hrmQ further proved that HrmQ is a halogenase catalyzing the 
chlorination of Chpca. The results also showed that hrmI and hrmJ are essential for the 
biosynthesis of (3-Ncp)Ala. To further investigate the roles of HrmI and HrmJ in vitro during 
the biosynthesis from L-Lys to (3-Ncp)Ala, soluble HrmI was successfully expressed in E. 
coli, and intitial buffer stability tests were performed in this work. Enzymatic assays of HrmI 
will be pursued via combination of HrmJ expressed by Dr. Crüsemann in 2012. Manipulation 
of hrmD revealed its indispensable role in the biosynthesis of (4-Pe)Pro. Additionally, an 
eighth HRM analogue (HRM A8) was generated by feeding (4-Et)Pro into hrmD mutant. 
HRM A8 will be further employed to determine the molecular target of antibacterial and 
hormonal activities by “Click chemistry”.  
 
In this work, the new analogues HRM A1-7 document a previously unseen natural plasticity in 
HRM biosynthesis. All the analogues including HRM A8 generated by mutasynthesis provided 
useful SAR data that can aid in the design of non-natural active analogues. In addition, the 
HRM overproducer will be used for providing sufficient amount of HRM to screen the 
potential drug candidate and also can be applied to increasing the antibiotic production in 
other Streptomyces spp..  
  
HRM, as a bacterial hormone, can induce the aerial mycelia formation in other Streptomyces 
spp.. To test its hormonal activity and understand the mechanism, in this study, HRM was 
applied to seven bld mutants derived from well-known S. coelicolor A3(2) and three “bald” 
mutants generated from S. griseus. The results showed that HRM did induce the mycelia 
formation of some of the “bald” mutants and all the wild type strains including its producing 
strain S. griseoflavus W-384. However, some bld mutants that were expected to form aerial 
hyphae failed to produce the aerial mycelia after exposure to HRM. Since the HRM hormonal 
mechanism is still unknown, “Click chemistry” is currently being employed to determine the 
cellular targets of HRM for its antibacterial and hormonal activities, which eventually will 
help us to understand how HRM induce the aerial mycelia formation and the antibacterial 
mode of action.  
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Bioinformatic analysis revealed a trans-AT PKS gene cluster in the genome of S. griseoflavus 
W-384. As a side project of this work, I aimed to identify a trans-AT PKS-derived polyketide 
from S. griseoflavus W-384 via genome mining. In this study, the sequence of the trans-AT 
PKS gene cluster was completed. A putative trans-AT PKS mutant was generated via single 
cross-over. The initial comparative metabolic profiling by HPLC between the WT and this 
mutant showed that three obvious metabolites were absent in the mutant. Due to the structural 
difference between the polyketide and HRM, the UV wavelength used for detection of these 
two different compounds is supposed to be different. To further analyze the extracts from 
these two strains, the detection conditions will be further optimized. The fermentation in a 
large scale will be carried out to isolate the potential trans-AT PKS-derived polyketide and 
elucidate its structure. Furthermore, the trans-AT PKS gene cluster will be annotated 
according to the structure of this polyketide. With this polyketide and its gene cluster in hand, 
the bioactivity of this trans-AT PKS-derived polyketide will be tested for potential drug 
candidate and novel natural products could be generated by genetically engineering its 
biosynthetic pathway. 
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Chapter 4  Materials and Methods 
4.1 Chemicals and materials  
Table 4.1: Chemicals and materials used in this study. 
Chemicals and materials source 
Agarose 
Chemicals for different solution and buffers 
 
 
 
 
DNA and protein ladders 
 
 
dNTPs 
Ingredients for all kinds of media               
 
 
 
 
Ni-NTA-Agarose  
Roth, Karlsruhe 
Fluka, Seelze 
Merck, Darmstadt 
Roth, Karlsruhe 
Sigma-Aldrich, Seelze 
KMF, Lohmar 
Roth, Karlsruhe 
Fermentas 
Invitrogent, Karlsruhe 
Invitrogen, Karlsruhe 
Difco, Detroit, USA 
Merck, Darmstadt 
Oxoid, Wesel 
Roth, Karlsruhe 
Fluka, Seelze 
MACHENREY-NAGEL, Düren 
Solvents    
                             
Hybond N
+ 
nylonmembranes  
Membrane filters BA 85 (0.2 μm and 0.45 μm)  
3MM Whatman filter paper 
X-ray film Hyperfilm-MP  
Fisher scientific, Schwerte 
Merck, Darmstadt 
Amersham Bioscience, Freiburg  
Schleicher & Schuell, Dassel 
Whatman, Maidstone, GB 
Amersham Bioscience, Freiburg 
 
4.2 Enzymes 
Table 4.2: Enzymes used in this study. 
Enzymes source 
Antarctic phosphatase 
Expand High Fidelity
PLUS
 PCR System  
Lysozyme 
Restriction enzymes 
RNase A  
T4 DNA ligase  
Taq DNA polymerase 
NEB, Frankfurt/Main 
Roche 
Roth, Karlsruhe  
NEB, Frankfurt/Main, Jena Bioscience, Jena 
Roth, Karlsruhe 
Jena Bioscience, Jena 
NEB, Frankfurt/Main 
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4.3 Antibiotics 
Table 4.3: Antibiotics used in this study. 
 
Antibiotic 
 
 
Stock solution 
(mg/mL) 
 
Solvent 
Final conc.  
(µg/mL) 
 
Source 
Streptomyces 
spp. 
E. coli 
Ampicillin 
Apramycin 
Chloramphenicol 
Erythromycin 
Kanamycin 
Nalidixic acid 
Spectinomycin 
Streptomycin 
Thiostrepton 
100  
50 
25 
50 
50 
25 
50 
25 
50 
Water 
Water 
Ethonal 
Water 
Water 
0.3 M NaOH 
Water 
Water 
DMSO 
- 
25 
- 
25 
25 
20 
50 
25 
25 
100 
50      
25 
25     
50 
25 
50 
25 
- 
Roth 
Sigma 
Fluka 
Sigma 
Roth 
Roth 
Sigma 
Sigma 
AppliChem 
 
4.4 Media  
4.4.1 Cultivation media for Escherichia coli strains 
LB (Luria Broth) (per Liter) 
Tryptone                                   10 g 
Yeast extract                                 5 g 
NaCl                                      10 g 
(Agar)                                     15 g 
 
SOB (per Liter) 
Tryptone                                   20 g 
Yeast extract                                 5 g 
NaCl                                    0.58 g 
KCl                                     0.19 g 
After autoclaving, add: 
MgCl2.6H2O (1M)                         10 mL 
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MgSO4.7H2O (1M)                        10 mL 
SOC (per Liter) 
D-glucose                         3.60 g  in SOB 
 
TB :  
A )     
Tryptone                                   12 g 
Yeast extract                                24 g 
Glycerol                                   4 mL 
Distilled water to 900 mL, autoclave. 
B) 
Salt solution (per Liter) 
KH2PO4 (170 mM)                        23.14 g 
K2HPO4.3H2O (720 mM)                   164.5 g 
Autoclaving, 
Before using for cultivation, mix 900 mL of A and 100 mL of B  
 
4.4.2 Cultivation media for Streptomyces strains 
GYM (per Liter) 
Glucose                                     4 g 
Yeast extract                                 4 g 
Malt extract                                  4 g 
CaCO3                                      2 g 
Agar                                       20 g 
pH                                        7.0-7.2 
 
GSY (per Liter) 
Soluble starch                                 2 g 
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Yeast extract                                  5 g 
NaCl                                       0.5 g 
KNO3                                        1 g 
K2HPO4                                     0.5 g 
MgSO4.7H2O                                 0.5 g 
FeSO4.7H2O                                  0.1 g 
Agar                                        20 g 
pH                                          7.0 
 
YD (per Liter) 
Yeast extract                                  4 g 
Maltose                                     10 g 
Glucose                                      4 g 
MgCl2                                       2 g 
CaCl2                                      1.5 g 
Agar                                       15 g 
pH                                         7.2 
 
Gauze I (per Liter) 
Soluble starch                                20 g 
Yeast extract                                  5 g 
K2HPO4                                    0.5 g 
MgSO4.7H2O                               0.5 g 
KNO3                                      0.5 g 
FeSO4.7H2O                                0.01 g 
NaCl                                       0.5 g 
Agar                                        20 g 
pH                                          7.0 
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R5 (per Liter) 
Sucrose                                     103 g 
D-glucose                                    10 g 
MgCl2.6 H2O                              10.12 g 
K2SO4                                    0.25 g 
Difco casamino acids                         0.1 g 
Yeast extract                                  5 g 
Trace element solution                        2 mL 
TES                                      5.73 g 
Distilled water to                              1 L  
Divide the solution into 5 × 250 mL flasks, 100ml per each with 2.2 g Difico Bacto Agar. 
Then close the flasks and autoclave.  
After autoclaving , add to each flask in the order list: 
KH2PO4 (0.5%)                               10 mL 
CaCl2.2H2O (5M)                            0.4 mL 
L-proline (20%)                              1.5 mL 
NaOH (1 M) adjust                          pH to 7.3  
   
Trace elements solution (per Liter) (used for R5 medium preparation) 
ZnCl2                                        40 g 
FeCl2.6H2O                                  200 g 
CuCl2.2H2O                                  10 g 
MnCl2                                       10 g 
Na2B4O7.10H2O                               10 g 
(NH4)6Mo7O4.4H2O                            10 g 
 
MS (per Liter) 
Mannitol                                     20 g 
Soypeptone                                   20 g 
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(Agar)                                       20 g 
Tap water                                    1L 
 
SY (per Liter) 
Soluble starch                                 20 g 
Yeast extract                                   4 g 
Agar                                         20 g 
pH                                          7.0 
SYC (per Liter)  
Casamino acids 10 g into SY 
 
MM (per Liter) (Kieser 2000) 
(NH4)2SO4                                     1 g 
K2HPO4                                      0.5 g 
MgSO4.7H2O                                 0.2 g 
FeSO4.7H2O                                 0.01 g 
D-glucose                                     10 g 
Agar                                         20 g 
pH                                           7.0 
 
YEME (per Liter) (Kieser 2000)  
Yeast extract                                   3 g 
Peptone                                       5 g 
Malt extract                                    3 g 
D-glucose                                     10 g 
Sucrose                                      340 g 
After autoclaving, add: 
MgCl2.6H2O (2.5 M)                            2 mL 
Glycine (20%)                                25 mL 
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pH                                           7.0 
 
MMS (per Liter) 
D-mannitol                                     10 g 
Meat extract                                   20 g 
Soypeptone                                    20 g 
NaCl                                         0.2 g 
ZnSO4.7H2O                                  0.5 g 
Tap water                                      1 L 
pH                                           7.0 
 
TSB (per Liter) 
Oxoid Tryptone Soya Broth powder                 30 g 
 
2 × YT (per Liter) 
Tryptone                                      16 g 
Yeast extract                                   10 g 
NaCl                                          5 g 
 
TSBY (per Liter) 
Tryptone                                      30 g 
Yeast extract                                    5 g 
Sucrose                                      10.3 g 
pH                                            7.2 
 
Super YEME (per Liter) 
Sucrose                                      103 g  
Difco yeast extract                               3 g  
Difco Bacto-peptone                              5 g  
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Amino acid mixture                           10 mL  
Glucose                                       10 g  
MgCl2.6H2O                                   1.1 g 
Glycine                                         5 g  
Cystine                                     0.075 g 
pH                                           7.2  
 
Amino acid mixture (per Liter) (used for Super YEME medium preparation) 
Proline                                       0.75 g 
Arginine                                      0.75 g  
Histidine                                        1 g 
Uracil                                        0.15 g  
 
SGGP (per Liter) 
Peptone                                        4 g 
Yeast extract                                    4 g 
Casamino acid                                   4 g 
Glycine                                        2 g 
MgSO4·7H2O                                  0.5 g  
H2O                                         960 mL 
pH                                            7.2 
After autoclaving, add: 
Glucose (50%)                                 20 mL  
KH2PO4 (0.5 M )                               20 mL  
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4.5 Buffers 
4.5.1 Buffers for plasmid isolation 
Buffer I  
Tris-HCl (pH 8.0)                             50 mM 
EDTA                                      10 mM 
RNase A                                   100 μg/mL 
 
Buffer II         
NaOH                                      200 mM 
SDS                                        1% 
 
Buffer III         
Potassium acetate                          3 M (pH 5.5) 
 
4.5.2 Buffers for protoplast transformation 
P buffer 
Sucrose                                      103 g 
K2SO4                                       0.25 g 
MgCl2.6H2O                                 2.02 g 
Trace element solution                          2 mL 
Distilled water to                             800 mL 
Dispense in 80 mL aliquots and autoclave. Before using, add to each flask in order:  
KH2PO4 (0.5%)                                 1 mL 
CaCl2.2H2O (3.68%)                            10 mL 
TES buffer (5.73%, adjusted to pH7.2)              10 mL 
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4.5.3 Buffers for protein purification 
Lysis buffer (per Liter) 
NaH2PO4.2H2O                               50 mM 
NaCl                                       300 mM 
Imidazole                                    10 mM 
Glycerol                                     100 mL 
pH                                          8.0 
 
Washing buffer I (per Liter) 
NaH2PO4.2H2O                               50 mM 
NaCl                                       300 mM 
Imidazole                                    20 mM 
Glycerol                                    100 mL 
pH                                         8.0 
 
Washing buffer II (per Liter) 
NaH2PO4.2H2O                               50 mM 
NaCl                                       300 mM 
Imidazole                                    40 mM 
Glycerol                                    100 mL 
pH                                         8.0 
 
Elution buffer (per Liter) 
NaH2PO4.2H2O                               50 mM 
NaCl                                       300 mM 
Imidazole                                   250 mM 
Glycerol                                    100 mL 
pH                                         8.0 
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10 × Running buffer (per Liter) 
Tris-base                                   30.28 g 
Glycine                                    187.7 g 
SDS                                         10 g 
 
Destaining solution (per Liter) 
Methanol                                    250 mL 
Acetic acid                                   100 mL 
 
Protein gel loading dye (2 ×) 
Tris-HCl (pH 6.8)                             0.09 M  
Glycerol                                     20% 
SDS                                         2% 
Bromophenol blue                              0.1 M  
DDT                                        0.02% 
 
4.5.4 Buffers for preparation of genomic DNA from Streptomyces strains 
STE buffer 
NaCl                                        75 mM 
EDTA                                       25 mM 
Tris                                         20 mM 
pH                                          7.5 
 
TE buffer (Sambrook 2001) 
Tris                                         10 mM 
EDTA                                        1 mM 
pH                                           8.0 
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4.5.5 Buffers for agarose gel electrophoresis of DNA fragments (Sambrook 
2001) 
DNA loading buffer (10 × per Liter) 
Sucrose                                     500 g 
EDTA (pH 8.0)                               160 mM 
Bromophenol Blue                            0.5 g 
Xylene cyanol                                0.5 g 
 
TAE buffer (50 × per Liter) 
Tris                                        242 g 
Glacial acetic acid                            57.1 mL 
EDTA (pH 8.0)                               100 mL 
 
4.5.6 Buffers for DNA-DNA hybridization 
-Southern Blotting: 
Depurination buffer      
HCl                                        2.5 N 
Autoclave 
 
Denaturing buffer   
NaOH                                      0.5 N 
NaCl                                       1.5 M 
Autoclave 
 
Neutralization buffer  
Tris-HCl (pH 8.0)                              1 M  
NaCl                                       1.5 M 
Autoclave 
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Transfer buffer ( 20 × SSC per Liter) 
NaCl                                      175.3 g 
Na3Citrate                                   88.2 g 
pH                                          7.0 
Autoclave 
 
-Colony in situ hybridization: 
Lysis buffer (per Liter) 
SDS                                        100 g 
 
-Washing buffer: 
Wash solution I (2 × per Liter) 
SSC (20 × )                                  200 mL 
SDS (10%)                                   10 mL 
 
Wash solution II (0.5 × per Liter) 
SSC (20 × )                                   25 mL 
SDS (10%)                                   10 mL 
 
Maleic Acid buffer (per Liter) 
Maleic Acid                                11.607 g 
NaOH                                      7.88 g 
NaCl                                       8.77 g 
pH                                          7.5 
Autoclave 
 
Washing buffer (per Liter)                   
Maleic acid buffer (pH 7.5)                     997 mL 
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Tween-20                                     3 mL 
Autoclave 
 
Detection buffer (5 ×)  
Tris-HCl                                    0.5 M 
NaCl                                       0.5 M 
pH                                         9.5 
Autoclave 
 
4.6 Strains, plasmids and primers  
4.6.1 Strains 
Table 4.4: Strains used in this study. 
Strain Relevant Genotype Reference/Strain No. 
Escherichia coli    
DH5ɑ 
ET12567/pUZ8002 
BW25113 
XL1-Blue 
 
BL21(DE) 
 
recA endA supE44 hsdR17 
recF dam
-
 dcm
-
 Cml
R
 Str
R
 Tet
R 
Km
R
 
K12 derivative: △araBAD, △rhaBAD 
endA1 gyrA96(nalR) thi-1 recA1 relA1 
lac hsdR17 
F-, ompT, hsdS (rBB-mB-), 
gal, dcm (DE3) 
(Hanahan 1983) 
(Gust et al., 2003) 
(Gust et al., 2003) 
Stratagene, Heidelberg 
 
(Studier et al., 1990) 
 
Arthrobacter  
crystallopoietes ATCC15481 
G
+
, coryneform bacteria 
hormaomycin bioassay test 
(Andres et al., 1990) 
Streptomyces coelicolor    
A(3)2 wild type (Hopwood 1967) 
J1700  bldA null mutant (ΔBldA) John Innes Center 
J669 
J2166 
ΔBldD 
WC109 
NS17 
ΔBldM 
 
 
 
bldB43 agaA1 cysD18 mthB2 (ΔBldB) 
M600 bldC null mutant in frame 
M600 bldD null mutant in frame 
bldH null mutant (ΔBldH) 
bldK null mutant (ΔBldK) 
M600 bldM in frame apramycin resistant 
John Innes Center 
John Innes Center 
John Innes Center 
John Innes Center 
John Innes Center 
John Innes Center 
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Strain Relevant Genotype Reference/Strain No. 
Streptomyces griseus   
subsp. griseus 
ΔAfsA (IFO 13350) 
 
ΔAdpA (IFO 13350) 
 
ΔAdsA (IFO 13350) 
streptomycin wild producer 
no aerial mycelia formation and loss of 
A-factor productivity 
no aerial mycelia formation and 
streptomycin production 
no aerial mycelia but with streptomycin 
production or pigment production 
DSM 40236  
Prof. Horinouchi 
 
Prof. Horinouchi 
 
Prof. Horinouchi 
Streptomyces lincolnensis 
NRRL2936 
lincomycin wild producer (Mason et al., 1963) 
Streptomyces griseoflavus   
W-384 hormaomycin wild producer Prof. Zeeck 
ΔC hrmC knockout, aprR This study 
ΔD hrmD knockout, aprR This study 
ΔH hrmH knockout, aprR This study 
ΔI hrmI knockout, aprR This study 
ΔJ hrmJ knockout, aprR This study 
ΔN hrmN knockout, aprR This study 
ΔQ hrmQ knockout, aprR This study 
ΔC/HrmB HrmB overexpression in ΔC, aprR, tsrR This study 
ΔD/HrmB HrmB overexpression in ΔD, aprR, tsrR This study 
ΔH/HrmB HrmB overexpression in ΔH, aprR, tsrR This study 
ΔI/HrmB HrmB overexpression in ΔI, aprR, tsrR This study 
ΔJ/HrmB HrmB overexpression in ΔJ, aprR, tsrR This study 
ΔN/HrmB HrmB overexpression in ΔN, aprR, tsrR This study 
ΔQ/HrmB HrmB overexpression in ΔQ, aprR, tsrR This study 
XC1 HrmA overexpression in S. griseoflavus 
W-384, apr
R 
This study 
XC2 HrmB overexpression in S. griseoflavus 
W-384, apr
R
 
This study 
ΔQ/HrmB HrmB overexpression in ΔQ, aprR, tsrR This study 
XC3 HrmA and HrmB overexpression in wild 
producer, apr
R
, tsr
R
 
This study 
ΔD/HrmD HrmD expression in ΔD, aprR, tsrR This study 
ΔH/HrmH HrmH expression in ΔH, aprR, tsrR This study 
ΔI/HrmI HrmI expression in ΔI, aprR, tsrR This study 
ΔJ/HrmJ HrmJ expression in ΔJ, aprR, tsrR This study 
ΔQ/HrmQ HrmQ expression in ΔQ, aprR, tsrR This study 
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Strain Relevant Genotype Reference/Strain No. 
DSM: Deutsche Sammlung von Mikroorganismen und Zellkulturen,  NRRL: Northern Regional Research 
Laboratories. 
 
4.6.2 Plasmids 
Table 4.5: Plasmids used in this study. 
Cosmid/Plasmid Description References 
pHR6G10 
 
pWEB based cosmid with part of hrm gene  
cluster (hrmA-hrmO) 
(Höfer et al., 2011) 
pHR1F4 pWEB based cosmid with part of hrm gene  
cluster (hrmO-hrmW) 
(Höfer et al., 2011) 
pSET152 5.5 kb, aac(3)IV, oriT, int, attp pUC18 (Bierman 1992) 
pHZ199 6.6 kb, tsr, bla, hyg, oriT, pUC18  (Hu et al., 1994) 
pIJ773 4.3 kb, aac(3)IV, bla, oriT RK2, FRT   (Gust et al., 2003) 
pWHM4* 7.9 kb, permE*, lacZa, tsr, bla (Matseliukh 2001) 
pHZ1358 11 kb, bla, neo, SV40 ori,cosE1 oriT (Kieser 2000) 
pGEM easy 3.0 kb, bla, f1 ori, lacZ Promega 
pET28b 5.4 kb, km
R
, f1 ori,pBR322 ori, C and N terminal His- tag Novagen 
pET29b 
 
5.4 kb, km
R
 , f1 ori , T7 Promoter, MCS, lacI, C Terminal 
His-Tag, N Terminal S-Tag 
Novagen 
pXC1 3.8 kb, aac(3)IV, pBluescript SK II(+) This study 
pXC2 5.0 kb, 2.1 kb of hrmH left arm ligated to pBluescript SK 
II(+)  
This study 
pXC3 5.0 kb, 2.1 kb of hrmH right arm ligated to pBluescript SK 
II(+) 
This study 
pXC4 7.3 kb, left arm plus right arm of hrmH ligated to 
pBluescript SK II(+) 
This study 
pXC5 8.2 kb, left arm plus right arm of hrmH with apr
R
 in 
between ligated to pBluescript SK II(+)  
This study 
pXC6 10 kb, hrmH suicide plasmid, pDH5 This study 
pXC7 3.85 kb, lmbX (0.85 kb) ligated to pBluescript SK II(+) This study 
pXC8 16.8 kb, hrmH suicide plasmid, pHZ1358 This study 
pXC9 12.5 kb, hrmH suicide plasmid, pHZ199 This study 
pXC10 8.9 kb, tsr
R
 replaceb by apr
R
, in pWHM4* This study 
pXC11 3.5 kb, hrmB (0.6 kb ) ligated to pBluescript SK II(+) This study 
pXC12 4.0 kb, hrmA (1.0 kb) ligated to pBluescript SK II(+) This study 
pXC13 9.5 kb, hrmB (0.6 kb ) ligated to pXC10 This study 
pXC14 10 kb, hrmA (1.0 kb) ligated to pXC10 This study 
pXC15 11.3 kb, orf20 (8.4 kb) from trans-AT PKS gene cluster of 
S. griseoflavus W-384 genome ligated to pBluescript SK 
II(+) 
This study 
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Cosmid/Plasmid Description References 
pXC16 15.5 kb, orf20 (8.4 kb) from trans-AT PKS gene cluster of 
S. griseoflavus W-384 genome ligated to pHZ199 
This study 
pXC17   3.9 kb, hrmC (1.08 kb) ligated to pBluescript SK II (+) This study 
pXC18  3.8 kb, hrmD (0.9 kb) ligated to pBluescript SK II (+) This study 
pXC19 
pXC20 
3.4 kb, hrmH (0.4 kb) ligated to pBluescript SK II (+) 
4.0 kb, hrmI (1.053 kb) ligated to pBluescript SK II (+) 
This study 
This study 
pXC21 3.7 kb, hrmJ (0.7 kb) ligated to pBluescript SK II (+) This study 
pXC22 4.1 kb, hrmN (1.17 kb) ligated to pBluescript SK I I(+) This study 
pXC23 4.4 kb, hrmQ (1.4 kb) ligated to pBluescript SK II (+) This study 
pXC24 9.0 kb, hrmC (1.08 kb) ligated to pWHM4* This study 
pXC25 8.8 kb, hrmD (0.9 kb) ligated to pWHM4* This study 
pXC26 8.3 kb, hrmH (0.4 kb) ligated to pWHM4* This study 
pXC27 8.9 kb, hrmI (1.053 kb) ligated to pWHM4* This study 
pXC28 8.6 kb, hrmJ (0.7 kb) ligated to pWHM4* This study 
pXC29 9.1 kb, hrmN (1.17 kb) ligated to pWHM4* This study 
pXC30 9.4 kb, hrmQ (1.4 kb) ligated to pWHM4* This study 
pXC31 8.5 kb, hrmB (0.6 kb) ligated to pWHM4* This study 
pXC32 5.1 kb, ~2.1 kb DNA containing the first KS domain 
coding gene in orf20 (8.4 kb) in trans-AT PKS gene 
cluster of S. griseoflavus W-384 genome ligated to 
pBluescript SK II(+) 
This study 
pXC35A 
pXC35B 
4.05 kb, hrmI with stop codon ligated to pGEM easy 
4.05 kb, hrmI with stop codon ligated to pGEM easy 
This study 
This study 
pXC36 6.4 kb, hrmI with stop codon ligated to pET28b(+) This study 
pXC37 6.4 kb, hrmI without stop codon ligated to pET29b(+) This study 
pXC38 9.1 kb, ~4.1 kb DNA containing the first KS domain 
coding gene in orf20 (8.4 kb) in trans-AT PKS gene 
cluster of S. griseoflavus W-384 genome ligated to 
pBluescript SK II(+) 
This study 
pXC39 4.9 kb, ~1.9 kb DNA containing the second KS domain 
coding gene in orf20 in trans-AT PKS gene cluster of S. 
griseoflavus W-384 genome ligated to pBluescript SK 
II(+) 
This study 
pXC40 9.1 kb, ~4.1 kb DNA containing the second KS domain 
coding gene in orf20 (8.4 kb) in trans-AT PKS gene 
cluster of S. griseoflavus W-384 genome ligated to 
pBluescript SK II(+) 
This study 
pXC41 4.8 kb,Thio
R
 replaced by apr
R
, in pHZ199 This study 
pXC42 
 
 
 
6.9 kb, ~2.1 kb DNA containing the first KS domain 
coding gene in orf20 in trans-AT PKS gene cluster of S. 
griseoflavus W-384 genome ligated to pXC41 
This study 
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Cosmid/Plasmid Description References 
pXC43 8.9 kb, ~4.1 kb DNA containing the first KS domain 
coding gene in orf20 in trans-AT PKS gene cluster of S. 
griseoflavus W-384 genome ligated to pXC41 
This study 
pXC44 
 
 
pXC45 
6.7 kb, ~1.9 kb DNA containing the second KS domain 
coding gene in orf20 in trans-AT PKS gene cluster of S. 
griseoflavus W-384 genome ligated to pXC41 
11.5 kb, ~4.1 kb DNA containing the second KS domain 
coding gene in orf20 in trans-AT PKS gene cluster of S. 
griseoflavus W-384 genome ligated to pXC41 
This study 
 
 
This study 
  
4.6.3 Primers  
Table 4.6: Primers used in this study. 
Primer 
Name 
Target Gene Sequence 
XF1F 
XF1R 
apr
R 
(~0.8 kb) 5’ –GCTCTAGAGTGCAATACGAATGGCGAAAAGCCG– 3’ 
5’ –TCCCCGCGGGCTCTAGATCAGCCAATCGACTGGCG– 3’ 
XF2F 
XF2R 
left arm of hrmH 5’ –CCCAAGCTTGGGCGAGAGAATGATCGGTTC– 3’ 
5’ –GCTCTAGACCTGTCCTCCCCA ACA AGTGAC– 3’ 
XF3F 
 
XF3R 
right arm of hrmH 5’-GCTCTAGATACCGGATCCGTTGCAGGAAAAACCTCC 
TGAGAATC– 3’ 
5’ –ATAAGAATGCGGCCGCCCCAAGCTTGGGGTTCCCCG 
GCGTCGAGC– 3’ 
XF6F 
XF6R 
lmbX 5’ –GGAATTCATGATCGTGGTCCCGTTC– 3’ 
5’ –CCCAAGCTTCTACACGGAAGCGACCGC– 3’ 
XF9F 
XF9R 
apr
R
 cassette (~1.4 kb) 5’ –CCATCGATCTGACGCCGTTGGATACACCAG– 3’ 
5’ –CCGGATATCTTAGCCAATCGACTGGCGAGCG– 3’ 
XF10F 
XF10R 
hrmA 5’ – GCTCTAGAGGGGACTCATGAACCGGGCCC– 3’ 
5’ – GGAATTCTCAGGCCGACGGGGTAGGGC– 3’ 
XF11F 
 
XF11R 
hrmB 5’ –CAAGCTTTTAATTAAGGAGGAGGAACACCATGACC 
ACCTAC– 3’ 
5’ –GGAATTCTCAAACCGCTCTGTCGAGAAC– 3’ 
XF12F 
 
XF12R 
apr
R
 cassette for hrmC 
replacement 
5’ –TTGCTGACGTCAACCATCGGAAGAGGTTGTAACGC 
TGTGA TTCCGGGGATCCGTCGACC– 3’ 
5’ –GCCGTTCCGGCAGGATCACCACTCCGACGCGCA 
CGCTCAT GTAGGCTGGAGCTGCTTC– 3’ 
XF13F 
 
XF13R 
apr
R
 cassette for hrmD 
replacement 
5’ –CTTCTACGACCTCGCACCGGCCGCGGAGGAC 
TGAGCGTGATTCCGGGGATCCGTCGACC– 3’ 
5’ –GGCCGCGGCCTCCGGCGTCGGTTCGCCCGGTC 
CGGATCA TGTAGGCTGGAGCTGCTTC– 3’ 
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Primer 
Name 
Target Gene Sequence 
XF14F 
 
XF14R 
apr
R
 cassette for hrmI 
replacement 
5’ –CCGTTGCAGGAAAAACCTCCTGAGAATCTTGG 
ACGCGTGATTCCGGGGATCCGTCGACC– 3’ 
5’ –TAACCACGGTCGTTGAGCGGCATGCGCGTGACC 
TCCTCATG TAGGCTGGAGCTGCTTC– 3’ 
XF15F 
 
XF15R 
apr
R
 cassette for hrmJ 
replacement 
5’ –ACTCCGCCGCACACACGTCCTGAGGAGGTCAC 
GCGCATGA TTCCGGGGATCCGTCGACC– 3’ 
5’ –CCCGGTTCCGGGGGTGCTGCTCATGACCGCCG 
CTCCTCAT GTAGGCTGGAGCTGCTTC– 3’ 
XF16F 
 
XF16R 
apr
R
 cassette for hrmN 
replacement 
5’ –GTCGAGAACTGACGCCGACACACCGAGGGGGA 
ACGCATG ATTCCGGGGATCCGTCGACC– 3’ 
5’ –GGCAGGCGCCGAGTCGGGGACGACGGGGGCGGG 
CCGTCA TGTAGGCTGGAGCTGCTTC– 3’ 
XF17F 
 
XF17R 
apr
R
 cassette for hrmQ 
replacement 
5’ –CCTGCGGGAAATGAATCCGACGAGTGAGGGAGA 
AAAATG ATTCCGGGGATCCGTCGACC– 3’ 
5’ –CTCGATCTCGTCGGAAACGAGCAGGGGTGGGCG 
AGCTCA TGTAGGCTGGAGCTGCTTC– 3’ 
XF18F 
 
XF18R 
apr
R
 cassette for hrmH 
replacement 
5’ –GCTGCGACGCCAATGTCACTTGTTGGGGAGGAC 
AGGGTG ATTCCGGGGATCCGTCGACC– 3’ 
5’ –GATTCTCAGGAGGTTTTTCCTGCAACGGATCCG 
GTATCATGTAGGCTGGAGCTGCTTC– 3’ 
XF19F 
XF19R 
hrmC 5’ –AACTGCAGGAGGGCTGTGGCGGACTAC– 3’ 
5’ –GCTCTAGATCAGTCCTCCGCGGCCGG– 3’ 
XF20F 
XF20R 
hrmD 5’ –AACTGCAGGAGGAGCGTGCGCGTCGGAG– 3’ 
5’ –GCTCTAGATCAGAGTGCGCGCACCG– 3’ 
XF21F 
XF21R 
hrmI 5’ –AACTGCAGGAGAAGCGTGATGATTCCTG– 3’ 
5’ –GCTCTAGATCAGGACGTGTGTGCGGC– 3’ 
XF22F 
XF22R 
hrmQ 5’ –AACTGCAGGAGGGAAATGAGCGACTTC– 3’ 
5’ –GCTCTAGATCAGAAGAGCGGAGCCGC– 3’ 
XF23F 
XF23R 
hrmJ 5’ –GCTCTAGAGGAGGGCATGCCGCTCAAC– 3’ 
5’ –GGAATTCTCAGCCCTCGGCCAGGGC– 3’ 
XF24F 
XF24R 
hrmH 5’ –GCTCTAGAGGAGGGGGTGACCACTTCTTC– 3’ 
5’ –GGAATTCTCACTCGTTCACCAGCGCGTC– 3’ 
XF25F 
XF25R 
hrmN 5’ –GCTCTAGAGGGGAACATGGAACACCGGAC– 3’ 
5’ –GGAATTCTCACCAGTCGAAGTTGCGCAC– 3’ 
XF26F 
XF26R 
Identification of 
mutants 
5’ –ATCGAGGCCCTGCGTGCTGC– 3’ 
5’ –AGGGCCTCGATCAGTCCAAG– 3’ 
XF27F 
XF27R 
ΔC mutant 5’ –CGCAAGCAGGTCCGGGCGAG– 3’ 
5’ –GGGTGGCGGAAGTTCGGCGA– 3’ 
XF28F 
XF28R 
ΔD mutant 5’ –CTCCGGCCGGAAGATGCTCC– 3’ 
5’ –ACACGCTGCGCCCGGCGGTC– 3’ 
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Primer 
Name 
Target Gene Sequence 
XF29F 
XF29R 
ΔH mutant 5’ –GCGCGGGGCGGCCGTTCAAG– 3’ 
5’ –CCAGTACGTCGTGCAGCTCC– 3’ 
XF30F 
XF30R 
ΔI mutant 5’ –CGCCTCCCTCCAGGACGTGA– 3’ 
5’ –CGGATTCCGCCGGCCACGGG– 3’ 
XF31F 
XF31R 
ΔJ mutant 5’ –TCGGACTTCCGCGCGAGGGC– 3’ 
5’ –CACGATGGCCTGGTGGCCGC– 3’ 
XF32F 
XF32R 
ΔN mutant 5’ –GCGGCACTCACCAAGATCTC– 3’ 
5’ –CCGTGGATCTCGACGCACTG– 3’ 
XF33F 
XF33R 
ΔQ mutant 5’ –CTGCGCGTGAACTACAGTCC– 3’ 
5’ –CTCGTGGGTCGCATGTCCGT– 3’ 
MFF1-RE 
 
MFR1-RE 
orf 20 (~8.4 kb) in 
trans-AT PKS gene 
cluster  
5’ –GCGAAGCTTGTGAGGAGGACGTCGAGGA 
CCTGTA– 3’ 
5’ –GCGAAGCTTGAGCACGGTCTCCTCGGCTC– 3’ 
XF38F 
XF38R 
hygromycin resistance 
gene 
5’ –ATGGGTAAAAAGCCTGAAC– 3‘ 
5’ –TTATTCCTTTGCCCTCGGAC– 3’ 
XF39F 
XF39R 
thiostrepton resistance 
gene 
5’ –ATGACTGAGTTGGACACCATC– 3’ 
5’ – TTATCGGTTGGCCGCGAGATTC– 3’ 
Gap1-F 
Gap1-R 
trans-AT PKS gene 
cluster Gap1 
5’ –GCAGGAAGTCCGGTATCTGTT– 3’ 
5’ –CACAGGCGAGGTAGAGGACTT– 3’ 
Gap2-F 
Gap2-R 
trans-AT PKS gene 
cluster Gap2 
5’ –CGGCTCGCTGAGAGCAACA– 3’ 
5’ –CCCGGTGCTCCTTGACGTT– 3’ 
Gap3-F 
Gap3-R 
trans-AT PKS gene 
cluster Gap3 
5’ –GCCATCGGCTCGCTGAGAGCAA– 3’ 
5’ –CGTCCTCCTCACCGGCGACGAA– 3’ 
Gap4-F 
Gap4-R 
trans-AT PKS gene 
cluster Gap4 
5’ –CGTGACCGCCATGCCGGAACT– 3’ 
5’ –CGGGTTGCGGTGGTCGGCTT– 3’ 
Gap5-F 
Gap5-R 
trans-AT PKS gene 
cluster Gap5 
5’ –GTCGTCGCCGCGCCGGAGTA– 3’ 
5’ –CCGTCGAGGAGGCCGAAGGTCA– 3’ 
Gap6-F 
Gap6-R 
trans-AT PKS gene 
cluster Gap6 
5’ –CTACGTGGCGGGATCGGTGTT– 3’ 
5’ –GAGCAGGACACCGTGCCGTTT– 3’ 
Gap7-F 
Gap7-R 
trans-AT PKS gene 
cluster Gap7 
5’ –CCGAACGAGGCACCGGAACA- 3’ 
5’ –GGCCGGGTGGTGGTCTGAGA– 3’ 
Gap8-F 
Gap8-R 
trans-AT PKS gene 
cluster Gap8 
5’ –GCGCTACCGCACGCGGTTCA– 3’ 
5’ –GGTGGAGGCCAGCGGAAGCA– 3’ 
Gap9-F 
Gap9-R 
trans-AT PKS gene 
cluster Gap9 
5’ –GTCGGCCTCCACGACGACAA– 3’ 
5’ –CGCGACCAGGTTCTCCCAGAA– 3’ 
Gap10-F 
Gap10-R 
trans-AT PKS gene 
cluster Gap10 
5’ –GCGCTCTGGTCCATGAAGAT– 3’ 
5’ –GCCGCTGCTGCATGAGAT– 3’ 
XCKS-F1 
XCKS-R1 
identification of 
Δtrans-AT PKS 
5’ –CGCCGTTGGATACACCAAGGAAA– 3’ 
5’-CAGCACGAGACCGTCCTCCGT– 3’ 
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Primer 
Name 
Target Gene Sequence 
XCKS-F2 
 
XCKS-R2: 
identification of 
Δtrans-AT PKS 
5’ –CTGATCGTTCTCTCCGCGAAGGA– 3’ 
 
5’ –TCGGGTTTCGCCACCTCTGACT– 3’ 
XCF2’-RE 
MFFR1-RE 
ACP+KS2 (~2.0 kb)  
from orf20 in trans-AT 
PKS gene cluster 
5’ –GCGAAGCTTGGGCAAGGACCGTACCGGGAA– 3’ 
5’ –GCGAAGCTTGAGCACGGTCTCCTCGGCTC– 3’ 
XCF2-RE 
MFFR1-RE 
DH+KR+ACP+KS2 
(~4.0 kb) from orf20 
in trans-AT PKS gene 
cluster 
5’ –GCGAAGCTTCGTGTGCGACGACGACGGAA– 3’ 
5’ –GCGAAGCTTGAGCACGGTCTCCTCGGCTC– 3’ 
XF40F 
XF40R 
apr
R
 cassette (~1.4 kb) 5’ –GGAATTCCTGACGCCGTTGGATACACCAAG– 3’ 
5’ –CCGGATATCTCAGCCAATCGACTGGCGAGCG– 3’ 
 
4.7 General methods 
4.7.1 Cultivation and maintenance of E. coli 
E. coli strains were routinely cultivated at 37 °C on LB agar plates or in LB liquid medium. The 
strains containing plasmids were grown on plates or in liquid media with the appropriate 
antibiotics. E. coli strains were stored at -80 °C in 30% glycerol. 
 
4.7.2 Cultivation and maintenance of Streptomyces spp.  
Streptomyces strains were grown on GYM or MS plates for sporulation and R5 or Gauze I 
plates for regeneration of protoplast transformation. The liquid cultures were generally grown 
at 27-30 °C for 2-5 d in TSB, MS or another various fermentation media. Strains harboring 
plasmids were inoculated on plates or in liquid media containing the appropriate antibiotics. 
Spore suspensions were prepared by adding 500 µL sterilized water on the surface of a well 
sporulated plate, gently scraping the spores off with a sterilized cotton bud, pipetting to mix the 
spores and water, filtering the spores suspension into a Falcon tube via replacing the plunger of 
syringe into the syringe with one piece of cotton on the bottom, then harvesting spores pellet 
through centrifugation and resuspending the spores pellet into certain volume (depending on 
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the pellet size) of sterilized 20% (v/v) glycerol. The spore suspensions were stored at -70 °C. 
 
4.7.3 Isolation of DNA from bacteria and manipulation of bacteria and DNA  
4.7.3.1 Isolation DNA plasmid from E. coli 
3 mL overnight culture was harvested by centrifugation at 12000 rpm for one min twice. 200 µL 
Buffer I was added into the cell pellets after decanting the supernatants and mixed with cells by 
vortexing. 300 µL Buffer II was immediately add into the mixture above and mixed by 
inverting the tubes several times. Then the tube with cells mixture was inverted again to mix 
after adding 300 µL Buffer III Immediately. The cell debris was spun down at 14000 rpm for 5 
min. Most of the supernatant was transferred into a new 1.5 mL tube and mixed with 400 µL 
phenol/chloroform by vortexing two seconds and then spun at 14000 rpm for 5 min. Around 
600 µL upper layer was transferred into a new tube and the same volume of isopropanol was 
added to precipitate DNA by vortexing two seconds and leaving on ice for 5 min, then spinning 
down at 14000 rpm for 5 min to precipitate DNA. DNA pellet was washed with 500 µL 70% 
ethanol by spinning for 2 min at 14000 rpm. The DNA white pellet was dried under the clean 
bench for 30 min after discarding the ethanol completely, dissolved in 50 µL TE buffer and 
stored at -20 °C. 
 
4.7.3.2 Isolation of genomic DNA from Streptomyces spp. 
Streptomyces spore suspension was inoculated in 20 mL MS or TSB media with appropriate 
antibiotics and grown at 30 °C, 250 rpm for 2 d. The mycelia of 2 mL culture were harvested by 
centrifugation at 12000 rpm for 2 min, washed with 1 mL TE buffer by spinning at 12000 rpm 
for 1 min, resuspended the mycelia in 500 µL STE buffer with 5 mg/mL (final concentration) 
lysozyme after removing TE buffer then incubated at 37 °C, 250 rpm for 3 h in a shaker. 
Afterwards, 500 µL 10% SDS and 100 µL 3M NaAC (pH 5.3) were added to the mycelia, the 
suspension was mixed by vortexing and incubated at 37 °C, 250 rpm , at least 30 min. 250 µL 
phenol/chloroform/isopropanol was added and mixed by vortexing 30 sec. Around 800 µL 
upper layer was transferred into new tube after centrifugation for 5 min at 14000 rpm and mixed 
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with 250 µL phenol/chloroform/isopropanol by vortexing 30 sec. Around 750 µL of the upper 
layer was transferred into a new tube, mixed with 750 µL isopropanol to precipitate DNA by 
spinning at 10000 rpm for 5 min after centrifugation again for 5 min at 1400 rpm. The resulting 
white pellet was washed with 500 µL 70% ice-cold ethanol, dried under the clean bench after 
removing the ethanol completely and dissolved in 50 µL TE buffer. 
 
4.7.4 Preparation of E. coli competent cells and DNA transformation 
4.7.4.1 Chemical competent cells preparation and DNA transformation 
4.7.4.1.1 Chemical competent cells preparation 
One single colony from activated E. coli agar plate was inoculated into 3-5 mL fresh LB liquid 
media, incubated in a shaker at 37 °C, 250 rpm overnight. 100 µL overnight culture was 
transferred into 10 mL fresh LB and kept shaking at 37 °C for 2-2.5 h till the OD600 was up to 
0.4-0.6, then the culture was dispensed into 1.5 mL tubes and left on ice for 20 min. The cell 
pellet was harvested by centrifugation at 4 °C, 4000 rpm for 10 min and washed with 1 mL 0.1 
M freezing CaCl2 after discarding the supernatant and resuspended gently, lefts on ice for 
another 20 min. Then the cell pellet was collected by centrifugation at 4 °C, 4000 rpm for 10 
min and washed with CaCl2 again. Then, the cell pellet was resuspended in 100 µL freezing 0.1 
M CaCl2 containing 15% glycerol after removing the supernatant completely and stored at 
-70 °C. 
 
4.7.4.1.2 DNA transformation 
1 µL (100 ng/µL) DNA was mixed with 50 µL competent cells in a 1.5 mL tube gently and left 
on ice for 30 min. The cells were heat-shocked at 42 °C for 90 sec in a water bath and placed on 
ice immediately for 2-4 min. Then 800 µL fresh LB was added into the cells and mixed. The 
mixture was incubated in a shaker at 37 °C for 45-60min. The cell pellets were sedimented at 
5000 rpm for 5 min after incubation, resuspended the cells with the remaining LB after 
discarding the supernatant and spread on LB agar plates containing suitable antibiotics. 
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4.7.4.2 Electronic competent cells preparation and DNA transformation 
One single colony from activated E. coli agar plate was inoculated into 3-5 mL fresh LB liquid 
media with suitable antibiotics at 37 °C, shaken at 200 rpm overnight. 500 uL overnight culture 
was added into 50 mL fresh LB, then shaken at 37 °C for 2-3 h till the OD600 is up to 0.4-0.6. 
Then the culture was dispensed into 50 mL Falcon tubes on ice. The cells pellet was collected 
by centrifugation at 4000 rpm for 5 min at 4 °C, and resuspended by gently mixing in 40 mL 
ice-cold 10% glycerol and washed again with ice-cold the same volume of 10% glycerol. The 
cell pellet was resuspended into the remaining glycerol after discarding most of the supernatant 
and dispensed into 10 tubes, 100 µL per each, stored at -70 °C. 
 
4.7.4.2.1 Electroporation transformation 
Around 100 ng (1-2 µL) of DNA was mixed with 50 µL cell suspension. Then the 
electroporation was carried out in a 0.2 cm ice-cold electroporation cuvette using a BIO-RAD 
Gene Pulser Immediately 1 mL ice-cold SOC or LB media was added to shocked cells and the 
mixture was shaken at 37 °C for 1 h. The culture was spun at 5000 rpm for 5 min. The cell pellet 
was mixed with remaining media after decanting 800 mL supernatant. The mixture was spread 
onto LB agar plate containing appropriate antibiotics. 
  
4.7.5 Protoplast preparation and DNA transformation 
4.7.5.1 Protoplast preparation 
One single colony or 50 µL spores suspension was inoculated into 40 mL MS media (or with 
suitable antibiotics) and shaken at 30 °C for two days. The mycelium was harvested by 
centrifugation at 3000 rpm for 10 min. The supernatant was decanted gently, the mycelia were 
washed by adding 40 mL 10.3% sucrose and centrifugation at 3000 rpm for 10 min twice. After 
decanting the supernatant, the mycelia were resuspended in 15 mL P buffer, mixed with 
lysozyme to final concentration 1.5 mg/mL, incubated at 30 °C for 1.5 h, the tube with mycelia 
was gently inverted every 10-15 min until a creamy suspension formed, then another 5 mL P 
buffer was added to the mix and incubated for further 10 min to release the protoplasts. The 
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protoplasts were filtered through cotton wool, transferred to a new Falcon tube and spun down 
by centrifugation at 3000 rpm for 7 min. The protoplasts pellet was resuspended in 1 mL P 
buffer after decanting the supernatant and dispensed into 1.5 mL tubes and stored at -70 °C. 
 
4.7.5.2 DNA transformation 
50 µL protoplasts were dispensed in 1.5 mL tube, 5 µL DNA solution was added to the inside of 
the tube wall.and mixed with the protoplasts by tapping tube. Then, 200 µL 25% PEG1000 
was added into the protoplasts and mixed by pipetting up and down 4 times. The protoplasts 
suspension was plated on dried R5 plate. Then the plate was incubated at 30 °C, after 14-20 h, 
and overlaid with appropriate antibiotics for selection and kept incubation at 30 °C for 5-7 days.  
 
4.7.6 Conjugation from E. coli to Streptomyces 
To prepare competent cells of E. coli ET12567/pUZ8002, the bacteria were grown in the 
presence of kanamycin (25 µg/mL) and chloramphenicol (25 µg/mL) to maintain selection for 
pUZ8002 and the dam mutation, respectively. The oriT-containing vector was transformed into 
competent cells for screening of the incoming plasmid only. A single colony from the 
transformants was inoculated into 10 mL LB containing chloramphenicol, kanamycin and the 
antibiotic used to select for the oriT-containing plasmid and grown overnight. The overnight 
culture was diluted at 1:100 in fresh LB plus antibiotic selection and grown at 37 °C to OD600 
of 0.4-0.6. The cells was harvested by centrifugation and washed twice with an equal volume of 
LB (to remove antibiotics that might inhibit Streptomyces) and resuspended in 0.1 volume of 
LB. While washing the E. coli cells, for each conjugation approximately 1 × 10
8
 Streptomyces 
spores were added to 500 µL 2 × YT broth and heat-shocked at 50 °C for 10 min, then cooled 
down. 500 µL of E. coli cells were added to 0.5 mL heat-shocked spores, mixed and spun down 
briefly. Most of the supernatant was decanted, the cell pellet was then resuspended in the 
residual liquid and plated on MS agar with 10 mM MgCl2 and incubated at 30 °C for 16-20 h. 
The plate was overlaid with 1.5 mL sterilized water containing 0.5 mg nalidixic acid and 
appropriate antibiotics for plasmid selection. The antibiotic solution was spread evenly and 
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kept incubation at 30 °C for 3-7 d. The potential conjugants were picked off to selective media 
containing antibiotics and nalidixic acid (25 µg/mL). 
 
4.7.7 DNA agrose gel electrophoresis 
DNA Agarose gel electrophoresis was carried out according to the protocol of described by 
Samhook. DNA fragments were separated on 0.8%, 1.0% and 1.5% (depending on DNA sizes) 
agarose gel containing 0.1 µg/mL ethidium bromide. A volume DNA solution mixed with 1/10 
volume DNA loading dye was loaded into the well of the gel. Electrophoresis was performed at 
60-125 V for 1-10 h (for different purposes) in 1 x TAE buffer. The DNA gel was visualized by 
illumination with UV light. 
 
4.7.8 DNA fragment purification from agarose gel (QIA quick Gel 
Extraction Kit Protocol) 
The DNA fragment was excised from the agarose gel with a clean, sharp scalpel. The gel slices 
were weighed in a colorless tube. 3 volumes of Buffer QG was added to 1 volume of gel (100 
mg) and incubated at 50 °C for 10 min until the gel slices have completely been dissolved. One 
gel volume of isopropanol was added to the sample and mixed. The QIA quick spin column was 
placed in a 2 mL provided collection tube. To bind DNA, the sample was applied to the QIA 
quick column, and spun for one min at 13000 rpm. The flow-through was discarded and the 
QIA quick column was placed back in the same collection tube. 500 µL of Buffer QG was 
added to the column and spun for one min at 13000 rpm. 750 µL of Buffer PE was added to the 
column and spun for one min at 13000 rpm. The flow-through was discarded and the column 
was spun for an additional 1 min at 13000 rpm. The column was placed into a clean 1.5 mL tube. 
Finally, 30-50 µL of Buffer EB was applied to the center membrane of column and spun for one 
min. 
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4.7.9 DNA digestion with restriction enzymes 
The digestion of DNA was carried out with 2 units of restriction enzyme per 1 µg DNA in a 
reaction containing appropriate 1 × reaction buffer recommended by manufacturer and water 
filled up to desired volume, then incubated at 37 ºC for 1-3 h, then inactivated by heating at 
65 °C for 10 min. In this study, basically, two different volumes of DNA digestion volume were 
set up, 10 µL volume for testing the DNA size and 100 µL volume for isolating DNA fragment , 
which described as follows: 
 
Table 4.7: The composition of digestion. 
Composition  10 µL 100 µL 
Single digestion Double digestion Single digestion Double digestion 
DNA 
Enzyme I 
Enzyme II 
10 × Buffer 
10 × BSA 
dd H2O 
1 µL 
0.5 µL 
- 
1 µL  
1 µL 
6.5 µL 
1 µL 
0.5 µL 
0.5 µL 
1 µL 
1 µL 
6 µL 
30 µL 
5 µL 
- 
10 µL 
10 µL 
45 µL 
30 µL 
5 µL 
5 µL 
10 µL 
10 µL 
40 µL 
 
4.7.10 DNA precipitation 
DNA precipitation was applied to concentrating DNA or desalting the buffers after digestion, 
dephosphorylation and ligation of DNA in case of inhibition to further studies. 1/10 volume of 3 
M sodium acetate (pH 5.2) plus 2-3 volumes of cold 100% ethanol were added to the solution 
containing DNA. One volume was the volume of the solution containing the DNA. The 
solution was then placed at -20 °C for 2 h and finally was centrifuged at 14000 rpm for 15 min 
at 4 
o
C. The ethanol was removed and the pellet was rinsed once with 70% ethanol by 
centrifugation for 5 min at 14000 rpm at 4 
o
C. The ethanol was discarded and the pellet was 
allowed to dry in vacuum and then resuspended in clean aqueous for use. 
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4.7.11 Dephosphorylation of linearized plasmid vector 
To avoid self-religation of the linearized vector after digestion, dephosphorylation of the vector 
was carried out by adding 1/10 volume of 10 × Antarctic Phosphatase Reaction Buffer to 1 µg 
of DNA digested with a restriction enzyme, then mixed with 1 µL of Antarctic Phosphatase (5 
units) and incubated for 1 h at 37 
o
C. Afterwards, the reaction was inactivated by heating at 65 
o
C for 15 min. Then the plasmid vector after dephosphorylation was desalted by going through 
gel extraction column or precipitation for proceeding with ligation. 
 
4.7.12 Ligation of DNA fragments 
DNA fragments for ligation were basically purified using Qiagen or Fermentas gel extraction 
kit and mixed with a ratio of insert: linearized vector = 3:1. The DNA concentration was 
quantified by loading 1 µL of each fragment on the gel as well as DNA marker of known 
concentration. Ligation reactions were performed in a 10 µL final volume at 16 °C overnight 
using ligation kit of Jena Bioscience.  
 
4.7.13 DNA sequencing 
DNA sequencing was performed by GATC Biotech. 
 
4.7.14 PCR methods 
4.7.14.1 General PCR methods 
All the PCRs were carried out in 50 µL reaction volume using Expand High Fidelity
PLUS
 PCR 
System (Roche) for cloning or PCR-targeting strategy and using normal Taq DNA polymerase 
(NEB) for analysis of all the constructs and mutants. The components and amplification 
conditions were summarized in tables: 
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Table 4.8: The components of PCR reaction. 
Components Volume Final conc. 
Primer 1 (100 pmoles/µL) 
Primer 2 (100 pmoles/µL) 
Template DNA  
 
5 x Reaction buffer (Roche) 
10 x Reaction buffer(NEB) 
dNTPs (10 mM) 
0.5 µL 
1 µL 
 
10 µL 
- 
1 µL 
 0.5 µL 
0.5 µL  
1 µL 
 
- 
5 µL 
1 µL 
20 pmoles 
20 pmoles 
5-500 ng (genomic DNA) 
100 pg-10 ng (plasmid DNA) 
1 × 
1 × 
50 µM (per each) 
DMSO  
DNA polymerase (Roche) 
DNA polymerase (NEB) 
Milli-Q H2O                          
2.5 µL 
0.5 µL 
- 
34 µL 
2.5 µL 
- 
0.25 µL 
39.25 µL 
5% 
2.5 Units 
2.5 Units 
 
4.7.14.2 Standard PCR amplification conditions 
The PCR amplification protocol in this study mostly was designed for analysis of constructs, 
mutants and specific gene DNA fragments as follows: 
 
Table 4.9: PCR reaction cycles. 
Steps  Temperature  Time  Cycles  
Initial denaturation 
Denaturation 
Annealing 
Elongation 
Final elongation 
94 or 95 °C  
94 or 95 °C  
55 °C – 68 °C 
68 or 72 °C  
68 or 72 °C  
2 min 
10 – 30 sec 
30 – 45 sec 
30 sec – 5 min 
7 or 10 min 
1 × 
 
(25 – 35) ×  
 
1 × 
 
The denaturation temperature was chosen according to the protocols of two different DNA Taq 
polymerases from Roche (94 °C) and NEB (95 °C). Optional annealing temperature between 
55-68 °C was used depending on the melting temperature of primers. For the elongation 
temperature, normal Taq DNA polymerase from NEB usually was set up to 72 °C and Expand 
High Fidelity
plus 
was set up to 68 °C for the target fragment which were longer than 3 kb or 
72 °C for the regular fragments between 100 bp-3 kb. The elongation time was changed based 
on the length of PCR products. 
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4.7.14.3 PCR amplification of the extended resistance cassette 
All the PCR amplifications were performed according to the instructions of the Expand high 
fidelity PCR system (Roche). The reaction condition was set up as above in Table 4.8. 
 
To amplify the extended apramycin resistance cassette, a PCR was carried out by taking the 
apramycin resistance gene cassette purified after digestion of pIJ773 (Gust et al., 2003) as a 
template and using the suitable long primers under the following cycle conditions in Table 
4.10. 
 
Table 4.10: PCR program for amplification of the extended resistance cassette. 
Steps  Temperature  Time  Cycles  
Initial denaturation 94 °C 2 min 1 × 
Denaturation 94 °C 45 sec  
Annealing 50 °C 45 sec 10 × 
Extension 72 °C 45 sec  
Denaturation 94 °C 45 sec  
Annealing  55 °C 45 sec 15 × 
Extension  72 °C 45 sec  
Final extension 72 °C 5 min  
 
4.7.15 DNA-DNA hybridization 
4.7.15.1 Southern blotting 
After agarose gel electrophoresis, the gel and membrane were processed for DNA transfer, the 
area of the gel without any DNA was removed and a small part from the lower right corner of 
the gel was cut off for further direction identification. The gel was incubated into depurination 
buffer for 15 min and rinsed gently in Milli-Q water, then the DNA was denatured by incubating 
the gel in denaturation solution for 30 min and the gel was rinsed in Milli-Q water again. For 
neutralization, the gel was incubated in neutralization solution for 30 min. Then blotting stack 
was assembled. Meanwhile, a piece of Immobilon-Ny
+ 
membrane to the size of the gel was 
prepared and wetted by carefully laying it on top of Milli-Q water in a shallow tray. The tray 
was gently agitated once the membrane was wet to completely immerse the membrane. Then, 
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the membrane was transferred into a second tray containing transfer buffer (20 × SSC). Three 
sheets of Whatman 3MM filter paper, the size of the membrane in 20 × SSC were wetted, then 
the blot stack (Figure 4.1) was set up by placing the gel on the bottom, the membrane in the 
middle and the three sheets of filter paper on the top. The bubbles between these three layers 
were rolled out with pipette. Then, the 10 cm high stack of paper towels was placed on top of 
the filter paper and a glass plate was placed on top of the stack. Finally, the 250 g weight was 
placed on top of the plate to let the DNA transfer from gel to the membrane for 16 h.  
 
 
Figure 4.1: Capillary blotting stack (Southern blotting) (Amersham Bioscience). 
 
After this time, the paper towels and filter paper were removed. The blot membrane was lifted 
carefully with a pair of forceps and rinsed in 6 × SSC to remove any free particles of agarose. 
The blot membrane was put on a piece of filter paper to dry for 15 min at 80 °C. Then DNA 
fixation was performed by UV cross-linking (254 nm, 5000 µJ/cm
2
) for 5 min or placing it 
between two sheets of clean filter paper in a vacuum oven at 80 °C for 1-2 h. 
 
4.7.15.2 Colony in situ hybridization 
The membrane was placed on the LB agar plate containing appropriate antibiotics. The 
bacterial single colony from the library was transferred to the membrane with a 96-well 
inoculator, The membrane with plate was incubated at 37 °C, overnight, then lifted off the 
plates and placed onto the filter paper soaked into lysis buffer for 3 min (DNA lysis), the 
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membrane was transferred onto the filter paper soaked into denaturation buffer for 5 min (DNA 
denaturation), transferred onto the filter paper soaked into neutralization buffer for 5 min, then 
placed on one sheet of clean filter paper to dry at room temperature for 30 min. The DNA 
fixation was performed by incubating the membrane at 80 °C in a vacuum oven for 2 h. 
Afterwards, the blot membrane was rinsed in a shallow tray with washing buffer to gently 
remove the cell debris. Then the membrane was placed between two pieces of clean filter paper 
to dry. 
 
4.7.16 PCR targeted gene replacement in S. griseoflavus W-384  
To identify the function of genes involved in hormaomycin biosynthesis, several mutants of 
hormaomycin producer were generated by using the following approach called REDIRECT
© 
Technology: PCR targeting system which is much more efficient than the traditional gene 
replacement strategy in Streptomyces spp..  
 
4.7.16 .1 PCR primer design 
Two long PCR primers (58 bp and 59 bp) were designed for each gene disruption. The 
procedure was described in chapter. All the long primers used in this study were displayed in 
Table 4.6. 
 
4.7.16 .2 Purification of the PCR template 
Around 10 µg plasmid DNA of pIJ773 (Figure 4.2) (Gust et al., 2003) was digested with 50 
units of EcoRI and 50 units of HindIII in 1 × Buffer B in a 100 µL reaction volume at 37 °C for 
5 h. About 1382 bp apramycin resistance gene cassette was extracted from gel and purified 
using Qiagen gel kit. The resulting DNA fragment was eluted in Milli-Q water (pH 8.0) at a 
concentration of 100 ng/µL. 
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Figure 4.2: The physical map of plasmid pIJ773 (Gust et al., 2003). aac(3)IV, apramycin resistance 
gene; amp, ampicillin resistance gene; oriT of plasmid RP4, transferring DNA; FRT, FLP recognition 
targets. 
 
4.7.16.3 PCR amplification of the extended resistance cassette 
All the conditions were described in Table 4.8. The specific PCR fragment with the length of 
1.46 kb was amplified, purified from gel and finally eluted in in Milli-Q water (pH 8.0) at a 
concentration of 200 ng/µL. 
 
4.7.16.4 Introduction of cosmids into E. coli BW25113/pIJ790 by 
electroporation 
E. coli BW25113 carrying a plasmid pIJ790 (Figure 4.3) (Gust et al., 2003) containing 
chloramphenicol resistance gene cat and a temperature sensitive origin of replication requiring 
30 °C for replication was grown overnight at 30 °C in LB medium with 25 µg/mL 
chloramphenicol. 100 µL overnight culture of E. coli BW25113/pIJ790 was inoculated into 10 
mL SOB containing 20 mM MgSO4 and 25 µg/mL chloramphenicol to prepare the 
electro-competent cells. 2 µL of cosmid DNA was mixed with 50 µL competent cells 
suspension. Then electroporation was performed according to the procedure described above. 
After incubation at 30 °C for 1 h.The cells were spread on LB plates containing 50 µg/mL 
kanamycin, 25 µg/mL chloramphenicol and 100 µg/mL ampicillin. 
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4.7.16.5 PCR targeting of cosmids 
One transformant of E. coli BW25113/pIJ790 containing a Streptomyces cosmid was 
inoculated in 5 mL of LB medium and grown overnight at 30 °C. 100 µL of overnight culture 
was inoculated in 10 mL SOB-MgSO4 medium containing 100 µg/mL ampicillin, 50 µg/mL 
kanamycin and 25 µg/mL chloramphenicol with 10 mM L-arabinose inducing the red gene and 
shaken at 30 °C, 220 rpm to OD600 of ~0.4, and followed by preparation of electro-competent 
cells. Then, the PCR product of extended the resistance cassette was transformed into E. coli 
BW25113/pIJ790 containing a Streptomyces cosmid by electroporation. The cell culture was 
spread on LB plate containing 100 µg/mL ampicillin, 50 µg/mL kanamycin and 50 µg/mL 
apramycin and incubated overnight at 37 °C. (The higher temperature could promote the loss of 
pIJ790). 
 
 
Figure 4.3: The physical map of plasmid pIJ790 for λ-RED recombination (Gust et al., 2003). (araC, 
encodes arabinose activator; bet, encodes single strand DNA binding protein; cat, chloramphenicol 
resistance gene; exo, exonuclease gene, promotes recombination together with bet; gam, gene product 
inhibits the host exonuclease V; oriR101, origin of replication; ParaBAD, L-arabinose inducible 
promoter; repA101ts, temperature-sensitive replicon. 
 
Homologous recombination occurred and many colonies were observed in the next day. The 
bigger colonies from resulting transformants were inoculated into 5 mL of LB containing 100 
µg/mL ampicillin, 50 µg/mL kanamycin and 50 µg/mL apramycin, respectively and shaken 
overnight at 37 °C, 200 rpm. All potential mutant cosmids were isolated and analyzed by PCR. 
PCR analysis with a primer pair (test primers) annealing just ~100 bp outside the region 
affected by homologous recombination will generate the expected fragment after gene 
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disruption. The target mutant cosmid was isolated and transformed into E. coli 
ET12567/pUZ8002 by electroporation to get the unmethylated DNA for transformation into 
Streptomyces spp..  
 
4.7.16.6 Transformation of mutant cosmids to S. griseoflavus W-384 
A mutant cosmid was introduced into S. griseoflavus W-384 by protoplast transformation 
described above. After incubation 16-18 h, the R5 plate was overlayed with 1.5 mL sterilized 
water containing 25 µL apramycin (50 mg/mL). And the plate was kept incubation at 30 °C for 
5-7 d. Homologous recombination occurred and the transformants with apramycin resistance 
grew on the plate. The transformants from R5 plates were replica-plated on a GYM plate 
containing 25 µg/mL apramycin with or without 25 µg/mL kanamycin. Double cross-over 
exconjugants should be kanamycin sensitive and apramycin resistant. Each potential double 
cross-over exconjugants or transformants was inoculated into 10 mL MS media containing 25 
µg/mL apramycin and shaken at 30 °C, 220 rpm for 2 d. The genomic DNA of each 
transformant was isolated and the expected gene replacement in the genome was confirmed by 
PCR with different pairs of test primers (Table 4.6). 
 
4.7.17 DIG-DNA probe labeling  
(DIG-DNA labeling was carried out according to the procedure of Roche DIG High Prime 
DNA Labeling and Detection Starter Kit I) 
 
Around 1 μg template DNA (linear or supercoiled) was added into autoclaved double distilled 
water to a final volume of 16 μL to a reaction vial. The DNA was denatured by heating in a 
boiling water bath for 10 min and quickly chilling in an ice/water bath. Around 4 µL DIG-High 
Prime (vial 1) was mixed thoroughly and added into the denatured DNA, the mixture was spun 
down briefly and incubated for 16-20 h at 37 °C. The reaction was stopped by adding 2 µL 0.2 
M EDTA (pH 8.0) or by heating to 65 °C for 10 min. 
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4.7.17.1 Southern hybridization 
The appropriate volume of DIG Easy Hyb buffer (10 mL/100 cm
2
 filter paper) was pre-heated 
to hybridization temperature 42 °C. The blot membrane was placed into the hybridization bag 
with preheated hybridization solution and incubated at 42 °C for 30 min with gentle agitation. 
The DIG-labeled DNA probe (about 25 ng/mL DIG Easy Hyb buffer) was denatured by boiling 
for 5 min and rapidly cooling in ice/water. The denatured DIG-labeled DNA probe was added to 
the pre-heated DIG Easy Hyb buffer (3.5 mL/100 cm
2
 membrane) and mixed well gently to 
avoid foaming. The mixture with hybridization solution and the denatured probe was added to 
the membrane in the hybridization bag and incubated for 4-20 h at 42 °C with gentle agitation. 
 
4.7.17.2 Stringency washes 
The membrane was washed in 2 × SSC, 0.1% SDS for 5 min twice at 15-25 °C under constant 
agitation. Then, it was rinsed in 0.5 × SSC, 0.1% SDS (pre-warmed to wash temperature) for 15 
min twice at 68 °C under constant agitation. Meanwhile, the 1 × working solution was prepared 
by diluting 10 × Blocking solution (vial 6) 1:10 with Maleic acid buffer. Anti-Digoxigenin-AP 
(vial 4) was spun down for 5 min at 10000 rpm in the original vial prior to each use, and 5 µL of 
it was carefully taken from the surface and diluted into 25 mL 1 × Blocking buffer. (can be 
stored at 4 °C for 12 h). 200 µL of NBT/BCIP stock solution (vial 5) was added to 10 mL of 
Detection buffer for color development. 
 
4.7.17.3 Washing membrane and detection of signals 
After hybridization and stringency washes, the membrane was rinsed briefly for 5 min in 
washing buffer and incubated for 30 min in 100 mL blocking solution. Then the membrane was 
placed in 20 mL Antibody solution and incubated for 30 min. The membrane was washed in 
100 mL washing buffer for 15 min twice and transferred in 20 mL Detection buffer to 
equilibration for 2-5 min. Finally, the membrane was incubated in 10 mL freshly prepared color 
substrate solution in an appropriate container in the dark without shaking during color 
development. The reaction was stopped, when desired spot or band intensities are achieved, by 
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washing the membrane for 5 min with 50 mL of sterile double distilled water or with TE-buffer. 
 
4.7.18 Protein expression and purification 
4.7.18.1 Protein expression in E. coli 
The target gene was cloned into expression vector pET28b (+) (Figure 4.4) an N-terminal 
His-Tag in addition to an optional C-terminal His-Tag sequence or pET29b carrying an 
N-terminal S-Tag plus an optional C-terminal His-Tag sequence under the control of T7 
promoter, then transformed into E. coli BL21(DE). A single colony of the resulting 
transformants was inoculated into 5 mL of TB or LB media supplemented with 100 µg/mL of 
kanamycin and grown at 37 °C, 250 rpm overnight. 1mL of overnight culture was transferred 
into 100 mL of fresh TB or LB media containing 100 µg/mL of kanamycin and grown at 37 °C 
for 3-5 h until OD600 up to 1.5-2.0, then the flask with bacteria was immediately placed on ice 
for cooling down. 100 µL of 1 M IPTG (stock solution) was added into the bacteria culture to a 
final concentration of 1 mM IPTG for induction, and cultivated at 16 °C, 250 rpm, overnight. 
 
 
Figure 4.4: Plasmid map of pET-28b (+) (Novagen). The pET-28b(+) vector carries an N-terminal 
His-Tag/thrombin/T7-Tag configuration in addition to an optional C-terminal His-Tag sequence. Unique 
sites are shown on the circle map. The T7 expression region is reversed on the circular map due to the 
sequence numbering from the pBR322 convention. The f1 origin is oriented so that infection with helper 
phage will produce virions containing single-stranded DNA that corresponds to the coding strand. 
Therefore, the T7 terminator primer should be used when performing single stranded sequencing. 
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4.7.18.2 Protein purification 
A 50 mL Falcon tube was pre-weighed, then the cell pellets of E. coli BL21(DE) containing the 
expression plasmid of the target gene were harvested by centrifugation at 7000 rpm for 5 min, 
the supernatant was decanted completely. The Falcon tube with cell pellets was weighed again 
to calculate the net weight of the cell pellets. 4 mL lysis buffer per gram cell pellets was added 
into the tube, the cell pellets were resuspended gently with tips at 4 °C. Sonication was 
processed on the cell suspension 5 times, 10 sec, 70-90W in an ice/water bath. Afterwards, the 
lysis supernatant was collected by centrifugation of the cell lysis aliquot at 11000 rpm for 30 
min. The lysis supernatant was transferred into a new Falcon tube, mixed with 400 µL Ni-Resin 
agarose and incubated on ice with gently constant shaking for 1 h. The mixture above was 
centrifugated at 850 rcf for 10 min at 4 °C. The supernatant was decanted immediately to get the 
pellets. The pellets with Resin and protein were added into the column, then rinsed with 2 mL of 
20 mM washing buffer twice. Then, the column was rinsed by 2 mL of 40 mM washing buffer 
again. Finally, the protein was eluted off the column by 250 mM elution buffer. 
 
4.7.18.3 TCA protein precipitation 
To prepare 100% (w/v) TCA, 25 g TCA was dissolved into 17.5 mL dH2O, store at RT. 1 
volume of TCA stock was mixed with 4 volumes of protein sample by vortexing and spinning 
down at 14000 rpm at 4 °C for 15 min, the supernatant was removed from white pellet 
completely. The white pellet was resuspended with 1 × SDS loading dye and heated up at 95 °C 
for 10 min before loading sample onto SDS gel.  
 
4.7.18.4 Protein color development 
To test the protein concentration before loading sample on SDS gel, 40 µL of protein sample 
was mixed with 160 µL Roti-Nanoquant, the color would be changed into blue from brown. 
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4.7.18.5 Desalting and buffer exchange 
Desalting refers to the removal of salts from a sample, while buffer exchange refers to the 
replacement of one set of buffer salts with another set. Both goals are easily accomplished by 
size exclusion chromatography. Desalting is accomplished by first equilibrating the 
chromatography column with water. Buffer exchange, however, is performed by first 
equilibrating with the column resin with a buffer the sample should end up in. In both cases, the 
buffer constituents carrying the sample into the column will be replaced by the solution with 
which the column is pre-equilibrated. 
 
Eluted protein fractions (3.0 mL of 250 mM imidazole) were desalted into 50 mM Tris (pH 7.0, 
7.5, 8.0, 8.5) with 10% (v/v) glycerol, 50 mM MES (pH 6.0, 6.5) with 10% (v/v) glycerol, 50 
mM potassium phosphate buffer (pH 6.5, 7.0, 7.5, 8.0) with 10% (v/v) glycerol using PD-10 
disposable desalting columns as described by the manufacturer. 
 
4.7.18.6 Protein stability assay 
Reactions (200 µL) containing ~100µg of protein in 50 mM buffer were incubated overnight at 
37 °C. Buffers MES (pH 6.0, 6.5), potassium phosphate (pH 6.5, 7.0, 7.5, 8.0), and Tris (pH 7.0, 
7.5, 8.0, 8.5) were used in this experiment. The supernatants from reactions were harvested by 
spinning down at 14000 rpm for 30 min, and then precipitated by TCA. The supernatants were 
discarded and the pellets were resuspended in 20 µL of 1 × SDS loading dye in ~1.0 M Tris, pH 
8.5, to neutralize the acid. The resulting aliquots were analyzed by SDS-PAGE. The most stable 
protein in corresponding buffer showed the highest density on the SDS-PAGE gel. 
 
4.7.18.7 SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
SDS-PAGE was widely used to separate proteins based on their size. The proteins were 
denatured by a powerful detergent SDS and loaded to a discontinuous polyacrylamide gel 
composed of a resolving gel on the bottom with higher acrylamide concentration to let the 
proteins go through the gel slowly for separating the proteins and a stacking gel with very low 
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acrylamide concentration and used to form the wells into which the protein is loaded. 
Ammonium persulfate and TEMED were added to final concentrations of 1% and 0.1%, 
respectively, to initiate polymerization. In this study, the resolving gel and stacking gel were 
prepared as following recipes (Table 4.11): 
 
Table 4.11: The components of SDS-polyacrylamide gel. 
Composition 12% Resolving gel (15 mL) 4% Stacking gel (5 mL) 
dd H2O 6.75 mL 3.25 mL 
Resolving gel buffer  
(1M Tris-HCl, pH 8.8, 10% SDS) 
3.75 mL - 
Stacking gel buffer 
(1M Tris-HCl, pH 6.8, 10% SDS) 
- 1.25 mL 
40% acrylamide  4.5 mL 500 µL 
10% APS 150 µL  50 µL 
TEMED  15 µL   5 µL 
 
The purified protein sample was mixed with the equivalent volume of 1 × SDS loading dye and 
denatured by heating at 95 °C for 10 min. The denatured protein sample was centrifuged at 
14000 rpm for 1 min, and 10 µL of the supernatants was loaded into stacking gel well. Then 
electrophoresis was performed at 110 V for 1 h until the loading dye line almost arrived at the 
bottom of gel. Afterwards, the protein gel was carefully lifted up, gently transferred into a 
shallow tray with staining buffer and incubated for 30 min with constant shaking. Then, the gel 
was rinsed with water several times and incubated in 10% acetic acid to destain by heating up in 
microwave oven for 90 sec, then rinsed several times and showed the protein band. To get 
clearer protein gel, the gel was incubated in 10% acetic acid with constant shaking overnight at 
room temperature. 
 
4.7.19 Fermentation of S. griseoflavus W-384 strains 
50 µL of Streptomyces spores suspension was inoculated into 20 mL MMS (for seed culture) in 
50 mL Falcon tube and grown at 27 °C, 250 rpm for 2 d. 5 mL of seed culture was transferred 
into 45 mL fresh MMS media (for production culture) in 250 mL baffled flask and kept growing 
at 27 °C, 250 rpm for 3 d. For the preparative isolation of compounds, the cells were cultured as 
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described above by using 10 × 250 mL flasks in parallel for cultivation 3 times with 1.5 L of 
cultures in total.  
 
4.7.20 Chemical complementation of mutants 
The mutant strains derived from S. griseoflavus W-384 were individually fed with different 
amino acids. After two-day seed culture cultivation, production cultures were inoculated and 
immediately fed the above individual amino acids. During three days of growth in production 
medium, the amino acids were added every 12 hours for a total of five times with a final 
concentration of 0.3 mg/mL. Extraction and analysis of hormaomycin and its derivatives 
followed as described below. 
 
4.7.21 HPLC and LC-MS analysis of secondary metabolites from S. 
griseoflavus W-384 strains 
After fermentation, the culture was sedimented by spinning down at 14000 rpm for 10 min. The 
supernatant was transferred into a new falcon tube and extracted three times with EtOAc. After 
evaporation, the residue was resuspended in appropriate amount of methanol for further HPLC 
and LC-MS analysis and bioassay. 
 
The secondary metabolites from S. griseoflavus W-384 was analyzed by Jasco HPLC system 
with a reverse-phase column (KNAUER Eurospher II 100-5 RP C-18, 5um, 4.0 mm x 250mm) 
and LC-MS (Bruker Daltonics) at a flow rate 1.0 mL/min, for 50 min using acetonitrile (75%) 
and water supplemented with 0.1% TFA (v/v) (25%). The detection wavelength was 273nm. 
The retention times of HRM and HRM derivatives (HRM A1-A8) are: 7.2 min (HRM A7), 8.9 
min (HRM A8), 10.2 min (HRM A1, HRM A2), 13.4 min (HRM), 20.3 min (HRM A3, HRM A4), 
23.4 min (HRM A5) and 38.5 min (HRM A6). For the trans-AT PKS gene cluster mutants, the 
reversed-phase HPLC analysis was performed under the following conditions: column 
temperature, 40  °C; gradient elution, solvent A (CH3CN) and solvent B (0·5 % TFA in H2O), 
gradient profile (0-5 min, 5 % A; 5-35 min, 100 % A; 35-40 min, 100 % A; 40-45 min, 5 % A; 
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flow rate, 1.0 mL/min; 250-280 nm. 
 
4.7.22 MS and NMR analysis of HRM analogues 
High-resolution ESI-MS spectra were performed on a Thermo LTQ Orbitrap XL mass 
spectrometer, running Xcalibur 2.1.0 software. The spectra were recorded by infusion into the 
ESI source using methanol as the solvent. The instrument was first autotuned on the m/z value 
of the ion to be fragmented. Then, the [M+H]
+
 ion of each compound was isolated in the linear 
ion trap and fragmented by CID. Sets of consecutive, high-resolution, full MS/MS scans were 
acquired in centroid or profile mode and analyzed using the QualBrowser software (Thermo). 
NMR spectra were acquired on Varian Unity Inova spectrometers at 700 MHz; chemical shifts 
were referenced to the residual solvent signal (CD3OD: H 3.31). For an accurate measurement 
of the coupling constants, the one-dimensional 
1
H NMR spectra were transformed at 64 K 
points (digital resolution: 0.09 Hz). 
 
4.7.23 Antibacterial and hormonal assays 
The detection of HRM and its derivatives was prepared by applying 20 µL of culture 
supernatant to paper discs on LB plated covered with A. crystallopoietes as the test strain. The 
inhibition zones on plates were observed after incubation at 30 ºC overnight. To determine the 
MICs of hormaomyin and its analogues, five different dilutions of these compounds were 
added to A. crystallopoietes cells in a final 5 mL of LB medium and cultivated at 37 ºC, 250 rpm, 
overnight. The lowest concentration with no visible bacterial growth was designated as MIC.  
 
10 µL (1 × 10
8
 spores/µL) spores suspension of S. coelicolor, S. griseus and 100 µL mycelia 
pellets stock of their corresponding bld mutants were spread on Gauze I media plates, 
hormaomycin or goadsporin in methanol were absorbed in paper discs, and the discs dried, 
placed on the plates and incubated at 30 °C. Pigment production and cell differentiation around 
the paper disc were observed every 24 hours.  
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4.7.24 Methanolysis of HRM and HRM A7 
Less than 0.1 mg of HRM or HRM A7, dissolved in 100 µL of methanol, was dried and 
redissolved in 15 µL MeOH before addition of 10 µL of sodium methoxide and incubation at 
room temperature overnight. The mixture was then partitioned between H2O (750 µL) and 
EtOAc (750 µL × 3), the ethyl acetate fractions were dried, and the resulting peptide fragments 
were analyzed by ESI-MS/MS (Nakao et al., 2004). 
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Abbreviations 
(3-Ncp)Ala 3-(trans-2’-nitrocyclopropyl)alanine 
(4-Et)Pro 4-ethinylproline 
(4-Me)Pro 4-methylproline 
(4-Pe)Pro 4-(Z)-propenylproline 
6-dEB 6-deoxyerythronolide B 
(β-Me)Phe (2S,3R)-3-methylphenylalanine 
aac(3)IV, apr
R
 apramycin resistance gene 
ACT actinorhodin 
ACP acyl carrier protein 
A domain adenylation domain 
A factor 2-isocapryloyl-3R-hydroxymethyl-γ-butyrolactones 
AHBA 3-amino-5-hydroxybenzoic acid 
amp  ampicillin resistance gene 
AMP adenosine monophosphate 
APS ammonium persulfate 
ARO aromatase domain 
Arp A-factor-specific receptor 
AT domain acyl transferase domain 
ATP adenosine triphosphate 
attB phage    attachment site on bacterial chromosome 
attP attachment site on phage 
bla β-lactamase gene 
BLAST basic local alignment search tool 
bp base pair 
C cytosine 
calcd. calculated 
cat gene encoding chloramphenicol acetyltransferase 
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C domain condensation domain 
CDA calcium-dependent antibiotics 
Chpca 5-chloro-1-hydroxypyrrole-2-carboxylic acid 
CHSs naringenin-chalcone synthases 
CID collision-induced dissociation 
cis- AT PKs cis-AT polyketides 
CLF chain length factor domain 
CoA coenzyme A 
Conc. concentration 
cos cohesive site 
COSY correlation spectroscopy 
Crp cyclic AMP receptor protein 
CYC cyclase/cyclization domain 
d day/days 
dATP deoxyadenosine triphosphate 
DEBS 6-deoxyerythronolide B synthase 
DH dehydratase domain 
DMSO dimethyl sulfoxide 
ECF extracytoplasmic function 
E domain epimerase/epimerization domain 
EDTA ethylenediamine tetracetic acid 
e.g. exempli gratia (Latin) means “for example” 
EIC extracted ion chromatogram 
ER enoyl reductase domain 
ESI-MS electrospray ionization mass spectrometry 
EtOAc ethylacetate 
FAD flavin adenine dinucleotide 
F domain Formylation domain 
G guanine 
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GlcNAc N-acetylglucosamine 
GS goadsporin 
h hour/hours 
HBM 4-hydroxy-2-2’-bipyrrole-5-methanol 
HMBC heteronuclear multiple-bond correlation spectroscopy 
HPLC high performance liquid chromatography 
HRM  hormaomycin 
HSQC heteronuclear single-quantum correlation spectroscopy 
i.e. id est (Latin) means “that is” 
int gene encoding integrase of phage 
IPTG isopropyl β- D-1-thiogalactopyranoside 
kb kilobase 
KR ketoreductase domain 
KS ketosynthase domain 
LAL large ATP-binding regulators of the LuxR 
LB Luria-Bertani medium 
LC-MS liquid chromatography-mass spectrometry  
L-DOPA L-3,4-dihydroxyphenylalanine 
MCS multiple cloning site 
MES 2-(N-morpholino)ethanesulfonic acid 
MIC minimum inhibition concentration 
min minute/minutes 
MS mass spectroscopy 
MT domain methyltransferase domain 
m/z mass- to- charge ratios 
NaAC sodium acetate 
NADH nicotinamide adenine dinucleotide 
NBT nitro-blue tetrazolium 
NMT domain N-methylation domain 
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NMR nuclear magnetic resonance 
NOESY nuclear overhauser effect spectroscopy 
NRPs nonribosomal peptides 
NRPS nonribosomal peptide synthetases 
nt nucleotide 
OD optical density 
ORF open reading frame 
ori origin of replication 
oriT origin of transfer 
Ox domain oxidation domain 
PCP peptidyl carrier peptide 
PCR polymerase chain reaction 
PDB Precursor-directed biosynthesis 
PEG polyethylene glycol 
PKs polyketides 
PKS polyketide synthase 
PKSs polyketide synthases 
PKs-NRPs hybrids of polyketides and nonribosomal peptides 
PLP pyridoxal phosphate 
(p)ppGpp guanosine pentaphosphate 
PPTase phosphopantethienyl transferase 
r resistance 
RBS ribosomal binding site 
rcf relative centrifugal force 
RED undecylprodigiosin 
Red domain Reduction domain 
RNA ribonucleic acid 
ROESY rotating frame nuclear overhauser effect spectroscopy 
rpm revolutions per minute 
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RT room temperature 
RT-PCR reverse transcription polymerase chain reaction 
S. Streptomyces 
s sensitive 
SAM s-adenosylmethionine 
SAR structure activity relationship 
SARP Streptomyces antibiotic regulatory protein 
SDS sodium dodecyl sulphate 
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis 
sec second/seconds 
SSC solution of sodium citrate 
STSs stilbene synthases 
TAE buffer tris-acetic acid EDTA buffer 
TCA trichloroacetic acid 
T domain thiolation domain 
TE domain termination domain 
TE buffer Tris-EDTA buffer 
TEMED tetramethylethylenediamine 
TOCSY total correlation spectroscopy 
trans-AT PKs trans-AT polyketides 
tsr/Thio
R
 thiostrepton resistance gene 
Tra  transfer protein  
UV ultra-violet 
whi gene involved in Streptomyces differentiation 
X-gal 5-bromo-4-chloro-3-indolyl beta-D-galactopyranoside 
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